101
|
Pilling LC, Atkins JL, Bowman K, Jones SE, Tyrrell J, Beaumont RN, Ruth KS, Tuke MA, Yaghootkar H, Wood AR, Freathy RM, Murray A, Weedon MN, Xue L, Lunetta K, Murabito JM, Harries LW, Robine JM, Brayne C, Kuchel GA, Ferrucci L, Frayling TM, Melzer D. Human longevity is influenced by many genetic variants: evidence from 75,000 UK Biobank participants. Aging (Albany NY) 2016; 8:547-60. [PMID: 27015805 PMCID: PMC4833145 DOI: 10.18632/aging.100930] [Citation(s) in RCA: 87] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2016] [Accepted: 03/10/2016] [Indexed: 11/25/2022]
Abstract
Variation in human lifespan is 20 to 30% heritable in twins but few genetic variants have been identified. We undertook a Genome Wide Association Study (GWAS) using age at death of parents of middle-aged UK Biobank participants of European decent (n=75,244 with father's and/or mother's data, excluding early deaths). Genetic risk scores for 19 phenotypes (n=777 proven variants) were also tested. In GWAS, a nicotine receptor locus(CHRNA3, previously associated with increased smoking and lung cancer) was associated with fathers' survival. Less common variants requiring further confirmation were also identified. Offspring of longer lived parents had more protective alleles for coronary artery disease, systolic blood pressure, body mass index, cholesterol and triglyceride levels, type-1 diabetes, inflammatory bowel disease and Alzheimer's disease. In candidate analyses, variants in the TOMM40/APOE locus were associated with longevity, but FOXO variants were not. Associations between extreme longevity (mother >=98 years, fathers >=95 years, n=1,339) and disease alleles were similar, with an additional association with HDL cholesterol (p=5.7x10-3). These results support a multiple protective factors model influencing lifespan and longevity (top 1% survival) in humans, with prominent roles for cardiovascular-related pathways. Several of these genetically influenced risks, including blood pressure and tobacco exposure, are potentially modifiable.
Collapse
Affiliation(s)
- Luke C. Pilling
- Epidemiology and Public Health Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Janice L. Atkins
- Epidemiology and Public Health Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Kirsty Bowman
- Epidemiology and Public Health Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Samuel E. Jones
- Genetics of Complex Traits Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Jessica Tyrrell
- Genetics of Complex Traits Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Robin N. Beaumont
- Genetics of Complex Traits Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Katherine S. Ruth
- Genetics of Complex Traits Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Marcus A. Tuke
- Genetics of Complex Traits Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Hanieh Yaghootkar
- Genetics of Complex Traits Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Andrew R. Wood
- Genetics of Complex Traits Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Rachel M. Freathy
- Genetics of Complex Traits Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Anna Murray
- Genetics of Complex Traits Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Michael N. Weedon
- Genetics of Complex Traits Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Luting Xue
- School of Public Health, Department of Biostatistics, Boston University, Boston, MA 02215, USA
| | - Kathryn Lunetta
- School of Public Health, Department of Biostatistics, Boston University, Boston, MA 02215, USA
- The Framingham Heart Study, Framingham, MA 01702, USA
| | - Joanne M. Murabito
- The Framingham Heart Study, Framingham, MA 01702, USA
- Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA
| | - Lorna W. Harries
- Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - Jean-Marie Robine
- Institut National de la Santé et de la Recherche Médicale (INSERM U1198), 34394 Montpellier, France
- Ecole Pratique des Hautes études (EPHE), 75014 Paris, France
| | - Carol Brayne
- Cambridge Institute of Public Health, School of Clinical Medicine, University of Cambridge, Cambridge, CB2 0SR, UK
| | - George A. Kuchel
- Center on Aging, University of Connecticut, Farmington, CT 06030, USA
| | | | - Timothy M. Frayling
- Genetics of Complex Traits Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
| | - David Melzer
- Epidemiology and Public Health Group, University of Exeter Medical School, RILD Level 3, Royal Devon and Exeter Hospital, Exeter, EX2 5DW, UK
- Center on Aging, University of Connecticut, Farmington, CT 06030, USA
| |
Collapse
|
102
|
Therkelsen KE, Pedley A, Rosenquist KJ, Hoffmann U, Massaro JM, Murabito JM, Fox CS. Adipose tissue attenuation as a marker of adipose tissue quality: Associations with six-year changes in body weight. Obesity (Silver Spring) 2016; 24:499-505. [PMID: 26694629 PMCID: PMC4770559 DOI: 10.1002/oby.21337] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/27/2015] [Accepted: 08/21/2015] [Indexed: 11/11/2022]
Abstract
OBJECTIVE Weight gain is associated with fat volume increases, but associations with fat quality are less well characterized The associations of weight change with visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) volume and attenuation were investigated. METHODS Computed tomography abdominal scans were acquired on a Framingham Heart Study subset (N = 836; 40.2% women; mean age 45.7 years), a mean of 6.1 years apart. Fat attenuation estimated fat quality. RESULTS Mean weight change was +2.0 (SD 6.8; IQR -0.7, 5.0) kg in women and +2.7 (SD 6.0; IQR -0.5, 5.4) kg in men. Per 2.5 kg weight increase in women, VAT volume increased 126 cm(3) (95% CI, 112-140, p < 0.0001), SAT volume increased 258 cm(3) (95% CI, 239-278, p < 0.0001), and fat attenuation decreased (i.e., fat quality worsened) in VAT and SAT (p < 0.0001). Increasing VAT volume was associated with decreasing fat attenuation even after accounting for weight change. Relative to weight-stable women (n = 129), women who lost >2.5 kg (n = 58) had smaller SAT attenuation decreases (p < 0.0001). Similar patterns were seen in men. CONCLUSIONS Weight gain was associated with decreases in fat attenuation independent of VAT and SAT volume changes. These findings highlighted the associations of weight gain and worsening fat attenuation, suggesting fat attenuation may be dynamic.
Collapse
Affiliation(s)
- Kate E. Therkelsen
- National Heart, Lung, and Blood Institute, Division of Intramural Research and the Center for Population Studies, Framingham, MA
- Boston University School of Medicine, Boston, MA
| | - Alison Pedley
- National Heart, Lung, and Blood Institute, Division of Intramural Research and the Center for Population Studies, Framingham, MA
| | | | - Udo Hoffmann
- Department of Medicine and Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA
| | - Joseph M. Massaro
- Department of Biostatistics, Boston University School of Public Health, Boston, MA
| | - Joanne M. Murabito
- Section of General Internal Medicine, Boston University School of Medicine, Boston, MA
| | - Caroline S. Fox
- National Heart, Lung, and Blood Institute, Division of Intramural Research and the Center for Population Studies, Framingham, MA
- Division of Endocrinology and Metabolism, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
| |
Collapse
|
103
|
Liu CK, Lyass A, Larson MG, Massaro JM, Wang N, D'Agostino RB, Benjamin EJ, Murabito JM. Biomarkers of oxidative stress are associated with frailty: the Framingham Offspring Study. Age (Dordr) 2016; 38:1. [PMID: 26695510 PMCID: PMC5005887 DOI: 10.1007/s11357-015-9864-z] [Citation(s) in RCA: 103] [Impact Index Per Article: 12.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/02/2015] [Accepted: 12/11/2015] [Indexed: 05/22/2023]
Abstract
Cardiovascular disease and frailty frequently occur together. Both are associated with inflammation, which may be partially triggered by oxidative stress, especially in cardiovascular disease. We investigated whether inflammatory and oxidative stress biomarkers linked to cardiovascular disease were associated with frailty and the related outcome of gait speed. We report cross-sectional associations of biomarkers and frailty assessed at Framingham Offspring Study cycle eight. Participants ≥60 years were eligible if they had information on frailty and at least one of the following: C-reactive protein, interleukin-6, tumor necrosis factor receptor 2, 8-epi-FGFα isoprostanes (isoprostanes), lipoprotein phospholipase A2 (LpPLA2) mass or activity, osteoprotegerin, intracellular adhesion molecule-1, monocyte chemoattractant protein-1 or P-selectin. Stepwise logistic models were utilized for frailty and stepwise linear models for gait speed. Covariates included age, sex, body mass index, smoking, and co-morbidities. Odds ratios (ORs) and slope estimates (B) are reported per standard deviation increase of loge-transformed biomarker. Of the 1919 participants, 142 (7 %) were frail. In a stepwise model, frailty odds increased with higher interleukin-6 (OR 1.90, 95 % CI 1.51, 2.38), isoprostanes (OR 1.46, 95 % CI 1.12, 1.92), and LpPLA2 mass (OR 1.29, 95 % CI 1.00, 1.65). Stepwise regression found that slower gait speeds were associated with interleukin-6 (B = -0.025 m/s, 95 % CI 0.04, -0.01), isoprostanes (B = -0.019, 95 % CI -0.03, -0.008), LpPLA2 mass (B = -0.016, 95 % CI -0.03, -0.004), and osteoprotegerin (B = -0.015, 95 % CI -0.03, -0.002, all p < 0.05). Interleukin-6, isoprostanes, and LpPLA2 mass were associated with greater frailty odds and slower gait speeds. Oxidative stress may be a mechanism contributing to frailty.
Collapse
Affiliation(s)
- Christine K Liu
- Section of Geriatrics, Department of Medicine, Boston University School of Medicine, 88 E Newton Street, Robinson 2, Boston, MA, 02118, USA.
- Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA, USA.
| | - Asya Lyass
- National Heart, Lung and Blood Institute's Framingham Heart Study, 73 Mount Wayte Ave, Suite 2, Framingham, MA, 01702, USA
- Department of Mathematics and Statistics, Boston University, Boston, MA, USA
| | - Martin G Larson
- National Heart, Lung and Blood Institute's Framingham Heart Study, 73 Mount Wayte Ave, Suite 2, Framingham, MA, 01702, USA
- Department of Mathematics and Statistics, Boston University, Boston, MA, USA
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
| | - Joseph M Massaro
- National Heart, Lung and Blood Institute's Framingham Heart Study, 73 Mount Wayte Ave, Suite 2, Framingham, MA, 01702, USA
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
| | - Na Wang
- Department of Mathematics and Statistics, Boston University, Boston, MA, USA
| | - Ralph B D'Agostino
- National Heart, Lung and Blood Institute's Framingham Heart Study, 73 Mount Wayte Ave, Suite 2, Framingham, MA, 01702, USA
- Department of Mathematics and Statistics, Boston University, Boston, MA, USA
| | - Emelia J Benjamin
- National Heart, Lung and Blood Institute's Framingham Heart Study, 73 Mount Wayte Ave, Suite 2, Framingham, MA, 01702, USA
- Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA
- Sections of Cardiovascular and Preventive Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA
| | - Joanne M Murabito
- National Heart, Lung and Blood Institute's Framingham Heart Study, 73 Mount Wayte Ave, Suite 2, Framingham, MA, 01702, USA.
- Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
| |
Collapse
|
104
|
Ma J, Hwang SJ, McMahon GM, Curhan GC, Mclean RR, Murabito JM, Fox CS. Mid-adulthood cardiometabolic risk factor profiles of sarcopenic obesity. Obesity (Silver Spring) 2016; 24:526-34. [PMID: 26813531 DOI: 10.1002/oby.21356] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/04/2015] [Revised: 09/08/2015] [Accepted: 09/14/2015] [Indexed: 12/24/2022]
Abstract
OBJECTIVE Midlife and contemporaneous cardiometabolic risk factors associated with sarcopenic obesity were examined. METHODS Utilizing BMI and sex-specific 24-h urinary creatinine excretion, 1,019 participants from the Framingham cohorts were categorized as non-sarcopenia non-obese (NSNO), non-obese sarcopenia, non-sarcopenic obesity, and sarcopenic obesity. Cardiometabolic risk factors were quantified by standard laboratory assessment cross-sectionally and 10, 20, and 30 years before sarcopenic obesity assessment. RESULTS NSNO, sarcopenia, obesity, and sarcopenic obesity accounted for 30.0%, 39.6%, 20.0%, and 10.4% of study participants, respectively. Cross-sectionally, participants with sarcopenic obesity had a higher proportion of hypertension, metabolic syndrome, and type 2 diabetes than those with NSNO or sarcopenia (all P < 0.03). Similar patterns were observed retrospectively at 10, 20, and 30 years. Compared with NSNO or sarcopenia, sarcopenic obesity was associated with a higher prevalence of type 2 diabetes at 10 years and hypertension and metabolic syndrome at all three time points before baseline (all P < 0.03). Individuals with sarcopenic obesity had more type 2 diabetes than those with obesity alone at baseline and 10 years prior (all P < 0.001). CONCLUSIONS Older adults with sarcopenic obesity had more adverse midlife cardiometabolic risks, particularly diabetes 10 years earlier, which suggests the importance of early identification of risk factors associated with sarcopenic obesity.
Collapse
Affiliation(s)
- Jiantao Ma
- National Heart, Lung, and Blood Institute's Framingham Heart Study and Population Sciences Branch, Framingham, Massachusetts, USA
| | - Shih-Jen Hwang
- National Heart, Lung, and Blood Institute's Framingham Heart Study and Population Sciences Branch, Framingham, Massachusetts, USA
| | - Gearoid M McMahon
- National Heart, Lung, and Blood Institute's Framingham Heart Study and Population Sciences Branch, Framingham, Massachusetts, USA
- Renal Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
| | - Gary C Curhan
- Renal Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA
| | - Robert R Mclean
- Hebrew SeniorLife, Institute for Aging Research, Boston, Massachusetts, USA
- Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
| | - Joanne M Murabito
- National Heart, Lung, and Blood Institute's Framingham Heart Study and Population Sciences Branch, Framingham, Massachusetts, USA
- Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
| | - Caroline S Fox
- National Heart, Lung, and Blood Institute's Framingham Heart Study and Population Sciences Branch, Framingham, Massachusetts, USA
| |
Collapse
|
105
|
Lu Y, Day FR, Gustafsson S, Buchkovich ML, Na J, Bataille V, Cousminer DL, Dastani Z, Drong AW, Esko T, Evans DM, Falchi M, Feitosa MF, Ferreira T, Hedman ÅK, Haring R, Hysi PG, Iles MM, Justice AE, Kanoni S, Lagou V, Li R, Li X, Locke A, Lu C, Mägi R, Perry JRB, Pers TH, Qi Q, Sanna M, Schmidt EM, Scott WR, Shungin D, Teumer A, Vinkhuyzen AAE, Walker RW, Westra HJ, Zhang M, Zhang W, Zhao JH, Zhu Z, Afzal U, Ahluwalia TS, Bakker SJL, Bellis C, Bonnefond A, Borodulin K, Buchman AS, Cederholm T, Choh AC, Choi HJ, Curran JE, de Groot LCPGM, De Jager PL, Dhonukshe-Rutten RAM, Enneman AW, Eury E, Evans DS, Forsen T, Friedrich N, Fumeron F, Garcia ME, Gärtner S, Han BG, Havulinna AS, Hayward C, Hernandez D, Hillege H, Ittermann T, Kent JW, Kolcic I, Laatikainen T, Lahti J, Leach IM, Lee CG, Lee JY, Liu T, Liu Y, Lobbens S, Loh M, Lyytikäinen LP, Medina-Gomez C, Michaëlsson K, Nalls MA, Nielson CM, Oozageer L, Pascoe L, Paternoster L, Polašek O, Ripatti S, Sarzynski MA, Shin CS, Narančić NS, Spira D, Srikanth P, Steinhagen-Thiessen E, Sung YJ, Swart KMA, Taittonen L, Tanaka T, Tikkanen E, van der Velde N, van Schoor NM, Verweij N, Wright AF, Yu L, Zmuda JM, Eklund N, Forrester T, Grarup N, Jackson AU, Kristiansson K, Kuulasmaa T, Kuusisto J, Lichtner P, Luan J, Mahajan A, Männistö S, Palmer CD, Ried JS, Scott RA, Stancáková A, Wagner PJ, Demirkan A, Döring A, Gudnason V, Kiel DP, Kühnel B, Mangino M, Mcknight B, Menni C, O'Connell JR, Oostra BA, Shuldiner AR, Song K, Vandenput L, van Duijn CM, Vollenweider P, White CC, Boehnke M, Boettcher Y, Cooper RS, Forouhi NG, Gieger C, Grallert H, Hingorani A, Jørgensen T, Jousilahti P, Kivimaki M, Kumari M, Laakso M, Langenberg C, Linneberg A, Luke A, Mckenzie CA, Palotie A, Pedersen O, Peters A, Strauch K, Tayo BO, Wareham NJ, Bennett DA, Bertram L, Blangero J, Blüher M, Bouchard C, Campbell H, Cho NH, Cummings SR, Czerwinski SA, Demuth I, Eckardt R, Eriksson JG, Ferrucci L, Franco OH, Froguel P, Gansevoort RT, Hansen T, Harris TB, Hastie N, Heliövaara M, Hofman A, Jordan JM, Jula A, Kähönen M, Kajantie E, Knekt PB, Koskinen S, Kovacs P, Lehtimäki T, Lind L, Liu Y, Orwoll ES, Osmond C, Perola M, Pérusse L, Raitakari OT, Rankinen T, Rao DC, Rice TK, Rivadeneira F, Rudan I, Salomaa V, Sørensen TIA, Stumvoll M, Tönjes A, Towne B, Tranah GJ, Tremblay A, Uitterlinden AG, van der Harst P, Vartiainen E, Viikari JS, Vitart V, Vohl MC, Völzke H, Walker M, Wallaschofski H, Wild S, Wilson JF, Yengo L, Bishop DT, Borecki IB, Chambers JC, Cupples LA, Dehghan A, Deloukas P, Fatemifar G, Fox C, Furey TS, Franke L, Han J, Hunter DJ, Karjalainen J, Karpe F, Kaplan RC, Kooner JS, McCarthy MI, Murabito JM, Morris AP, Bishop JAN, North KE, Ohlsson C, Ong KK, Prokopenko I, Richards JB, Schadt EE, Spector TD, Widén E, Willer CJ, Yang J, Ingelsson E, Mohlke KL, Hirschhorn JN, Pospisilik JA, Zillikens MC, Lindgren C, Kilpeläinen TO, Loos RJF. New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk. Nat Commun 2016; 7:10495. [PMID: 26833246 PMCID: PMC4740398 DOI: 10.1038/ncomms10495] [Citation(s) in RCA: 191] [Impact Index Per Article: 23.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2015] [Accepted: 12/16/2015] [Indexed: 12/24/2022] Open
Abstract
To increase our understanding of the genetic basis of adiposity and its links to cardiometabolic disease risk, we conducted a genome-wide association meta-analysis of body fat percentage (BF%) in up to 100,716 individuals. Twelve loci reached genome-wide significance (P<5 × 10(-8)), of which eight were previously associated with increased overall adiposity (BMI, BF%) and four (in or near COBLL1/GRB14, IGF2BP1, PLA2G6, CRTC1) were novel associations with BF%. Seven loci showed a larger effect on BF% than on BMI, suggestive of a primary association with adiposity, while five loci showed larger effects on BMI than on BF%, suggesting association with both fat and lean mass. In particular, the loci more strongly associated with BF% showed distinct cross-phenotype association signatures with a range of cardiometabolic traits revealing new insights in the link between adiposity and disease risk.
Collapse
Affiliation(s)
- Yingchang Lu
- The Charles Bronfman Institute for Personalized Medicine, The
Icahn School of Medicine at Mount Sinai, New York, New
York
10029, USA
- The Department of Preventive Medicine, The Icahn School of
Medicine at Mount Sinai, New York, New York
10029, USA
| | - Felix R. Day
- MRC Epidemiology Unit, University of Cambridge School of
Clinical Medicine, Institute of Metabolic Science, University of Cambridge,
Cambridge Biomedical Campus, Cambridge
CB2 0QQ, UK
| | - Stefan Gustafsson
- Science for Life Laboratory, Uppsala University, 750
85
Uppsala, Sweden
- Department of Medical Sciences, Molecular Epidemiology, Uppsala
University, 751 85
Uppsala, Sweden
| | - Martin L. Buchkovich
- Department of Genetics, University of North Carolina,
Chapel Hill, North Carolina
27599, USA
| | - Jianbo Na
- Department of Developmental and Regenerative Biology, The Icahn
School of Medicine at Mount Sinai, New York, New York
10029, USA
| | - Veronique Bataille
- West Herts NHS Trust, Herts
HP2 4AD, UK
- Department of Twin Research and Genetic Epidemiology,
King's College London, London
SE1 7EH, UK
| | - Diana L. Cousminer
- Institute for Molecular Medicine Finland, University of
Helsinki, FI-00290
Helsinki, Finland
| | - Zari Dastani
- Department Epidemiology, Biostatistics and Human Genetics, Lady
Davis Institute, Jewish General Hospital, McGill University,
Montréal, Quebec, Canada
H3T1E2
| | - Alexander W. Drong
- Wellcome Trust Centre for Human Genetics, University of
Oxford, Oxford
OX3 7BN, UK
| | - Tõnu Esko
- Estonian Genome Center, Univeristy of Tartu,
Tartu, 51010, Estonia
- Broad Institute of the Massachusetts Institute of Technology
and Harvard University, Cambridge
2142, USA
- Divisions of Endocrinology and Genetics and Center for Basic
and Translational Obesity Research, Boston Children's Hospital,
Boston, Massachusetts
02115, USA
- Department of Genetics, Harvard Medical School,
Boston, Massachusetts
02115, USA
| | - David M. Evans
- University of Queensland Diamantina Institute, Translational
Research Institute, Brisbane, Queensland
4102, Australia
- MRC Integrative Epidemiology Unit, School of Social and
Community Medicine, University of Bristol, Bristol
BS82BN, UKnited
| | - Mario Falchi
- Department of Twin Research and Genetic Epidemiology,
King's College London, London
SE1 7EH, UK
- Department of Genomics of Common Disease, School of Public
Health, Imperial College London, London
W12 0NN, UK
| | - Mary F. Feitosa
- Division of Statistical Genomics, Department of Genetics,
Washington University School of Medicine, St Louis,
Missouri
63108, USA
| | - Teresa Ferreira
- Wellcome Trust Centre for Human Genetics, University of
Oxford, Oxford
OX3 7BN, UK
| | - Åsa K. Hedman
- Science for Life Laboratory, Uppsala University, 750
85
Uppsala, Sweden
- Department of Medical Sciences, Molecular Epidemiology, Uppsala
University, 751 85
Uppsala, Sweden
- Wellcome Trust Centre for Human Genetics, University of
Oxford, Oxford
OX3 7BN, UK
| | - Robin Haring
- Institute of Clinical Chemistry and Laboratory Medicine,
University Medicine Greifswald, 17475
Greifswald, Germany
- European University of Applied Sciences, Faculty of Applied
Public Health, 18055
Rostock, Germany
| | - Pirro G. Hysi
- Department of Twin Research and Genetic Epidemiology,
King's College London, London
SE1 7EH, UK
| | - Mark M. Iles
- Leeds Institute of Cancer and Pathology, Cancer Research UK
Leeds Centre, University of Leeds, Leeds
LS9 7TF, UK
| | - Anne E. Justice
- Department of Epidemiology, University of North Carolina at
Chapel Hill, Chapel Hill, North Carolina
27599, USA
| | - Stavroula Kanoni
- William Harvey Research Institute, Barts and The London School
of Medicine and Dentistry, Queen Mary University of London,
London
EC1M 6BQ, UK
- Wellcome Trust Sanger Institute, Human Genetics,
Hinxton, Cambridge
CB10 1SA, UK
| | - Vasiliki Lagou
- Wellcome Trust Centre for Human Genetics, University of
Oxford, Oxford
OX3 7BN, UK
- Oxford Centre for Diabetes, Endocrinology and Metabolism,
University of Oxford, Churchill Hospital, Oxford
OX3 7LJ, UK
| | - Rui Li
- Department Epidemiology, Biostatistics and Human Genetics, Lady
Davis Institute, Jewish General Hospital, McGill University,
Montréal, Quebec, Canada
H3T1E2
| | - Xin Li
- Department of Epidemiology, Harvard School of Public
Health, Boston, Massachusetts
02115, USA
| | - Adam Locke
- Center for Statistical Genetics, Department of Biostatistics,
University of Michigan, Ann Arbor, Michigan
48109, USA
| | - Chen Lu
- Department of Biostatistics, Boston University School of Public
Health, Boston, Massachusetts
02118, USA
| | - Reedik Mägi
- Wellcome Trust Centre for Human Genetics, University of
Oxford, Oxford
OX3 7BN, UK
- Estonian Genome Center, Univeristy of Tartu,
Tartu, 51010, Estonia
| | - John R. B. Perry
- MRC Epidemiology Unit, University of Cambridge School of
Clinical Medicine, Institute of Metabolic Science, University of Cambridge,
Cambridge Biomedical Campus, Cambridge
CB2 0QQ, UK
| | - Tune H. Pers
- Divisions of Endocrinology and Genetics and Center for Basic
and Translational Obesity Research, Boston Children's Hospital,
Boston, Massachusetts
02115, USA
- Department of Genetics, Harvard Medical School,
Boston, Massachusetts
02115, USA
- Novo Nordisk Foundation Center for Basic Metabolic Research,
Section of Metabolic Genetics, Faculty of Health and Medical Sciences,
University of Copenhagen, 2100
Copenhagen, Denmark
- Medical and Population Genetics Program, Broad Institute of MIT
and Harvard, Cambridge
02142, USA
- Department of Epidemiology Research, Statens Serum
Institut, 2100
Copenhagen, Denmark
| | - Qibin Qi
- Department of Epidemiology and Popualtion Health, Albert
Einstein College of Medicine, Bronx, New York
10461, USA
| | - Marianna Sanna
- Department of Twin Research and Genetic Epidemiology,
King's College London, London
SE1 7EH, UK
- Department of Genomics of Common Disease, School of Public
Health, Imperial College London, London
W12 0NN, UK
| | - Ellen M. Schmidt
- Department of Computational Medicine and Bioinformatics,
University of Michigan, Ann Arbor, Michigan
48109, USA
| | - William R. Scott
- Department of Epidemiology and Biostatistics, Imperial College
London, London
W2 1PG, UK
- Ealing Hospital NHS Trust, Middlesex
UB1 3HW, UK
| | - Dmitry Shungin
- Lund University Diabetes Centre, Department of Clinical
Science, Genetic and Molecular Epidemiology Unit, Skåne University
Hosptial, 205 02
Malmö, Sweden
- Department of Public Health and Clinical Medicine, Unit of
Medicine, Umeå University, 901 87
Umeå, Sweden
- Department of Odontology, Umeå University,
901 85
Umeå, Sweden
| | - Alexander Teumer
- Institute for Community Medicine, University Medicine
Greifswald, 17475
Greifswald, Germany
- Interfaculty Institute for Genetics and Functional Genomics,
University Medicine Greifswald, 17475
Greifswald, Germany
| | | | - Ryan W. Walker
- The Charles Bronfman Institute for Personalized Medicine, The
Icahn School of Medicine at Mount Sinai, New York, New
York
10029, USA
- The Department of Preventive Medicine, The Icahn School of
Medicine at Mount Sinai, New York, New York
10029, USA
| | - Harm-Jan Westra
- Program in Medical and Population Genetics, Broad Institute of
Harvard and Massachusetts Institute of Technology, Cambridge,
Massachusetts
02142, USA
- Divisions of Genetics and Rheumatology, Department of Medicine,
Brigham and Women's Hospital and Harvard Medical School,
Boston, Massachusetts
02446, USA
- Partners Center for Personalized Genetic Medicine,
Boston, Massachusetts
02446, USA
| | - Mingfeng Zhang
- Department of Dermatology, Brigham and Women's
Hospital, Boston, Massachusetts
02115, USA
| | - Weihua Zhang
- Department of Epidemiology and Biostatistics, Imperial College
London, London
W2 1PG, UK
- Ealing Hospital NHS Trust, Middlesex
UB1 3HW, UK
| | - Jing Hua Zhao
- MRC Epidemiology Unit, University of Cambridge School of
Clinical Medicine, Institute of Metabolic Science, University of Cambridge,
Cambridge Biomedical Campus, Cambridge
CB2 0QQ, UK
| | - Zhihong Zhu
- Queensland Brain Institute, The University of Queensland,
Brisbane
4072, Australia
| | - Uzma Afzal
- Department of Epidemiology and Biostatistics, Imperial College
London, London
W2 1PG, UK
- Ealing Hospital NHS Trust, Middlesex
UB1 3HW, UK
| | - Tarunveer Singh Ahluwalia
- Novo Nordisk Foundation Center for Basic Metabolic Research,
Section of Metabolic Genetics, Faculty of Health and Medical Sciences,
University of Copenhagen, 2100
Copenhagen, Denmark
- Copenhagen Prospective Studies on Asthma in Childhood, Faculty
of Health and Medical Sceinces, University of Copenhagen, 2200
Copenhagen, Denmark
- Danish Pediatric Asthma Center, Gentofte Hospital, The Capital
Region, 2200
Copenhagen, Denmark
- Steno Diabetes Center A/S, DK-2820
Gentofte, Denmark
| | - Stephan J. L. Bakker
- University of Groningen, University Medical Center Groningen,
Department of Medicine, 9700 RB
Groningen, The Netherlands
| | - Claire Bellis
- Department of Genetics, Texas Biomedical Research
Institute, San Antonio, Texas
78245, USA
| | - Amélie Bonnefond
- CNRS UMR 8199, F-59019
Lille, France
- European Genomic Institute for Diabetes, 59000
Lille, France
- Université de Lille 2, 59000
Lille, France
| | - Katja Borodulin
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Aron S. Buchman
- Rush Alzheimer's Disease Center, Rush University
Medical Center, Chicago, Illinois
60612, USA
| | - Tommy Cederholm
- Department of Public Health and Caring Sciences, Clinical
Nutrition and Metabolism, Uppsala University, 751 85
Uppsala, Sweden
| | - Audrey C. Choh
- Lifespan Health Research Center, Wright State University
Boonshoft School of Medicine, Dayton, Ohio
45420, USA
| | - Hyung Jin Choi
- Department of Anatomy, Seoul National University College of
Medicine, Seoul
03080, Korea
| | - Joanne E. Curran
- South Texas Diabetes and Obesity Institute, University of Texas
Rio Grande Valley, Brownsville, Texas
78520
| | | | - Philip L. De Jager
- Program in Medical and Population Genetics, Broad Institute of
Harvard and Massachusetts Institute of Technology, Cambridge,
Massachusetts
02142, USA
- Harvard Medical School, Boston,
Massachusetts
02115, USA
- Program in Translational NeuroPsychiatric Genomics, Department
of Neurology, Brigham and Women's Hospital, Boston,
Massachusetts
02115, USA
| | | | - Anke W. Enneman
- Department of Internal Medicine, Erasmus Medical Center,
3015GE
Rotterdam, The Netherlands
| | - Elodie Eury
- CNRS UMR 8199, F-59019
Lille, France
- European Genomic Institute for Diabetes, 59000
Lille, France
- Université de Lille 2, 59000
Lille, France
| | - Daniel S. Evans
- California Pacific Medical Center Research Institute,
San Francisco, California
94107, USA
| | - Tom Forsen
- Department of General Practice and Primary Health Care,
University of Helsinki, FI-00014
Helsinki, Finland
| | - Nele Friedrich
- Institute of Clinical Chemistry and Laboratory Medicine,
University Medicine Greifswald, 17475
Greifswald, Germany
| | - Frédéric Fumeron
- INSERM, UMR_S 1138, Centre de Recherche des Cordeliers,
F-75006
Paris, France
- Sorbonne Universités, UPMC Univ Paris 06, UMR_S
1138, Centre de Recherche des Cordeliers, F-75006
Paris, France
- Université Paris Descartes, Sorbonne Paris
Cité, UMR_S 1138, Centre de Recherche des Cordeliers,
F-75006
Paris, France
- Univ Paris Diderot, Sorbonne Paris Cité, UMR_S 1138,
Centre de Recherche des Cordeliers, F-75006
Paris, France
| | - Melissa E. Garcia
- Laboratory of Epidemiology and Population Sciences, National
Institute on Aging, Bethesda, Maryland
20892, USA
| | - Simone Gärtner
- Department of Medicine A, University Medicine Greifswald,
17475
Greifswald, Germany
| | - Bok-Ghee Han
- Center for Genome Science, National Institute of Health, Osong
Health Technology Administration Complex, Chungcheongbuk-do
370914, Korea
| | - Aki S. Havulinna
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Caroline Hayward
- MRC Human Genetics Unit, Institute of Genetics and Molecular
Medicine, University of Edinburgh, Edinburgh
EH4 2XU, UK
| | - Dena Hernandez
- Laboratory of Neurogenetics, National Institute on Aging,
National Institutes of Health, Bethesda, Maryland
20892, USA
| | - Hans Hillege
- University of Groningen, University Medical Center Groningen,
Department of Cardiology, 9700 RB
Groningen, The Netherlands
| | - Till Ittermann
- Institute for Community Medicine, University Medicine
Greifswald, 17475
Greifswald, Germany
| | - Jack W. Kent
- Department of Genetics, Texas Biomedical Research
Institute, San Antonio, Texas
78245, USA
| | - Ivana Kolcic
- Department of Public Health, Faculty of Medicine, University of
Split, Split
21000, Croatia
| | - Tiina Laatikainen
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
- Hospital District of North Karelia, FI-80210
Joensuu, Finland
- Institute of Public Health and Clinical Nutrition, University
of Eastern Finland, FI-70211
Kuopio, Finland
| | - Jari Lahti
- Folkhälsan Research Centre, FI-00290
Helsinki, Finland
- Institute of Behavioural Sciences, University of
Helsinki, FI-00014
Helsinki, Finland
| | - Irene Mateo Leach
- University of Groningen, University Medical Center Groningen,
Department of Cardiology, 9700 RB
Groningen, The Netherlands
| | - Christine G. Lee
- Department of Medicine, Oregon Health and Science
University, Portland, Oregon
97239, USA
- Research Service, Veterans Affairs Medical Center,
Portland, Oregon
97239, USA
| | - Jong-Young Lee
- Center for Genome Science, National Institute of Health, Osong
Health Technology Administration Complex, Chungcheongbuk-do
370914, Korea
| | - Tian Liu
- Max Planck Institute for Molecular Genetics, Department of
Vertebrate Genomics, 14195
Berlin, Germany
- Max Planck Institute for Human Development,
14194
Berlin, Germany
| | - Youfang Liu
- Thurston Arthritis Research Center, University of North
Carolina at Chapel Hill, Chaper Hill, North Carolina
27599-7280, USA
| | - Stéphane Lobbens
- CNRS UMR 8199, F-59019
Lille, France
- European Genomic Institute for Diabetes, 59000
Lille, France
- Université de Lille 2, 59000
Lille, France
| | - Marie Loh
- Department of Epidemiology and Biostatistics, Imperial College
London, London
W2 1PG, UK
- Translational Laboratory in Genetic Medicine (TLGM), Agency for
Science, Technology and Research (A*STAR), 8A Biomedical
Grove, Immunos, Level 5, Singapore
138648, Singapore
| | - Leo-Pekka Lyytikäinen
- Department of Clinical Chemistry, University of Tampere School
of Medicine, FI-33014
Tampere, Finland
- Department of Clinical Chemistry, Fimlab Laboratories and
School of Medicine, University of Tampere, FI-33520
Tampere, Finland
| | - Carolina Medina-Gomez
- Department of Internal Medicine, Erasmus Medical Center,
3015GE
Rotterdam, The Netherlands
- Netherlands Genomics Initiative (NGI)-sponsored Netherlands
Consortium for Healthy Aging (NCHA), Rotterdam
The Netherlands
- Department of Epidemiology, Erasmus Medical Center,
3015GE
Rotterdam, The Netherlands
| | - Karl Michaëlsson
- Department of Surgical Sciences, Orthopedics, Uppsala
University, 751 85
Uppsala, Sweden
| | - Mike A. Nalls
- Laboratory of Neurogenetics, National Institute on Aging,
National Institutes of Health, Bethesda, Maryland
20892, USA
| | - Carrie M. Nielson
- School of Public Health, Oregon Health & Science
University, Portland, Oregon
97239, USA
- Bone & Mineral Unit, Oregon Health & Science
University, Portland, Oregon
97239, USA
| | | | - Laura Pascoe
- Institute of Cell & Molecular Biosciences, Newcastle
University, Newcastle
NE1 7RU, UK
| | - Lavinia Paternoster
- MRC Integrative Epidemiology Unit, School of Social and
Community Medicine, University of Bristol, Bristol
BS82BN, UKnited
| | - Ozren Polašek
- Department of Public Health, Faculty of Medicine, University of
Split, Split
21000, Croatia
- Centre for Global Health Research, Usher Institute of
Population Health Sciences and Informatics, University of Edinburgh, Teviot
Place, Edinburgh
EH8 9AG, UK
| | - Samuli Ripatti
- Institute for Molecular Medicine Finland, University of
Helsinki, FI-00290
Helsinki, Finland
- Wellcome Trust Sanger Institute, Human Genetics,
Hinxton, Cambridge
CB10 1SA, UK
- Hjelt Institute, University of Helsinki,
FI-00014
Helsinki, Finland
| | - Mark A. Sarzynski
- Human Genomics Laboratory, Pennington Biomedical Research
Center, Baton Rouge, Los Angeles
70808, USA
| | - Chan Soo Shin
- Department of Internal Medicine, Seoul National University
College of Medicine, Seoul
03080, Korea
| | | | - Dominik Spira
- The Berlin Aging Study II; Research Group on Geriatrics;
Charité—Universitätsmedizin Berlin,
13347
Berlin, Germany
- Lipid Clinic at the Interdisciplinary Metabolism Center,
Charité-Universitätsmedizin Berlin, 13353
Berlin, Germany
| | - Priya Srikanth
- School of Public Health, Oregon Health & Science
University, Portland, Oregon
97239, USA
- Bone & Mineral Unit, Oregon Health & Science
University, Portland, Oregon
97239, USA
| | - Elisabeth Steinhagen-Thiessen
- The Berlin Aging Study II; Research Group on Geriatrics;
Charité—Universitätsmedizin Berlin,
13347
Berlin, Germany
- Lipid Clinic at the Interdisciplinary Metabolism Center,
Charité-Universitätsmedizin Berlin, 13353
Berlin, Germany
| | - Yun Ju Sung
- Division of Biostatistics, Washington University School of
Medicine, St Louis, Missouri
63110, USA
| | - Karin M. A. Swart
- EMGO Institute for Health and Care Research, VU University
Medical Center, 1081 BT
Amsterdam, The Netherlands
- VUMC, Department of Epidemiology and Biostatistics,
1081 BT
Amsterdam, The Netherlands
| | - Leena Taittonen
- Department of Pediatrics, University of Oulu,
FI-90014
Oulu, Finland
- Department of Pediatrics, Vaasa Central Hospital,
FI-65100
Vaasa, Finland
| | - Toshiko Tanaka
- Translational Gerontology Branch, National Institute on
Aging, Baltimore, Maryland
21225, USA
| | - Emmi Tikkanen
- Institute for Molecular Medicine Finland, University of
Helsinki, FI-00290
Helsinki, Finland
- Hjelt Institute, University of Helsinki,
FI-00014
Helsinki, Finland
| | - Nathalie van der Velde
- Department of Internal Medicine, Erasmus Medical Center,
3015GE
Rotterdam, The Netherlands
| | - Natasja M. van Schoor
- EMGO Institute for Health and Care Research, VU University
Medical Center, 1081 BT
Amsterdam, The Netherlands
- VUMC, Department of Epidemiology and Biostatistics,
1081 BT
Amsterdam, The Netherlands
| | - Niek Verweij
- University of Groningen, University Medical Center Groningen,
Department of Cardiology, 9700 RB
Groningen, The Netherlands
| | - Alan F. Wright
- MRC Human Genetics Unit, Institute of Genetics and Molecular
Medicine, University of Edinburgh, Edinburgh
EH4 2XU, UK
| | - Lei Yu
- Rush Alzheimer's Disease Center, Rush University
Medical Center, Chicago, Illinois
60612, USA
| | - Joseph M. Zmuda
- Department of Epidemiology; University of Pittsburgh,
Pittsburgh, Pennsylvania
15261, USA
| | - Niina Eklund
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Terrence Forrester
- Tropical Metabolism Research Unit, Tropical Medicine Research
Institute, University of the West Indies, Mona
JMAAW15, Jamaica
| | - Niels Grarup
- Novo Nordisk Foundation Center for Basic Metabolic Research,
Section of Metabolic Genetics, Faculty of Health and Medical Sciences,
University of Copenhagen, 2100
Copenhagen, Denmark
| | - Anne U. Jackson
- Center for Statistical Genetics, Department of Biostatistics,
University of Michigan, Ann Arbor, Michigan
48109, USA
| | - Kati Kristiansson
- Institute for Molecular Medicine Finland, University of
Helsinki, FI-00290
Helsinki, Finland
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Teemu Kuulasmaa
- Faculty of Health Sciences, Institute of Clinical Medicine,
Internal Medicine, University of Eastern Finland, 70210
Kuopio, Finland
| | - Johanna Kuusisto
- Faculty of Health Sciences, Institute of Clinical Medicine,
Internal Medicine, University of Eastern Finland, 70210
Kuopio, Finland
- Department of Medicine, University of Eastern Finland,
70210
Kuopio, Finland
- Kuopio University Hospital, 70029
Kuopio, Finland
| | - Peter Lichtner
- Institute of Human Genetics, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
| | - Jian'an Luan
- MRC Epidemiology Unit, University of Cambridge School of
Clinical Medicine, Institute of Metabolic Science, University of Cambridge,
Cambridge Biomedical Campus, Cambridge
CB2 0QQ, UK
| | - Anubha Mahajan
- Wellcome Trust Centre for Human Genetics, University of
Oxford, Oxford
OX3 7BN, UK
| | - Satu Männistö
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Cameron D. Palmer
- Broad Institute of the Massachusetts Institute of Technology
and Harvard University, Cambridge
2142, USA
- Divisions of Endocrinology and Genetics and Center for Basic
and Translational Obesity Research, Boston Children's Hospital,
Boston, Massachusetts
02115, USA
| | - Janina S. Ried
- Institute of Genetic Epidemiology, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
| | - Robert A. Scott
- MRC Epidemiology Unit, University of Cambridge School of
Clinical Medicine, Institute of Metabolic Science, University of Cambridge,
Cambridge Biomedical Campus, Cambridge
CB2 0QQ, UK
| | - Alena Stancáková
- Department of Medicine, University of Eastern Finland and
Kuopio University Hospital, 70210
Kuopio, Finland
| | - Peter J. Wagner
- Institute for Molecular Medicine Finland, University of
Helsinki, FI-00290
Helsinki, Finland
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Ayse Demirkan
- Genetic Epidemiology Unit, Department of Epidemiology, Erasmus
University Medical Center, 3015GE
Rotterdam, The Netherlands
| | - Angela Döring
- Institute of Epidemiology I, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
- Institute of Epidemiology II, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur
201, Iceland
- University of Iceland, Faculty of Medicine,
Reykjavik
101, Iceland
| | - Douglas P. Kiel
- Department of Medicine Beth Israel Deaconess Medical Center
and Harvard Medical School, Boston, Massachusetts
02115
- Institute for Aging Research Hebrew Senior Life,
Boston, Massachusetts
02131, USA
| | - Brigitte Kühnel
- Institute of Genetic Epidemiology, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
- Institute of Epidemiology II, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
| | - Massimo Mangino
- Department of Twin Research and Genetic Epidemiology,
King's College London, London
SE1 7EH, UK
| | - Barbara Mcknight
- Cardiovascular Health Research Unit, University of
Washington, Seattle, Washington
98101, USA
- Program in Biostatistics and Biomathematics, Divison of Public
Health Sciences, Fred Hutchinson Cancer Research Center,
Seattle, Washington
98109, USA
- Department of Biostatistics, University of Washington,
Seattle, Washington
98195, USA
| | - Cristina Menni
- Department of Twin Research and Genetic Epidemiology,
King's College London, London
SE1 7EH, UK
| | - Jeffrey R. O'Connell
- Program for Personalized and Genomic Medicine, Division of
Endocrinology, Diabetes and Nutrition, Department of Medicine, University of
Maryland School of Medicine, Baltimore, Maryland
21201, USA
| | - Ben A. Oostra
- Genetic Epidemiology Unit, Department of Epidemiology, Erasmus
University Medical Center, 3015GE
Rotterdam, The Netherlands
| | - Alan R. Shuldiner
- Program for Personalized and Genomic Medicine, Division of
Endocrinology, Diabetes and Nutrition, Department of Medicine, University of
Maryland School of Medicine, Baltimore, Maryland
21201, USA
- Geriatric Research and Education Clinical Center, Vetrans
Administration Medical Center, Baltimore, Maryland
21042, USA
| | - Kijoung Song
- Genetics, Projects Clinical Platforms and Sciences,
GlaxoSmithKline, Philadelphia, Pennsylvania
19112, USA
| | - Liesbeth Vandenput
- Centre for Bone and Arthritis Research, Department of Internal
Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy,
University of Gothenburg, 413 45
Gothenburg, Sweden
| | - Cornelia M. van Duijn
- Netherlands Genomics Initiative (NGI)-sponsored Netherlands
Consortium for Healthy Aging (NCHA), Rotterdam
The Netherlands
- Genetic Epidemiology Unit, Department of Epidemiology, Erasmus
University Medical Center, 3015GE
Rotterdam, The Netherlands
- Center for Medical Systems Biology, 2300
Leiden, The Netherlands
| | - Peter Vollenweider
- Department of Internal Medicine, University Hospital Lausanne
(CHUV) and University of Lausanne, 1011
Lausanne, Switzerland
| | - Charles C. White
- Department of Biostatistics, Boston University School of Public
Health, Boston, Massachusetts
02118, USA
| | - Michael Boehnke
- Center for Statistical Genetics, Department of Biostatistics,
University of Michigan, Ann Arbor, Michigan
48109, USA
| | - Yvonne Boettcher
- University of Leipzig, IFB Adiposity Diseases,
04103
Leipzig, Germany
- University of Leipzig, Department of Medicine,
04103
Leipzig, Germany
| | - Richard S. Cooper
- Department of Public Health Sciences, Stritch School of
Medicine, Loyola University Chicago, Maywood, Illinois
61053, USA
| | - Nita G. Forouhi
- MRC Epidemiology Unit, University of Cambridge School of
Clinical Medicine, Institute of Metabolic Science, University of Cambridge,
Cambridge Biomedical Campus, Cambridge
CB2 0QQ, UK
| | - Christian Gieger
- Institute of Genetic Epidemiology, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
- Institute of Epidemiology II, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
| | - Harald Grallert
- Institute of Epidemiology II, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
- German Center for Diabetes Research (DZD),
85764
Neuherberg, Germany
| | - Aroon Hingorani
- Institute of Cardiovascular Science, University College
London, London
WC1E 6BT, UK
| | - Torben Jørgensen
- Department of Clinical Medicine, Faculty of Health and Medical
Sciences, University of Copenhagen, 2200
Copenhagen, Denmark
- Faculty of Medicine, University of Aalborg,
9220
Aalborg, Denmark
- Research Centre for Prevention and Health,
DK2600
Capital Region of Denmark, Denmark
| | - Pekka Jousilahti
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Mika Kivimaki
- Department of Epidemiology and Public Health, UCL,
London
WC1E 6BT, UK
| | - Meena Kumari
- Department of Epidemiology and Public Health, UCL,
London
WC1E 6BT, UK
| | - Markku Laakso
- Faculty of Health Sciences, Institute of Clinical Medicine,
Internal Medicine, University of Eastern Finland, 70210
Kuopio, Finland
- Department of Medicine, University of Eastern Finland,
70210
Kuopio, Finland
- Kuopio University Hospital, 70029
Kuopio, Finland
| | - Claudia Langenberg
- MRC Epidemiology Unit, University of Cambridge School of
Clinical Medicine, Institute of Metabolic Science, University of Cambridge,
Cambridge Biomedical Campus, Cambridge
CB2 0QQ, UK
- Department of Epidemiology and Public Health, UCL,
London
WC1E 6BT, UK
| | - Allan Linneberg
- Research Centre for Prevention and Health, Glostrup
Hospital, 2600
Glostrup, Denmark
| | - Amy Luke
- Department of Public Health Sciences, Stritch School of
Medicine, Loyola University Chicago, Maywood, Illinois
61053, USA
| | - Colin A. Mckenzie
- Tropical Metabolism Research Unit, Tropical Medicine Research
Institute, University of the West Indies, Mona
JMAAW15, Jamaica
| | - Aarno Palotie
- Institute for Molecular Medicine Finland, University of
Helsinki, FI-00290
Helsinki, Finland
- Wellcome Trust Sanger Institute, Human Genetics,
Hinxton, Cambridge
CB10 1SA, UK
- Massachusetts General Hospital, Center for Human Genetic
Research, Psychiatric and Neurodevelopmental Genetics Unit,
Boston, Massachusetts
02114, USA
| | - Oluf Pedersen
- Novo Nordisk Foundation Center for Basic Metabolic Research,
Section of Metabolic Genetics, Faculty of Health and Medical Sciences,
University of Copenhagen, 2100
Copenhagen, Denmark
| | - Annette Peters
- Institute of Epidemiology II, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
| | - Konstantin Strauch
- Institute of Genetic Epidemiology, Helmholtz Zentrum
München—German Research Center for Environmental
Health, 85764
Neuherberg, Germany
- Institute of Medical Informatics, Biometry and Epidemiology,
Chair of Genetic Epidemiology, Ludwig-Maximilians-Universität,
81377
Munich, Germany
| | - Bamidele O. Tayo
- Department of Public Health Sciences, Stritch School of
Medicine, Loyola University Chicago, Maywood, Illinois
61053, USA
| | - Nicholas J. Wareham
- MRC Epidemiology Unit, University of Cambridge School of
Clinical Medicine, Institute of Metabolic Science, University of Cambridge,
Cambridge Biomedical Campus, Cambridge
CB2 0QQ, UK
| | - David A. Bennett
- Rush Alzheimer's Disease Center, Rush University
Medical Center, Chicago, Illinois
60612, USA
| | - Lars Bertram
- School of Public Health, Faculty of Medicine, Imperial College
London, London
W6 8RP, UK
- Lübeck Interdisciplinary Platform for Genome
Analytics, Institutes of Neurogenetics and Integrative and Experimental
Genomics, University of Lübeck, 23562
Lübeck, Germany
| | - John Blangero
- South Texas Diabetes and Obesity Institute, University of Texas
Rio Grande Valley, Brownsville, Texas
78520
| | - Matthias Blüher
- University of Leipzig, IFB Adiposity Diseases,
04103
Leipzig, Germany
- University of Leipzig, Department of Medicine,
04103
Leipzig, Germany
| | - Claude Bouchard
- Human Genomics Laboratory, Pennington Biomedical Research
Center, Baton Rouge, Los Angeles
70808, USA
| | - Harry Campbell
- Centre for Global Health Research, Usher Institute of
Population Health Sciences and Informatics, University of Edinburgh, Teviot
Place, Edinburgh
EH8 9AG, UK
| | - Nam H. Cho
- Ajou University School of Medicine, Department of Preventive
Medicine, Suwon Kyoung-gi
443-721, Korea
| | - Steven R. Cummings
- California Pacific Medical Center Research Institute,
San Francisco, California
94107, USA
| | - Stefan A. Czerwinski
- Lifespan Health Research Center, Wright State University
Boonshoft School of Medicine, Dayton, Ohio
45420, USA
| | - Ilja Demuth
- The Berlin Aging Study II; Research Group on Geriatrics;
Charité—Universitätsmedizin Berlin,
13347
Berlin, Germany
- Institute of Medical and Human Genetics,
Charité—Universitätsmedizin Berlin,
13353
Berlin, Germany
| | - Rahel Eckardt
- The Berlin Aging Study II; Research Group on Geriatrics;
Charité—Universitätsmedizin Berlin,
13347
Berlin, Germany
| | - Johan G. Eriksson
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
- Department of General Practice and Primary Health Care,
University of Helsinki, FI-00014
Helsinki, Finland
- Folkhälsan Research Centre, FI-00290
Helsinki, Finland
| | - Luigi Ferrucci
- Translational Gerontology Branch, National Institute on
Aging, Baltimore, Maryland
21225, USA
| | - Oscar H. Franco
- Netherlands Genomics Initiative (NGI)-sponsored Netherlands
Consortium for Healthy Aging (NCHA), Rotterdam
The Netherlands
- Department of Epidemiology, Erasmus Medical Center,
3015GE
Rotterdam, The Netherlands
| | - Philippe Froguel
- CNRS UMR 8199, F-59019
Lille, France
- European Genomic Institute for Diabetes, 59000
Lille, France
- Université de Lille 2, 59000
Lille, France
| | - Ron T. Gansevoort
- University of Groningen, University Medical Center Groningen,
Department of Medicine, 9700 RB
Groningen, The Netherlands
| | - Torben Hansen
- Novo Nordisk Foundation Center for Basic Metabolic Research,
Section of Metabolic Genetics, Faculty of Health and Medical Sciences,
University of Copenhagen, 2100
Copenhagen, Denmark
- Faculty of Health Sciences, University of Southern
Denmark, 5000
Odense, Denmark
| | - Tamara B. Harris
- Laboratory of Epidemiology and Population Sciences, National
Institute on Aging, Bethesda, Maryland
20892, USA
| | - Nicholas Hastie
- MRC Human Genetics Unit, Institute of Genetics and Molecular
Medicine, University of Edinburgh, Edinburgh
EH4 2XU, UK
| | - Markku Heliövaara
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Albert Hofman
- Netherlands Genomics Initiative (NGI)-sponsored Netherlands
Consortium for Healthy Aging (NCHA), Rotterdam
The Netherlands
- Department of Epidemiology, Erasmus Medical Center,
3015GE
Rotterdam, The Netherlands
| | - Joanne M. Jordan
- Thurston Arthritis Research Center, University of North
Carolina at Chapel Hill, Chaper Hill, North Carolina
27599-7280, USA
| | - Antti Jula
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Mika Kähönen
- Department of Clinical Physiology, Tampere University
Hospital, FI-33521
Tampere, Finland
- Department of Clinical Physiology, University of Tampere
School of Medicine, FI-33014
Tampere, Finland
| | - Eero Kajantie
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
- Children's Hospital, Helsinki University Hospital and
University of Helsinki, FI-00029
Helsinki, Finland
- Department of Obstetrics and Gynecology, MRC Oulu, Oulu
University Hospital and University of Oulu, FI-90029
Oulu, Finland
| | - Paul B. Knekt
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Seppo Koskinen
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Peter Kovacs
- University of Leipzig, IFB Adiposity Diseases,
04103
Leipzig, Germany
| | - Terho Lehtimäki
- Department of Clinical Chemistry, University of Tampere School
of Medicine, FI-33014
Tampere, Finland
- Department of Clinical Chemistry, Fimlab Laboratories and
School of Medicine, University of Tampere, FI-33520
Tampere, Finland
| | - Lars Lind
- Department of Medical Sciences, Uppsala University,
751 85
Uppsala, Sweden
| | - Yongmei Liu
- Center for Human Genetics, Division of Public Health Sciences,
Wake Forest School of Medicine, Winston-Salem, North
Carolina
27157, USA
| | - Eric S. Orwoll
- Bone & Mineral Unit, Oregon Health & Science
University, Portland, Oregon
97239, USA
| | - Clive Osmond
- MRC Lifecourse Epidemiology Unit, University of Southampton,
Southampton General Hospital, Southampton
SO16 6YD, UK
| | - Markus Perola
- Institute for Molecular Medicine Finland, University of
Helsinki, FI-00290
Helsinki, Finland
- Estonian Genome Center, Univeristy of Tartu,
Tartu, 51010, Estonia
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Louis Pérusse
- Department of Kinesiology, Laval University,
Québec City, Quebec, Canada
G1V 0A6
- Institute of Nutrition and Functional Foods, Laval
University, Québec City, Quebec,
Canada
G1V 0A6
| | - Olli T. Raitakari
- Department of Clinical Physiology and Nuclear Medicine, Turku
University Hospital, FI-20521
Turku, Finland
- Research Centre of Applied and Preventive Cardiovascular
Medicine, University of Turku, FI-20520
Turku, Finland
| | - Tuomo Rankinen
- Human Genomics Laboratory, Pennington Biomedical Research
Center, Baton Rouge, Los Angeles
70808, USA
| | - D. C. Rao
- Division of Statistical Genomics, Department of Genetics,
Washington University School of Medicine, St Louis,
Missouri
63108, USA
- Division of Biostatistics, Washington University School of
Medicine, St Louis, Missouri
63110, USA
- Department of Psychiatry, Washington University School of
Medicine, St Louis, Missouri
63110, USA
| | - Treva K. Rice
- Division of Biostatistics, Washington University School of
Medicine, St Louis, Missouri
63110, USA
- Department of Psychiatry, Washington University School of
Medicine, St Louis, Missouri
63110, USA
| | - Fernando Rivadeneira
- Department of Internal Medicine, Erasmus Medical Center,
3015GE
Rotterdam, The Netherlands
- Netherlands Genomics Initiative (NGI)-sponsored Netherlands
Consortium for Healthy Aging (NCHA), Rotterdam
The Netherlands
- Department of Epidemiology, Erasmus Medical Center,
3015GE
Rotterdam, The Netherlands
| | - Igor Rudan
- Centre for Global Health Research, Usher Institute of
Population Health Sciences and Informatics, University of Edinburgh, Teviot
Place, Edinburgh
EH8 9AG, UK
| | - Veikko Salomaa
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Thorkild I. A. Sørensen
- MRC Integrative Epidemiology Unit, School of Social and
Community Medicine, University of Bristol, Bristol
BS82BN, UKnited
- Novo Nordisk Foundation Center for Basic Metabolic Research,
Section of Metabolic Genetics, Faculty of Health and Medical Sciences,
University of Copenhagen, 2100
Copenhagen, Denmark
- Institute of Preventive Medicine, Bispebjerg and Frederiksberg
Hospital, The Capital Region, 2000
Frederiksberg, Denmark
| | - Michael Stumvoll
- University of Leipzig, IFB Adiposity Diseases,
04103
Leipzig, Germany
- University of Leipzig, Department of Medicine,
04103
Leipzig, Germany
| | - Anke Tönjes
- University of Leipzig, Department of Medicine,
04103
Leipzig, Germany
| | - Bradford Towne
- Lifespan Health Research Center, Wright State University
Boonshoft School of Medicine, Dayton, Ohio
45420, USA
| | - Gregory J. Tranah
- California Pacific Medical Center Research Institute,
San Francisco, California
94107, USA
| | - Angelo Tremblay
- Department of Kinesiology, Laval University,
Québec City, Quebec, Canada
G1V 0A6
| | - André G. Uitterlinden
- Department of Internal Medicine, Erasmus Medical Center,
3015GE
Rotterdam, The Netherlands
- Netherlands Genomics Initiative (NGI)-sponsored Netherlands
Consortium for Healthy Aging (NCHA), Rotterdam
The Netherlands
- Department of Epidemiology, Erasmus Medical Center,
3015GE
Rotterdam, The Netherlands
| | - Pim van der Harst
- University of Groningen, University Medical Center Groningen,
Department of Cardiology, 9700 RB
Groningen, The Netherlands
- Durrer Center for Cardiogenetic Research, Interuniversity
Cardiology Institute Netherlands-Netherlands Heart Institute, 3501
DG
Utrecht, The Netherlands
- Department of Genetics, University Medical Center Groningen,
University of Groningen, 9700 RB
Groningen, The Netherlands
| | - Erkki Vartiainen
- National Institute for Health and Welfare,
FI-00271
Helsinki, Finland
| | - Jorma S. Viikari
- Department of Medicine, University of Turku,
FI-20521
Turku, Finland
| | - Veronique Vitart
- MRC Human Genetics Unit, Institute of Genetics and Molecular
Medicine, University of Edinburgh, Edinburgh
EH4 2XU, UK
| | - Marie-Claude Vohl
- Institute of Nutrition and Functional Foods, Laval
University, Québec City, Quebec,
Canada
G1V 0A6
- School of Nutrition, Laval University,
Québec City, Quebec, Canada
G1V 0A6
| | - Henry Völzke
- Institute for Community Medicine, University Medicine
Greifswald, 17475
Greifswald, Germany
- DZHK (German Centre for Cardiovascular Research), partner site
Greifswald, 17475
Greifswald, Germany
- DZD (German Centre for Diabetes Research), partner site
Greifswald, 17475
Greifswald, Germany
| | - Mark Walker
- Program in Medical and Population Genetics, Broad Institute of
Harvard and Massachusetts Institute of Technology, Cambridge,
Massachusetts
02142, USA
- Institute of Cellular Medicine, Newcastle University,
Newcastle
NE2 4HH, UK
| | - Henri Wallaschofski
- Institute of Clinical Chemistry and Laboratory Medicine,
University Medicine Greifswald, 17475
Greifswald, Germany
- DZHK (German Centre for Cardiovascular Research), partner site
Greifswald, 17475
Greifswald, Germany
| | - Sarah Wild
- Centre for Population Health Sciences, Usher Institute of
Population Health Sciences and Informatics, University of Edinburgh,
Edinburgh
EH8 9AG, UK
| | - James F. Wilson
- MRC Human Genetics Unit, Institute of Genetics and Molecular
Medicine, University of Edinburgh, Edinburgh
EH4 2XU, UK
- Centre for Global Health Research, Usher Institute of
Population Health Sciences and Informatics, University of Edinburgh, Teviot
Place, Edinburgh
EH8 9AG, UK
| | - Loïc Yengo
- CNRS UMR 8199, F-59019
Lille, France
- European Genomic Institute for Diabetes, 59000
Lille, France
- Université de Lille 2, 59000
Lille, France
| | - D. Timothy Bishop
- Leeds Institute of Cancer and Pathology, Cancer Research UK
Leeds Centre, University of Leeds, Leeds
LS9 7TF, UK
| | - Ingrid B. Borecki
- Division of Statistical Genomics, Department of Genetics,
Washington University School of Medicine, St Louis,
Missouri
63108, USA
- Analytical Genetics Group, Regeneron Genetics Center,
Regeneron Pharmaceuticals, Inc., Tarrytown, New York
10591, USA
| | - John C. Chambers
- Department of Epidemiology and Biostatistics, Imperial College
London, London
W2 1PG, UK
- Ealing Hospital NHS Trust, Middlesex
UB1 3HW, UK
- Imperial College Healthcare NHS Trust, London
W12 0HS, UK
| | - L. Adrienne Cupples
- Department of Biostatistics, Boston University School of Public
Health, Boston, Massachusetts
02118, USA
- National Heart, Lung, and Blood Institute, the Framingham
Heart Study, Framingham, Massachusetts
01702, USA
| | - Abbas Dehghan
- Department of Epidemiology, Erasmus Medical Center,
3000CA
Rotterdam/Zuidholland, The Netherlands
| | - Panos Deloukas
- William Harvey Research Institute, Barts and The London School
of Medicine and Dentistry, Queen Mary University of London,
London
EC1M 6BQ, UK
- Wellcome Trust Sanger Institute, Human Genetics,
Hinxton, Cambridge
CB10 1SA, UK
- Princess Al-Jawhara Al-Brahim Centre of Excellence in Research
of Hereditary Disorders (PACER-HD), King Abdulaziz University,
Jeddah
21589, Saudi Arabia
| | - Ghazaleh Fatemifar
- MRC Integrative Epidemiology Unit, School of Social and
Community Medicine, University of Bristol, Bristol
BS82BN, UKnited
| | - Caroline Fox
- Harvard Medical School, Boston,
Massachusetts
02115, USA
- National Heart, Lung, and Blood Institute, the Framingham
Heart Study, Framingham, Massachusetts
01702, USA
| | - Terrence S. Furey
- Department of Genetics, University of North Carolina,
Chapel Hill, North Carolina
27599, USA
- Department of Biology, University of North Carolina,
Chapel Hill, North Carolina
27599, USA
| | - Lude Franke
- University of Groningen, University Medical Center Groningen,
Department of Cardiology, 9700 RB
Groningen, The Netherlands
- Department of Genetics, University Medical Center Groningen,
University of Groningen, 9700 RB
Groningen, The Netherlands
| | - Jiali Han
- Department of Epidemiology, Richard M. Fairbanks School of
Public Health, Melvin and Bren Simon Cancer Center,
Indianapolis, Indiana
46202, USA
| | - David J. Hunter
- Broad Institute of the Massachusetts Institute of Technology
and Harvard University, Cambridge
2142, USA
- Department of Epidemiology, Harvard School of Public
Health, Boston, Massachusetts
02115, USA
- Channing Division of Network Medicine, Department of Medicine,
Brigham and Women's Hospital and Harvard Medical School,
Boston, Massachusetts
02115, USA
- Department of Nutrition, Harvard School of Public
Health, Boston, Massachusetts
02115, USA
| | - Juha Karjalainen
- Department of Genetics, University Medical Center Groningen,
University of Groningen, 9700 RB
Groningen, The Netherlands
| | - Fredrik Karpe
- Oxford Centre for Diabetes, Endocrinology and Metabolism,
University of Oxford, Churchill Hospital, Oxford
OX3 7LJ, UK
- Oxford NIHR Biomedical Research Centre,
Oxford
OX3 7LJ, UK
| | - Robert C. Kaplan
- Department of Epidemiology and Popualtion Health, Albert
Einstein College of Medicine, Bronx, New York
10461, USA
| | - Jaspal S. Kooner
- Ealing Hospital NHS Trust, Middlesex
UB1 3HW, UK
- Imperial College Healthcare NHS Trust, London
W12 0HS, UK
- National Heart and Lung Institute, Imperial College
London, London
W12 0NN, UK
| | - Mark I. McCarthy
- Wellcome Trust Centre for Human Genetics, University of
Oxford, Oxford
OX3 7BN, UK
- Oxford Centre for Diabetes, Endocrinology and Metabolism,
University of Oxford, Churchill Hospital, Oxford
OX3 7LJ, UK
- Oxford NIHR Biomedical Research Centre,
Oxford
OX3 7LJ, UK
| | - Joanne M. Murabito
- Boston University School of Medicine, Department of Medicine,
Section of General Internal Medicine, Boston,
Massachusetts
02118, USA
- NHLBI's and Boston University's Framingham
Heart Study, Framingham, Massachusetts
01702, USA
| | - Andrew P. Morris
- Wellcome Trust Centre for Human Genetics, University of
Oxford, Oxford
OX3 7BN, UK
- Department of Biostatistics, University of Liverpool,
Liverpool
L69 3GA, UK
| | - Julia A. N. Bishop
- Leeds Institute of Cancer and Pathology, Cancer Research UK
Leeds Centre, University of Leeds, Leeds
LS9 7TF, UK
| | - Kari E. North
- Carolina Center for Genome Sciences and Department of
Epidemiology, University of North Carolina at Chapel Hill, Chapel
Hill, North Carolina
27599-7400, USA
| | - Claes Ohlsson
- Centre for Bone and Arthritis Research, Department of Internal
Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy,
University of Gothenburg, 413 45
Gothenburg, Sweden
| | - Ken K. Ong
- MRC Epidemiology Unit, University of Cambridge School of
Clinical Medicine, Institute of Metabolic Science, University of Cambridge,
Cambridge Biomedical Campus, Cambridge
CB2 0QQ, UK
- MRC Unit for Lifelong Health and Ageing at UCL,
London
WC1B 5JU, UK
- Department of Paediatrics, University of Cambridge,
Cambridge
CB2 0QQ, UK
| | - Inga Prokopenko
- Wellcome Trust Centre for Human Genetics, University of
Oxford, Oxford
OX3 7BN, UK
- Department of Genomics of Common Disease, School of Public
Health, Imperial College London, London
W12 0NN, UK
- Oxford Centre for Diabetes, Endocrinology and Metabolism,
University of Oxford, Churchill Hospital, Oxford
OX3 7LJ, UK
| | - J. Brent Richards
- Department Epidemiology, Biostatistics and Human Genetics, Lady
Davis Institute, Jewish General Hospital, McGill University,
Montréal, Quebec, Canada
H3T1E2
- Department of Medicine, Lady Davis Institute, Jewish General
Hospital, McGill University, Montréal,
Quebec, Canada
H3T1E2
- Department of Twin Research, King's College
London, London
SE1 1E7, UK
- Division of Endocrinology, Lady Davis Institute, Jewish
General Hospital, McGill University, Montréal,
Quebec, Canada
H3T1E2
| | - Eric E. Schadt
- Icahn Institute for Genomics and Multiscale Biology, Icahn
School of Medicine at Mount Sinai, New York, New York
10029, USA
- Department of Genetics and Genomic Sciences, Icahn School of
Medicine at Mount Sinai, New York, New York
10029, USA
| | - Tim D. Spector
- Department of Twin Research and Genetic Epidemiology,
King's College London, London
SE1 7EH, UK
| | - Elisabeth Widén
- Institute for Molecular Medicine Finland, University of
Helsinki, FI-00290
Helsinki, Finland
| | - Cristen J. Willer
- Department of Computational Medicine and Bioinformatics,
University of Michigan, Ann Arbor, Michigan
48109, USA
- Department of Human Genetics, University of Michigan,
Ann Arbor, Michigan
48109, USA
- Department of Internal Medicine, Division of Cardiovascular
Medicine, University of Michigan, Ann Arbor, Michigan
48109, USA
| | - Jian Yang
- Queensland Brain Institute, The University of Queensland,
Brisbane
4072, Australia
| | - Erik Ingelsson
- Science for Life Laboratory, Uppsala University, 750
85
Uppsala, Sweden
- Department of Medical Sciences, Molecular Epidemiology, Uppsala
University, 751 85
Uppsala, Sweden
- Department of Medicine, Division of Cardiovascular Medicine,
Stanford University School of Medicine, Stanford,
California
94305, USA
| | - Karen L. Mohlke
- Department of Genetics, University of North Carolina,
Chapel Hill, North Carolina
27599, USA
| | - Joel N. Hirschhorn
- Broad Institute of the Massachusetts Institute of Technology
and Harvard University, Cambridge
2142, USA
- Divisions of Endocrinology and Genetics and Center for Basic
and Translational Obesity Research, Boston Children's Hospital,
Boston, Massachusetts
02115, USA
- Department of Genetics, Harvard Medical School,
Boston, Massachusetts
02115, USA
| | - John Andrew Pospisilik
- Department of Epigenetics, Max Planck Institute of
Immunobiology and Epigenetics, D-76108
Freiburg, Germany
| | - M. Carola Zillikens
- Department of Internal Medicine, Erasmus Medical Center,
3015GE
Rotterdam, The Netherlands
- Netherlands Genomics Initiative (NGI)-sponsored Netherlands
Consortium for Healthy Aging (NCHA), Rotterdam
The Netherlands
| | - Cecilia Lindgren
- Wellcome Trust Centre for Human Genetics, University of
Oxford, Oxford
OX3 7BN, UK
- Broad Institute of the Massachusetts Institute of Technology
and Harvard University, Cambridge
2142, USA
- The Big Data Institute, University of Oxford,
Oxford
OX3 7LJ, UK
| | - Tuomas Oskari Kilpeläinen
- MRC Epidemiology Unit, University of Cambridge School of
Clinical Medicine, Institute of Metabolic Science, University of Cambridge,
Cambridge Biomedical Campus, Cambridge
CB2 0QQ, UK
- Novo Nordisk Foundation Center for Basic Metabolic Research,
Section of Metabolic Genetics, Faculty of Health and Medical Sciences,
University of Copenhagen, 2100
Copenhagen, Denmark
| | - Ruth J. F. Loos
- The Charles Bronfman Institute for Personalized Medicine, The
Icahn School of Medicine at Mount Sinai, New York, New
York
10029, USA
- The Department of Preventive Medicine, The Icahn School of
Medicine at Mount Sinai, New York, New York
10029, USA
- MRC Epidemiology Unit, University of Cambridge School of
Clinical Medicine, Institute of Metabolic Science, University of Cambridge,
Cambridge Biomedical Campus, Cambridge
CB2 0QQ, UK
- The Genetics of Obesity and Related Metabolic Traits Program,
The Icahn School of Medicine at Mount Sinai, New York, New
York, 10029, USA
- The Mindich Child Health and Development Institute, The Icahn
School of Medicine at Mount Sinai, New York, New York
10029, USA
| |
Collapse
|
106
|
Lunetta KL, Day FR, Sulem P, Ruth KS, Tung JY, Hinds DA, Esko T, Elks CE, Altmaier E, He C, Huffman JE, Mihailov E, Porcu E, Robino A, Rose LM, Schick UM, Stolk L, Teumer A, Thompson DJ, Traglia M, Wang CA, Yerges-Armstrong LM, Antoniou AC, Barbieri C, Coviello AD, Cucca F, Demerath EW, Dunning AM, Gandin I, Grove ML, Gudbjartsson DF, Hocking LJ, Hofman A, Huang J, Jackson RD, Karasik D, Kriebel J, Lange EM, Lange LA, Langenberg C, Li X, Luan J, Mägi R, Morrison AC, Padmanabhan S, Pirie A, Polasek O, Porteous D, Reiner AP, Rivadeneira F, Rudan I, Sala CF, Schlessinger D, Scott RA, Stöckl D, Visser JA, Völker U, Vozzi D, Wilson JG, Zygmunt M, Boerwinkle E, Buring JE, Crisponi L, Easton DF, Hayward C, Hu FB, Liu S, Metspalu A, Pennell CE, Ridker PM, Strauch K, Streeten EA, Toniolo D, Uitterlinden AG, Ulivi S, Völzke H, Wareham NJ, Wellons M, Franceschini N, Chasman DI, Thorsteinsdottir U, Murray A, Stefansson K, Murabito JM, Ong KK, Perry JRB. Corrigendum: Rare coding variants and X-linked loci associated with age at menarche. Nat Commun 2015; 6:10257. [PMID: 26674845 PMCID: PMC4703878 DOI: 10.1038/ncomms10257] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Nature Communications 6, Article number: 7756 (2015); Published 4 August 2015; Updated 17 December 2015 In the Results section and in the legend of Table 1 of this Article, the company deCODE genetics, Inc. is incorrectly referred to as ‘Diabetes Epidemiology: collaborative analysis of Diagnostic criteria in Europe’.
Collapse
|
107
|
Day FR, Bulik-Sullivan B, Hinds DA, Finucane HK, Murabito JM, Tung JY, Ong KK, Perry JRB. Shared genetic aetiology of puberty timing between sexes and with health-related outcomes. Nat Commun 2015; 6:8842. [PMID: 26548314 PMCID: PMC4667609 DOI: 10.1038/ncomms9842] [Citation(s) in RCA: 83] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2015] [Accepted: 10/07/2015] [Indexed: 12/16/2022] Open
Abstract
Understanding of the genetic regulation of puberty timing has come largely from studies of rare disorders and population-based studies in women. Here, we report the largest genomic analysis for puberty timing in 55,871 men, based on recalled age at voice breaking. Analysis across all genomic variants reveals strong genetic correlation (0.74, P=2.7 × 10−70) between male and female puberty timing. However, some loci show sex-divergent effects, including directionally opposite effects between sexes at the SIM1/MCHR2 locus (Pheterogeneity=1.6 × 10−12). We find five novel loci for puberty timing (P<5 × 10−8), in addition to nine signals in men that were previously reported in women. Newly implicated genes include two retinoic acid-related receptors, RORB and RXRA, and two genes reportedly disrupted in rare disorders of puberty, LEPR and KAL1. Finally, we identify genetic correlations that indicate shared aetiologies in both sexes between puberty timing and body mass index, fasting insulin levels, lipid levels, type 2 diabetes and cardiovascular disease. Past studies on genetics of puberty relied on rare disorders or age of menarche in women. Here, Day et al. examine puberty timing in men by the age of voice breaking, and find some loci with sexually dimorphic effects and genetic architectures shared with other health conditions.
Collapse
Affiliation(s)
- Felix R Day
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
| | - Brendan Bulik-Sullivan
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA.,Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.,Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts 02142, USA
| | - David A Hinds
- 23andMe Inc., 899 W. Evelyn Avenue, Mountain View, California 94041, USA
| | - Hilary K Finucane
- Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts 02115, USA.,Department of Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
| | - Joanne M Murabito
- NHLBI's and Boston University's Framingham Heart Study, Framingham, Massachusetts 01702-5827, USA.,Boston University School of Medicine, Department of Medicine, Section of General Internal Medicine, Boston, Massachusetts 02118, USA
| | - Joyce Y Tung
- 23andMe Inc., 899 W. Evelyn Avenue, Mountain View, California 94041, USA
| | - Ken K Ong
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK.,Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK
| | - John R B Perry
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
| |
Collapse
|
108
|
Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, Sulem P, Bulik-Sullivan B, Esko T, Johnson AD, Elks CE, Franceschini N, He C, Altmaier E, Brody JA, Franke LL, Huffman JE, Keller MF, McArdle PF, Nutile T, Porcu E, Robino A, Rose LM, Schick UM, Smith JA, Teumer A, Traglia M, Vuckovic D, Yao J, Zhao W, Albrecht E, Amin N, Corre T, Hottenga JJ, Mangino M, Smith AV, Tanaka T, Abecasis G, Andrulis IL, Anton-Culver H, Antoniou AC, Arndt V, Arnold AM, Barbieri C, Beckmann MW, Beeghly-Fadiel A, Benitez J, Bernstein L, Bielinski SJ, Blomqvist C, Boerwinkle E, Bogdanova NV, Bojesen SE, Bolla MK, Borresen-Dale AL, Boutin TS, Brauch H, Brenner H, Brüning T, Burwinkel B, Campbell A, Campbell H, Chanock SJ, Chapman JR, Chen YDI, Chenevix-Trench G, Couch FJ, Coviello AD, Cox A, Czene K, Darabi H, De Vivo I, Demerath EW, Dennis J, Devilee P, Dörk T, dos-Santos-Silva I, Dunning AM, Eicher JD, Fasching PA, Faul JD, Figueroa J, Flesch-Janys D, Gandin I, Garcia ME, García-Closas M, Giles GG, Girotto GG, Goldberg MS, González-Neira A, Goodarzi MO, Grove ML, Gudbjartsson DF, Guénel P, Guo X, Haiman CA, Hall P, Hamann U, Henderson BE, Hocking LJ, Hofman A, Homuth G, Hooning MJ, Hopper JL, Hu FB, Huang J, Humphreys K, Hunter DJ, Jakubowska A, Jones SE, Kabisch M, Karasik D, Knight JA, Kolcic I, Kooperberg C, Kosma VM, Kriebel J, Kristensen V, Lambrechts D, Langenberg C, Li J, Li X, Lindström S, Liu Y, Luan J, Lubinski J, Mägi R, Mannermaa A, Manz J, Margolin S, Marten J, Martin NG, Masciullo C, Meindl A, Michailidou K, Mihailov E, Milani L, Milne RL, Müller-Nurasyid M, Nalls M, Neale BM, Nevanlinna H, Neven P, Newman AB, Nordestgaard BG, Olson JE, Padmanabhan S, Peterlongo P, Peters U, Petersmann A, Peto J, Pharoah PD, Pirastu NN, Pirie A, Pistis G, Polasek O, Porteous D, Psaty BM, Pylkäs K, Radice P, Raffel LJ, Rivadeneira F, Rudan I, Rudolph A, Ruggiero D, Sala CF, Sanna S, Sawyer EJ, Schlessinger D, Schmidt MK, Schmidt F, Schmutzler RK, Schoemaker MJ, Scott RA, Seynaeve CM, Simard J, Sorice R, Southey MC, Stöckl D, Strauch K, Swerdlow A, Taylor KD, Thorsteinsdottir U, Toland AE, Tomlinson I, Truong T, Tryggvadottir L, Turner ST, Vozzi D, Wang Q, Wellons M, Willemsen G, Wilson JF, Winqvist R, Wolffenbuttel BB, Wright AF, Yannoukakos D, Zemunik T, Zheng W, Zygmunt M, Bergmann S, Boomsma DI, Buring JE, Ferrucci L, Montgomery GW, Gudnason V, Spector TD, van Duijn CM, Alizadeh BZ, Ciullo M, Crisponi L, Easton DF, Gasparini PP, Gieger C, Harris TB, Hayward C, Kardia SL, Kraft P, McKnight B, Metspalu A, Morrison AC, Reiner AP, Ridker PM, Rotter JI, Toniolo D, Uitterlinden AG, Ulivi S, Völzke H, Wareham NJ, Weir DR, Yerges-Armstrong LM, Price AL, Stefansson K, Visser JA, Ong KK, Chang-Claude J, Murabito JM, Perry JR, Murray A. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nat Genet 2015; 47:1294-1303. [PMID: 26414677 PMCID: PMC4661791 DOI: 10.1038/ng.3412] [Citation(s) in RCA: 261] [Impact Index Per Article: 29.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2015] [Accepted: 09/02/2015] [Indexed: 02/02/2023]
Abstract
Menopause timing has a substantial impact on infertility and risk of disease, including breast cancer, but the underlying mechanisms are poorly understood. We report a dual strategy in ∼70,000 women to identify common and low-frequency protein-coding variation associated with age at natural menopause (ANM). We identified 44 regions with common variants, including two regions harboring additional rare missense alleles of large effect. We found enrichment of signals in or near genes involved in delayed puberty, highlighting the first molecular links between the onset and end of reproductive lifespan. Pathway analyses identified major association with DNA damage response (DDR) genes, including the first common coding variant in BRCA1 associated with any complex trait. Mendelian randomization analyses supported a causal effect of later ANM on breast cancer risk (∼6% increase in risk per year; P = 3 × 10(-14)), likely mediated by prolonged sex hormone exposure rather than DDR mechanisms.
Collapse
Affiliation(s)
- Felix R. Day
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - Katherine S. Ruth
- Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, EX2 5DW, UK
| | - Deborah J. Thompson
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
| | - Kathryn L. Lunetta
- Boston University School of Public Health, Department of Biostatistics. Boston, Massachusetts 02118, USA
- NHLBI’s and Boston University’s Framingham Heart Study, Framingham, Massachusetts 01702-5827, USA
| | - Natalia Pervjakova
- Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia
- Institute of Molecular and Cell Biology, University of Tartu, Tartu 51010, Estonia
| | - Daniel I. Chasman
- Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA 02215
- Harvard Medical School, Boston, MA 02115, USA
| | - Lisette Stolk
- Department of Internal Medicine, Erasmus MC, 3015GE Rotterdam, the Netherlands
- Netherlands Consortium on Health Aging and National Genomics Initiative, 2300 RC Leiden, the Netherlands
| | - Hilary K. Finucane
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
- Department of Mathematics, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139-4307, USA
| | - Patrick Sulem
- deCODE genetics/Amgen, Inc., IS-101 Reykjavik, Iceland
| | - Brendan Bulik-Sullivan
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA
- Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
- Medical and Population Genetics, Broad Institute, Cambridge, MA 02142, US
| | - Tõnu Esko
- Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia
- Division of Endocrinology, Boston Children’s Hospital, Boston, MA 02115, USA
- Department of Genetics, Harvard Medical School, Boston, MA 02115, USA
- Broad Institute of the Massachusetts Institute of Technology and Harvard University, 140 Cambridge 02142, MA, USA
| | - Andrew D. Johnson
- NHLBI’s and Boston University’s Framingham Heart Study, Framingham, Massachusetts 01702-5827, USA
| | - Cathy E. Elks
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - Nora Franceschini
- Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA
| | - Chunyan He
- Department of Epidemiology, Indiana University Richard M. Fairbanks School of Public Health, Indianapolis, IN 46202, USA
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA
| | - Elisabeth Altmaier
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
- Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
- Institute of Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Jennifer A. Brody
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle Washington 98101 USA
| | - Lude L. Franke
- Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
| | - Jennifer E. Huffman
- NHLBI’s and Boston University’s Framingham Heart Study, Framingham, Massachusetts 01702-5827, USA
- Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Margaux F. Keller
- Merck Pharmaceuticals, 33 Avenue Louis Pasteur, Boston, MA 02115, United States
| | - Patrick F. McArdle
- Program in Personalized Medicine, Division of Endocrinology, Diabetes and Nutrition - University of Maryland School of Medicine, USA. Baltimore, MD 21201
| | - Teresa Nutile
- Institute of Genetics and Biophysics - CNR, via Pietro Castellino 111, 80131, Naples, Italy
| | - Eleonora Porcu
- Institute of Genetics and Biomedical Research, National Research Council, Cagliari, 09042 Sardinia, Italy
- University of Sassari, Department of Biomedical Sciences, Sassari, 07100 Sassari, Italy
- Center for Statistical Genetics, Ann Arbor, University of Michigan, Michigan 48109-2029, USA
| | - Antonietta Robino
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo”, 34137 Trieste, Italy
| | - Lynda M. Rose
- Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA 02215
| | - Ursula M. Schick
- Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, WA 98109-1024, USA
| | - Jennifer A. Smith
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA
| | - Alexander Teumer
- Institute for Community Medicine, University Medicine Greifswald, 17475 Greifswald, Germany
| | - Michela Traglia
- Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132 Milano, Italy
| | - Dragana Vuckovic
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo”, 34137 Trieste, Italy
- Department of Clinical Medical Sciences, Surgical and Health, University of Trieste, 34149 Trieste, Italy
| | - Jie Yao
- The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, LABioMed at Harbor-UCLA Medical Center, Torrance, California, USA
| | - Wei Zhao
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA
| | - Eva Albrecht
- Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Najaf Amin
- Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, 3015 GE, Rotterdam, the Netherlands
| | - Tanguy Corre
- Department of Medical Genetics, University of Lausanne, CH-1005 Lausanne, Switzerland
- Swiss Institute of Bioinformatics, CH-1015, Lausanne, Switzerland
| | - Jouke-Jan Hottenga
- Department of Biological Psychology, VU University Amsterdam, van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands
| | - Massimo Mangino
- Department of Twin Research and Genetic Epidemiology, King’s College London, London SE1 7EH, UK
- National Institute for Health Research (NIHR) Biomedical Research Centre at Guy’s and St. Thomas’ Foundation Trust, London, UK
| | - Albert V. Smith
- Icelandic Heart Association, Kopavogur, Iceland
- Faculty of Medicine, University of Iceland, IS-101 Reykjavik, Iceland
| | - Toshiko Tanaka
- Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, Baltimore, Maryland 21224, United States of America
| | - Goncalo Abecasis
- Center for Statistical Genetics, Ann Arbor, University of Michigan, Michigan 48109-2029, USA
| | - Irene L. Andrulis
- Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario M5G 1X5, Canada
- Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada
| | - Hoda Anton-Culver
- Department of Epidemiology, University of California Irvine, Irvine, California, USA
| | - Antonis C. Antoniou
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
| | - Volker Arndt
- Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Alice M. Arnold
- Department of Biostatistics, University of Washington, Seattle, WA, USA
| | - Caterina Barbieri
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo”, 34137 Trieste, Italy
- Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132 Milano, Italy
| | - Matthias W. Beckmann
- Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
| | - Alicia Beeghly-Fadiel
- Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
| | - Javier Benitez
- Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
- Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain
| | | | - Suzette J. Bielinski
- Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
| | - Carl Blomqvist
- Department of Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
| | - Eric Boerwinkle
- Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
- Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA
| | | | - Stig E. Bojesen
- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark
| | - Manjeet K. Bolla
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
| | - Anne-Lise Borresen-Dale
- Department of Genetics, Institute for Cancer Research, Radiumhospitalet, Oslo University Hospital, Oslo University Hospital, Oslo, Norway
- Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
| | - Thibaud S Boutin
- Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Hiltrud Brauch
- Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany
- University of Tübingen, Tübingen, Germany
- German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Hermann Brenner
- Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
- German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany
- Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Thomas Brüning
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany
| | - Barbara Burwinkel
- Division of Molecular Genetic Epidemiology, German Cancer Research Center, Heidelberg, Germany
- Molecular Biology of Breast Cancer, Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany
| | - Archie Campbell
- Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Harry Campbell
- Institute for Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, Scotland
| | - Stephen J. Chanock
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
| | - J. Ross Chapman
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
| | - Yii-Der Ida Chen
- The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, LABioMed at Harbor-UCLA Medical Center, Torrance, California, USA
| | | | - Fergus J. Couch
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
| | - Andrea D. Coviello
- Boston University School of Medicine, Department of Medicine, Sections of Preventive Medicine and Endocrinology, Boston, MA
| | - Angela Cox
- Sheffield Cancer Research, Department of Oncology, University of Sheffield, Sheffield, UK
| | - Kamila Czene
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden
| | - Hatef Darabi
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden
| | - Immaculata De Vivo
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA
| | - Ellen W. Demerath
- Division of Epidemiology & Community Health, University of Minnesotta, Minneapolis MN 55455
| | - Joe Dennis
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
| | - Peter Devilee
- Department of Human Genetics, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
- Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - Thilo Dörk
- Gynaecology Research Unit, Hannover Medical School, Hannover, Germany
| | - Isabel dos-Santos-Silva
- Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK
| | - Alison M. Dunning
- Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK
| | - John D. Eicher
- NHLBI’s and Boston University’s Framingham Heart Study, Framingham, Massachusetts 01702-5827, USA
| | - Peter A. Fasching
- Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany
- David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, CA, USA
| | - Jessica D. Faul
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA
| | - Jonine Figueroa
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA
| | - Dieter Flesch-Janys
- Department of Cancer Epidemiology/Clinical Cancer Registry, University Clinic Hamburg-Eppendorf, Hamburg, Germany
- Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany
| | - Ilaria Gandin
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo”, 34137 Trieste, Italy
- Department of Clinical Medical Sciences, Surgical and Health, University of Trieste, 34149 Trieste, Italy
| | - Melissa E. Garcia
- Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Bethesda, MD, USA
| | - Montserrat García-Closas
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
- Division of Cancer Studies, Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
| | - Graham G. Giles
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
- Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia
| | - Giorgia G. Girotto
- Department of Clinical Medical Sciences, Surgical and Health, University of Trieste, 34149 Trieste, Italy
| | - Mark S. Goldberg
- Department of Medicine, McGill University, Montreal, Canada
- Division of Clinical Epidemiology, Royal Victoria Hospital, McGill University, Montreal, Canada
| | - Anna González-Neira
- Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
| | - Mark O. Goodarzi
- Division of Endocrinology, Diabetes and Metabolism, Cedars-Sinai Medical Center, Los Angeles, California, USA
| | - Megan L. Grove
- Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
| | - Daniel F. Gudbjartsson
- deCODE genetics/Amgen, Inc., IS-101 Reykjavik, Iceland
- School of Engineering and Natural Sciences, University of Iceland, IS-101 Reykjavik, Iceland
| | - Pascal Guénel
- Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France
- University Paris-Sud, UMRS 1018, Villejuif, France
| | - Xiuqing Guo
- The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, LABioMed at Harbor-UCLA Medical Center, Torrance, California, USA
| | - Christopher A. Haiman
- Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| | - Per Hall
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden
| | - Ute Hamann
- Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany
| | - Brian E. Henderson
- Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
| | - Lynne J. Hocking
- Musculoskeletal Research Programme, Division of Applied Medicine, University of Aberdeen, Aberdeen AB25 2ZD, UK
| | - Albert Hofman
- Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, 3015 GE, Rotterdam, the Netherlands
| | - Georg Homuth
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, 17475 Greifswald, Germany
| | - Maartje J. Hooning
- Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - John L. Hopper
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
| | - Frank B. Hu
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA
- Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
| | - Jinyan Huang
- State Key Laboratory of Medical Genomics,Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
| | - Keith Humphreys
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden
| | - David J. Hunter
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
- Broad Institute of the Massachusetts Institute of Technology and Harvard University, 140 Cambridge 02142, MA, USA
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA
- Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
| | - Anna Jakubowska
- Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
| | - Samuel E. Jones
- Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, EX2 5DW, UK
| | - Maria Kabisch
- Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany
| | - David Karasik
- Harvard Medical School, Boston, MA 02115, USA
- Hebrew SeniorLife Institute for Aging Research, Boston, MA, 02131, USA
| | - Julia A. Knight
- Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Canada
- Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - Ivana Kolcic
- Faculty of Medicine, University of Split, Split, Croatia
| | - Charles Kooperberg
- Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, WA 98109-1024, USA
| | - Veli-Matti Kosma
- Cancer Center, Kuopio University Hospital, Kuopio, Finland
- School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland
- Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland
| | - Jennifer Kriebel
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
- Institute of Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
- German Center for Diabetes Research, 85764 Neuherberg, Germany
| | - Vessela Kristensen
- Department of Genetics, Institute for Cancer Research, Radiumhospitalet, Oslo University Hospital, Oslo University Hospital, Oslo, Norway
- Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
- Department of Clinical Molecular Biology, Oslo University Hospital, University of Oslo, Oslo, Norway
| | - Diether Lambrechts
- Vesalius Research Center (VRC), VIB, Leuven, Belgium
- Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium
| | - Claudia Langenberg
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - Jingmei Li
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, 17177 Stockholm, Sweden
| | - Xin Li
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
| | - Sara Lindström
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
| | - Yongmei Liu
- Center for Human Genetics, Division of Public Health Sciences, Wake Forest School of Medicine
| | - Jian’an Luan
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - Jan Lubinski
- Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland
| | - Reedik Mägi
- Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia
| | - Arto Mannermaa
- Cancer Center, Kuopio University Hospital, Kuopio, Finland
- School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland
- Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland
| | - Judith Manz
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
- Institute of Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Sara Margolin
- Department of Oncology - Pathology, Karolinska Institutet, Stockholm 17177, Sweden
| | - Jonathan Marten
- Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Nicholas G. Martin
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | - Corrado Masciullo
- Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132 Milano, Italy
| | - Alfons Meindl
- Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany
| | - Kyriaki Michailidou
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
| | - Evelin Mihailov
- Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia
| | - Lili Milani
- Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia
| | - Roger L. Milne
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
- Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia
| | - Martina Müller-Nurasyid
- Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
- Department of Medicine I, Ludwig-Maximilians-University Munich, 81377 Munich, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
| | - Michael Nalls
- Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA
| | - Ben M. Neale
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, USA
- Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
- Medical and Population Genetics, Broad Institute, Cambridge, MA 02142, US
| | - Heli Nevanlinna
- Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
| | - Patrick Neven
- KULeuven (University of Leuven), Department of Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, Belgium
| | - Anne B. Newman
- Department of Epidemiology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
- Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
- Department of Clinical and Translational Science, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
| | - Børge G. Nordestgaard
- Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark
| | - Janet E. Olson
- Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA
| | - Sandosh Padmanabhan
- British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, UK
| | - Paolo Peterlongo
- IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy
| | - Ulrike Peters
- Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, WA 98109-1024, USA
| | - Astrid Petersmann
- Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, 17475 Greifswald, Germany
| | - Julian Peto
- Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK
| | - Paul D.P. Pharoah
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
- Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK
| | - Nicola N. Pirastu
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo”, 34137 Trieste, Italy
- Department of Clinical Medical Sciences, Surgical and Health, University of Trieste, 34149 Trieste, Italy
| | - Ailith Pirie
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
| | - Giorgio Pistis
- Institute of Genetics and Biomedical Research, National Research Council, Cagliari, 09042 Sardinia, Italy
- University of Sassari, Department of Biomedical Sciences, Sassari, 07100 Sassari, Italy
- Center for Statistical Genetics, Ann Arbor, University of Michigan, Michigan 48109-2029, USA
| | - Ozren Polasek
- Faculty of Medicine, University of Split, Split, Croatia
| | - David Porteous
- Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Bruce M. Psaty
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle Washington 98101 USA
- Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA 98195, USA
- Group Health Research Institute, Group Health Cooperative, Seattle, Washington 98101, USA
- Department of Health Services, University of Washington, Seattle, Washington 98101, USA
| | - Katri Pylkäs
- Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry, University of Oulu, Oulu, Finland
- Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland
| | - Paolo Radice
- Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy
| | - Leslie J. Raffel
- Medical Genetics Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
- UCLA Clinical & Translational Science Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
| | - Fernando Rivadeneira
- Department of Internal Medicine, Erasmus MC, 3015GE Rotterdam, the Netherlands
- Netherlands Consortium on Health Aging and National Genomics Initiative, 2300 RC Leiden, the Netherlands
- Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, 3015 GE, Rotterdam, the Netherlands
| | - Igor Rudan
- Institute for Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, Scotland
| | - Anja Rudolph
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Daniela Ruggiero
- Institute of Genetics and Biophysics - CNR, via Pietro Castellino 111, 80131, Naples, Italy
| | - Cinzia F. Sala
- Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132 Milano, Italy
| | - Serena Sanna
- Institute of Genetics and Biomedical Research, National Research Council, Cagliari, 09042 Sardinia, Italy
| | - Elinor J. Sawyer
- Research Oncology, Guy’s Hospital, King’s College London, London, UK
| | - David Schlessinger
- National Institute on Aging, Intramural Research Program, Baltimore, MD 20892, USA
| | - Marjanka K. Schmidt
- Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands
| | - Frank Schmidt
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, 17475 Greifswald, Germany
| | - Rita K. Schmutzler
- Division of Molecular Gyneco-Oncology, Department of Gynaecology and Obstetrics, University Hospital of Cologne, Cologne, Germany
- Center of Familial Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany
- Center for Integrated Oncology, University Hospital of Cologne, Cologne, Germany
| | - Minouk J. Schoemaker
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
| | - Robert A. Scott
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - Caroline M. Seynaeve
- Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Jacques Simard
- Centre Hospitalier Universitaire de Québec Research Center, Laval University, Québec City, Canada
| | - Rossella Sorice
- Institute of Genetics and Biophysics - CNR, via Pietro Castellino 111, 80131, Naples, Italy
| | - Melissa C. Southey
- Department of Pathology, The University of Melbourne, Melbourne, Australia
| | - Doris Stöckl
- Institute of Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Konstantin Strauch
- Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
- Institute of Medical Informatics, Biometry and Epidemiology, Chair of Genetic Epidemiology, Ludwig-Maximilians-Universität, 81377 Munich, Germany
| | - Anthony Swerdlow
- Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK
- Division of Breast Cancer Research, The Institute of Cancer Research, London, UK
| | - Kent D. Taylor
- The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, LABioMed at Harbor-UCLA Medical Center, Torrance, California, USA
| | - Unnur Thorsteinsdottir
- deCODE genetics/Amgen, Inc., IS-101 Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, IS-101 Reykjavik, Iceland
| | - Amanda E. Toland
- Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA
| | - Ian Tomlinson
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
- NIHR Oxford Biomedical Research Centre, Churchill Hospital, OX3 7LE Oxford, UK
| | - Thérèse Truong
- Environmental Epidemiology of Cancer, Center for Research in Epidemiology and Population Health, INSERM, Villejuif, France
- University Paris-Sud, UMRS 1018, Villejuif, France
| | | | - Stephen T. Turner
- Division of Nephrology and Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA
| | - Diego Vozzi
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo”, 34137 Trieste, Italy
| | - Qin Wang
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
| | - Melissa Wellons
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, 37203, USA
| | - Gonneke Willemsen
- Department of Biological Psychology, VU University Amsterdam, van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands
| | - James F. Wilson
- Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
- Institute for Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh, EH8 9AG, Scotland
| | - Robert Winqvist
- Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry, University of Oulu, Oulu, Finland
- Laboratory of Cancer Genetics and Tumor Biology, Northern Finland Laboratory Centre NordLab, Oulu, Finland
| | - Bruce B.H.R. Wolffenbuttel
- Department of Endocrinology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
- LifeLines Cohort Study and Biobank, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
| | - Alan F. Wright
- Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Drakoulis Yannoukakos
- Molecular Diagnostics Laboratory, IRRP, National Centre for Scientific Research “Demokritos“, Athens, Greece
| | | | - Wei Zheng
- Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA
| | - Marek Zygmunt
- Department of Obstetrics and Gynecology, University Medicine Greifswald, 17475 Greifswald, Germany
| | - Sven Bergmann
- Department of Medical Genetics, University of Lausanne, CH-1005 Lausanne, Switzerland
- Swiss Institute of Bioinformatics, CH-1015, Lausanne, Switzerland
| | - Dorret I. Boomsma
- Department of Biological Psychology, VU University Amsterdam, van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands
| | - Julie E. Buring
- Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA 02215
- Harvard Medical School, Boston, MA 02115, USA
| | - Luigi Ferrucci
- Longitudinal Studies Section, Translational Gerontology Branch, National Institute on Aging, Baltimore, Maryland 21224, United States of America
| | | | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur, Iceland
- Faculty of Medicine, University of Iceland, IS-101 Reykjavik, Iceland
| | - Tim D. Spector
- Department of Twin Research and Genetic Epidemiology, King’s College London, London SE1 7EH, UK
| | - Cornelia M van Duijn
- Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, 3015 GE, Rotterdam, the Netherlands
| | - Behrooz Z. Alizadeh
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Marina Ciullo
- Institute of Genetics and Biophysics - CNR, via Pietro Castellino 111, 80131, Naples, Italy
| | - Laura Crisponi
- Institute of Genetics and Biomedical Research, National Research Council, Cagliari, 09042 Sardinia, Italy
| | - Douglas F. Easton
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
- Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, CB1 8RN, UK
| | - Paolo P. Gasparini
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo”, 34137 Trieste, Italy
- Department of Clinical Medical Sciences, Surgical and Health, University of Trieste, 34149 Trieste, Italy
| | - Christian Gieger
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
- Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
- Institute of Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, 85764 Neuherberg, Germany
| | - Tamara B. Harris
- Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Bethesda, MD, USA
| | - Caroline Hayward
- Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Sharon L.R. Kardia
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA
| | - Peter Kraft
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
- Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA
| | - Barbara McKnight
- Department of Biostatistics, University of Washington, Seattle, WA, USA
| | - Andres Metspalu
- Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia
| | - Alanna C. Morrison
- Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
| | - Alex P. Reiner
- Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, WA 98109-1024, USA
- Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA 98195, USA
| | - Paul M. Ridker
- Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA 02215
- Harvard Medical School, Boston, MA 02115, USA
| | - Jerome I. Rotter
- The Institute for Translational Genomics and Population Sciences, Department of Pediatrics, LABioMed at Harbor-UCLA Medical Center, Torrance, California, USA
| | - Daniela Toniolo
- Division of Genetics and Cell Biology, San Raffaele Scientific Institute, 20132 Milano, Italy
| | - André G. Uitterlinden
- Department of Internal Medicine, Erasmus MC, 3015GE Rotterdam, the Netherlands
- Netherlands Consortium on Health Aging and National Genomics Initiative, 2300 RC Leiden, the Netherlands
- Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, 3015 GE, Rotterdam, the Netherlands
| | - Sheila Ulivi
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo”, 34137 Trieste, Italy
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, 17475 Greifswald, Germany
| | - Nicholas J. Wareham
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - David R. Weir
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA
| | - Laura M. Yerges-Armstrong
- Program in Personalized Medicine, Division of Endocrinology, Diabetes and Nutrition - University of Maryland School of Medicine, USA. Baltimore, MD 21201
| | | | | | - AOCS Investigators
- Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Australia
| | - Generation Scotland
- A Collaboration between the University Medical Schools and NHS in Aberdeen, Dundee, Edinburgh and Glasgow, UK
| | | | | | - Alkes L. Price
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
| | - Kari Stefansson
- deCODE genetics/Amgen, Inc., IS-101 Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, IS-101 Reykjavik, Iceland
| | - Jenny A. Visser
- Department of Internal Medicine, Erasmus MC, 3015GE Rotterdam, the Netherlands
| | - Ken K. Ong
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
- Department of Paediatrics,University of Cambridge,Cambridge, CB2 0QQ, UK
| | - Jenny Chang-Claude
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Joanne M. Murabito
- NHLBI’s and Boston University’s Framingham Heart Study, Framingham, Massachusetts 01702-5827, USA
- Boston University School of Medicine, Department of Medicine, Section of General Internal Medicine, Boston, MA 02118, USA
| | - John R.B. Perry
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - Anna Murray
- Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, EX2 5DW, UK
| |
Collapse
|
109
|
Peters MJ, Joehanes R, Pilling LC, Schurmann C, Conneely KN, Powell J, Reinmaa E, Sutphin GL, Zhernakova A, Schramm K, Wilson YA, Kobes S, Tukiainen T, Ramos YF, Göring HHH, Fornage M, Liu Y, Gharib SA, Stranger BE, De Jager PL, Aviv A, Levy D, Murabito JM, Munson PJ, Huan T, Hofman A, Uitterlinden AG, Rivadeneira F, van Rooij J, Stolk L, Broer L, Verbiest MMPJ, Jhamai M, Arp P, Metspalu A, Tserel L, Milani L, Samani NJ, Peterson P, Kasela S, Codd V, Peters A, Ward-Caviness CK, Herder C, Waldenberger M, Roden M, Singmann P, Zeilinger S, Illig T, Homuth G, Grabe HJ, Völzke H, Steil L, Kocher T, Murray A, Melzer D, Yaghootkar H, Bandinelli S, Moses EK, Kent JW, Curran JE, Johnson MP, Williams-Blangero S, Westra HJ, McRae AF, Smith JA, Kardia SLR, Hovatta I, Perola M, Ripatti S, Salomaa V, Henders AK, Martin NG, Smith AK, Mehta D, Binder EB, Nylocks KM, Kennedy EM, Klengel T, Ding J, Suchy-Dicey AM, Enquobahrie DA, Brody J, Rotter JI, Chen YDI, Houwing-Duistermaat J, Kloppenburg M, Slagboom PE, Helmer Q, den Hollander W, Bean S, Raj T, Bakhshi N, Wang QP, Oyston LJ, Psaty BM, Tracy RP, Montgomery GW, Turner ST, Blangero J, Meulenbelt I, Ressler KJ, Yang J, Franke L, Kettunen J, Visscher PM, Neely GG, Korstanje R, Hanson RL, Prokisch H, Ferrucci L, Esko T, Teumer A, van Meurs JBJ, Johnson AD. The transcriptional landscape of age in human peripheral blood. Nat Commun 2015; 6:8570. [PMID: 26490707 PMCID: PMC4639797 DOI: 10.1038/ncomms9570] [Citation(s) in RCA: 407] [Impact Index Per Article: 45.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Accepted: 09/07/2015] [Indexed: 02/08/2023] Open
Abstract
Disease incidences increase with age, but the molecular characteristics of ageing that lead to increased disease susceptibility remain inadequately understood. Here we perform a whole-blood gene expression meta-analysis in 14,983 individuals of European ancestry (including replication) and identify 1,497 genes that are differentially expressed with chronological age. The age-associated genes do not harbor more age-associated CpG-methylation sites than other genes, but are instead enriched for the presence of potentially functional CpG-methylation sites in enhancer and insulator regions that associate with both chronological age and gene expression levels. We further used the gene expression profiles to calculate the ‘transcriptomic age' of an individual, and show that differences between transcriptomic age and chronological age are associated with biological features linked to ageing, such as blood pressure, cholesterol levels, fasting glucose, and body mass index. The transcriptomic prediction model adds biological relevance and complements existing epigenetic prediction models, and can be used by others to calculate transcriptomic age in external cohorts. Ageing increases the risk of many diseases. Here the authors compare blood cell transcriptomes of over 14,000 individuals and identify a set of about 1,500 genes that are differently expressed with age, shedding light on transcriptional programs linked to the ageing process and age-associated diseases.
Collapse
Affiliation(s)
- Marjolein J Peters
- Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam 3000CA, The Netherlands
| | - Roby Joehanes
- The National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, Massachusetts 01702, USA.,Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20817, USA
| | - Luke C Pilling
- Epidemiology and Public Health, University of Exeter Medical School, Exeter EX4 1DB, UK
| | - Claudia Schurmann
- Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald 17493, Germany.,The Charles Bronfman Institute for Personalized Medicine, Genetics of Obesity &Related Metabolic Traits Program, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York 10029, USA
| | - Karen N Conneely
- Department of Human Genetics, School of Medicine, Emory University, Atlanta, Georgia 30301, USA
| | - Joseph Powell
- Centre for Neurogenetics and Statistical Genomics, Queensland Brain Institute, University of Queensland, St Lucia, Brisbane, Queensland 4000, Australia.,The Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4000, Australia
| | - Eva Reinmaa
- Estonian Genome Center, University of Tartu, Tartu 0794, Estonia
| | - George L Sutphin
- Nathan Shock Center of Excellence in the Basic Biology of Aging, The Jackson Laboratory, Bar Harbor, Maine 04609, USA
| | - Alexandra Zhernakova
- Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen 9700RB, The Netherlands
| | - Katharina Schramm
- Institute of Human Genetics, Helmholz Zentrum München - German Research Center for Environmental Health, Neuherberg 85764, Germany.,Institute of Human Genetics, Technical University Munich, Munich 85540, Germany
| | - Yana A Wilson
- Neuroscience Division, Garvan Institute of Medical Research, Australia and Charles Perkins Centre and School of Molecular Bioscience, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Sayuko Kobes
- Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Phoenix, Arizona 85001, USA
| | - Taru Tukiainen
- Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki 00131, Finland.,Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki 00131, Finland
| | | | - Yolande F Ramos
- Department of Molecular Epidemiology, Leiden University Medical Center, Leiden 2300RC, The Netherlands
| | - Harald H H Göring
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas 78201, USA
| | - Myriam Fornage
- Division of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, University of Texas Health Sciences, Center at Houston, Texas 77001, USA.,Institute of Molecular Medicine, University of Texas Health Sciences Center at Houston, Houston, Texas 77001, USA
| | - Yongmei Liu
- Department of Epidemiology and Prevention, Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina 27101, USA
| | - Sina A Gharib
- Computational Medicine Core, Center for Lung Biology, University of Washington, Seattle, Washington 98101, USA
| | - Barbara E Stranger
- Section of Genetic Medicine, Institute for Genomics and Systems Biology, University of Chicago, Chicago, Illinois 60290, USA
| | - Philip L De Jager
- Program in Translational NeuroPsychiatric Genomics, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02108, USA
| | - Abraham Aviv
- Center of Human Development and Aging, New Jersey Medical School, Newark 07101, USA
| | - Daniel Levy
- The National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, Massachusetts 01702, USA.,Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20817, USA
| | - Joanne M Murabito
- The National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, Massachusetts 01702, USA.,General Internal Medicine Section, Boston University, Boston, Massachusetts 02108, USA
| | - Peter J Munson
- The Mathematical and Statistical Computing Laboratory, Center for Information Technology, National Institutes of Health, Bethesda, Maryland 20817, USA
| | - Tianxiao Huan
- The National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, Massachusetts 01702, USA.,Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20817, USA
| | - Albert Hofman
- Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000CA, The Netherlands
| | - André G Uitterlinden
- Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam 3000CA, The Netherlands.,Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000CA, The Netherlands
| | - Fernando Rivadeneira
- Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam 3000CA, The Netherlands.,Department of Epidemiology, Erasmus Medical Center, Rotterdam 3000CA, The Netherlands
| | - Jeroen van Rooij
- Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam 3000CA, The Netherlands
| | - Lisette Stolk
- Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam 3000CA, The Netherlands
| | - Linda Broer
- Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam 3000CA, The Netherlands
| | - Michael M P J Verbiest
- Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam 3000CA, The Netherlands
| | - Mila Jhamai
- Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam 3000CA, The Netherlands
| | - Pascal Arp
- Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam 3000CA, The Netherlands
| | - Andres Metspalu
- Estonian Genome Center, University of Tartu, Tartu 0794, Estonia
| | - Liina Tserel
- Molecular Pathology, Institute of Biomedicine, University of Tartu, Tartu 0794, Estonia
| | - Lili Milani
- Estonian Genome Center, University of Tartu, Tartu 0794, Estonia
| | - Nilesh J Samani
- Department of Cardiovascular Sciences, University of Leicester, Leicester LE1, UK.,National Institute for Health Research Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester LE1, UK
| | - Pärt Peterson
- Molecular Pathology, Institute of Biomedicine, University of Tartu, Tartu 0794, Estonia
| | - Silva Kasela
- Institute of Molecular and Cell Biology, Estonian Genome Center, University of Tartu, Tartu 0794, Estonia
| | - Veryan Codd
- Department of Cardiovascular Sciences, University of Leicester, Leicester LE1, UK.,National Institute for Health Research Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester LE1, UK
| | - Annette Peters
- Institute of Epidemiologie II, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg 85764, Germany.,Research Unit of Molecular Epidemiology, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg 85764, Germany
| | - Cavin K Ward-Caviness
- Institute of Epidemiologie II, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg 85764, Germany
| | - Christian Herder
- Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf 40593, Germany
| | - Melanie Waldenberger
- Institute of Epidemiologie II, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg 85764, Germany.,Research Unit of Molecular Epidemiology, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg 85764, Germany
| | - Michael Roden
- Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf 40593, Germany.,Division of Endocrinology and Diabetology, University Hospital Düsseldorf, Heinrich Heine University, Düsseldorf 40593, Germany
| | - Paula Singmann
- Institute of Epidemiologie II, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg 85764, Germany.,Research Unit of Molecular Epidemiology, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg 85764, Germany
| | - Sonja Zeilinger
- Institute of Epidemiologie II, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg 85764, Germany.,Research Unit of Molecular Epidemiology, Helmholtz Zentrum Muenchen, German Research Center for Environmental Health, Neuherberg 85764, Germany
| | - Thomas Illig
- Hannover Unified Biobank, Hannover Medical School, Hannover 30519, Germany
| | - Georg Homuth
- Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald 17493, Germany
| | - Hans-Jörgen Grabe
- Department of Psychiatry and Psychotherapy, Helios Hospital Stralsund, University Medicine Greifswald, Greifswald 17489, Germany
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, Greifswald 17489, Germany
| | - Leif Steil
- Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald 17493, Germany
| | - Thomas Kocher
- Unit of Periodontology, Department of Restorative Dentistry, Periodontology and Endodontology, University Medicine Greifswald, Greifswald 17489, Germany
| | - Anna Murray
- Epidemiology and Public Health, University of Exeter Medical School, Exeter EX4 1DB, UK
| | - David Melzer
- Epidemiology and Public Health, University of Exeter Medical School, Exeter EX4 1DB, UK
| | - Hanieh Yaghootkar
- Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter EX2 5DW, UK
| | | | - Eric K Moses
- Centre for Genetic Origins of Health and Disease, The University of Western Australia, and Faculty of Health Sciences, Curtin University, Perth, Western Australia 9011, Australia
| | - Jack W Kent
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas 78201, USA
| | - Joanne E Curran
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas 78201, USA
| | - Matthew P Johnson
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas 78201, USA
| | | | - Harm-Jan Westra
- Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen 9700RB, The Netherlands.,Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge 02138, USA.,Divisions of Genetics and Rheumatology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02108, USA.,Partners Center for Personalized Genetic Medicine, Boston, Massachusetts 02108, USA
| | - Allan F McRae
- The Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4000, Australia.,University of Queensland Diamantina Institute, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4000, Australia
| | - Jennifer A Smith
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan 48103, USA
| | - Sharon L R Kardia
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan 48103, USA
| | - Iiris Hovatta
- Department of Biosciences, University of Helsinki, Helsinki 00100, Finland.,Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki 00100, Finland
| | - Markus Perola
- Estonian Genome Center, University of Tartu, Tartu 0794, Estonia.,Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki 00131, Finland.,Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki 00131, Finland
| | - Samuli Ripatti
- Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki 00131, Finland.,Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki 00131, Finland.,Wellcome Trust Sanger Institute, Hinxton, Cambridge CB4, UK.,Department of Public Health, Hjelt Institute, University of Helsinki, Helsinki 00100, Finland
| | - Veikko Salomaa
- Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki 00131, Finland
| | - Anjali K Henders
- The Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4000, Australia
| | - Nicholas G Martin
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4000, Australia
| | - Alicia K Smith
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30301, USA
| | - Divya Mehta
- Max-Planck Institute of Psychiatry, Munich 80331, Germany
| | | | - K Maria Nylocks
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30301, USA
| | - Elizabeth M Kennedy
- Department of Human Genetics, School of Medicine, Emory University, Atlanta, Georgia 30301, USA
| | | | - Jingzhong Ding
- Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina 27101, USA
| | - Astrid M Suchy-Dicey
- Department of Epidemiology, University of Washington, Seattle, Washington 98101, USA
| | - Daniel A Enquobahrie
- Department of Epidemiology, University of Washington, Seattle, Washington 98101, USA
| | - Jennifer Brody
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington 98101, USA
| | - Jerome I Rotter
- Institute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California 90501, USA
| | - Yii-Der I Chen
- Institute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California 90501, USA
| | | | - Margreet Kloppenburg
- Department of Rheumatology, Leiden University Medical Center, Leiden 2300RC, The Netherlands.,Department of Clinical Epidemiology, Leiden University Medical Center, Leiden 2300RC, The Netherlands
| | - P Eline Slagboom
- Department of Molecular Epidemiology, Leiden University Medical Center, Leiden 2300RC, The Netherlands
| | - Quinta Helmer
- Department of Medical Statistics, Leiden University Medical Center, Leiden 2300RC, The Netherlands
| | - Wouter den Hollander
- Department of Molecular Epidemiology, Leiden University Medical Center, Leiden 2300RC, The Netherlands
| | - Shannon Bean
- Nathan Shock Center of Excellence in the Basic Biology of Aging, The Jackson Laboratory, Bar Harbor, Maine 04609, USA
| | - Towfique Raj
- Division of Immunology, Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02138, USA
| | - Noman Bakhshi
- Neuroscience Division, Garvan Institute of Medical Research, Australia and Charles Perkins Centre and School of Molecular Bioscience, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Qiao Ping Wang
- Neuroscience Division, Garvan Institute of Medical Research, Australia and Charles Perkins Centre and School of Molecular Bioscience, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Lisa J Oyston
- Neuroscience Division, Garvan Institute of Medical Research, Australia and Charles Perkins Centre and School of Molecular Bioscience, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Bruce M Psaty
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington 98195, USA.,Cardiovascular Health Research Unit, Department of Epidemiology, University of Washington, Seattle, Washington 98195, USA.,Cardiovascular Health Research Unit, Department of Health Services, University of Washington, Seattle, Washington 98195, USA.,Group Health Research Institute, Group Health Cooperative, Seattle, Washington 98195, USA
| | - Russell P Tracy
- Department of Pathology, University of Vermont College of Medicine, Colchester, Vermont 98195, USA
| | - Grant W Montgomery
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4000, Australia
| | - Stephen T Turner
- Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55901, USA
| | - John Blangero
- Department of Genetics, Texas Biomedical Research Institute, San Antonio, Texas 78201, USA
| | - Ingrid Meulenbelt
- Department of Molecular Epidemiology, Leiden University Medical Center, Leiden 2300RC, The Netherlands
| | - Kerry J Ressler
- Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, Georgia 30301, USA
| | - Jian Yang
- The Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4000, Australia.,University of Queensland Diamantina Institute, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4000, Australia
| | - Lude Franke
- Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen 9700RB, The Netherlands
| | - Johannes Kettunen
- Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki 00131, Finland.,Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki 00131, Finland.,Computational Medicine, Institute of Health Sciences, Faculty of Medicine, University of Oulu, Oulu 90570, Finland
| | - Peter M Visscher
- The Queensland Brain Institute, University of Queensland, Brisbane, Queensland 4000, Australia.,University of Queensland Diamantina Institute, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland 4000, Australia
| | - G Gregory Neely
- Neuroscience Division, Garvan Institute of Medical Research, Australia and Charles Perkins Centre and School of Molecular Bioscience, The University of Sydney, Sydney, New South Wales 2006, Australia
| | - Ron Korstanje
- Nathan Shock Center of Excellence in the Basic Biology of Aging, The Jackson Laboratory, Bar Harbor, Maine 04609, USA
| | - Robert L Hanson
- Phoenix Epidemiology and Clinical Research Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Phoenix, Arizona 85001, USA
| | - Holger Prokisch
- Institute of Human Genetics, Helmholz Zentrum München - German Research Center for Environmental Health, Neuherberg 85764, Germany.,Institute of Human Genetics, Technical University Munich, Munich 85540, Germany
| | - Luigi Ferrucci
- Clinical Research Branch, National Institute on Aging, Baltimore, Maryland 21218, USA
| | - Tonu Esko
- Estonian Genome Center, University of Tartu, Tartu 0794, Estonia.,Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge 02138, USA.,Division of Endocrinology, Children's Hospital Boston, Boston, Massachusetts 02108, USA.,Department of Genetics, Harvard Medical School, Boston, Massachusetts 02108, USA
| | - Alexander Teumer
- Department of Functional Genomics, Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald 17493, Germany
| | - Joyce B J van Meurs
- Department of Internal Medicine, Erasmus Medical Centre Rotterdam, Rotterdam 3000CA, The Netherlands
| | - Andrew D Johnson
- The National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, Massachusetts 01702, USA.,Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20817, USA
| |
Collapse
|
110
|
Pilling LC, Joehanes R, Melzer D, Harries LW, Henley W, Dupuis J, Lin H, Mitchell M, Hernandez D, Ying SX, Lunetta KL, Benjamin EJ, Singleton A, Levy D, Munson P, Murabito JM, Ferrucci L. Gene expression markers of age-related inflammation in two human cohorts. Exp Gerontol 2015; 70:37-45. [PMID: 26087330 PMCID: PMC4600657 DOI: 10.1016/j.exger.2015.05.012] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2014] [Revised: 04/13/2015] [Accepted: 05/19/2015] [Indexed: 12/19/2022]
Abstract
INTRODUCTION Chronically elevated circulating inflammatory markers are common in older persons but mechanisms are unclear. Many blood transcripts (>800 genes) are associated with interleukin-6 protein levels (IL6) independent of age. We aimed to identify gene transcripts statistically mediating, as drivers or responders, the increasing levels of IL6 protein in blood at older ages. METHODS Blood derived in-vivo RNA from the Framingham Heart Study (FHS, n=2422, ages 40-92 yrs) and InCHIANTI study (n=694, ages 30-104 yrs), with Affymetrix and Illumina expression arrays respectively (>17,000 genes tested), were tested for statistical mediation of the age-IL6 association using resampling techniques, adjusted for confounders and multiple testing. RESULTS In FHS, IL6 expression was not associated with IL6 protein levels in blood. 102 genes (0.6% of 17,324 expressed) statistically mediated the age-IL6 association of which 25 replicated in InCHIANTI (including 5 of the 10 largest effect genes). The largest effect gene (SLC4A10, coding for NCBE, a sodium bicarbonate transporter) mediated 19% (adjusted CI 8.9 to 34.1%) and replicated by PCR in InCHIANTI (n=194, 35.6% mediated, p=0.01). Other replicated mediators included PRF1 (perforin, a cytolytic protein in cytotoxic T lymphocytes and NK cells) and IL1B (Interleukin 1 beta): few other cytokines were significant mediators. CONCLUSIONS This transcriptome-wide study on human blood identified a small distinct set of genes that statistically mediate the age-IL6 association. Findings are robust across two cohorts and different expression technologies. Raised IL6 levels may not derive from circulating white cells in age related inflammation.
Collapse
Affiliation(s)
- Luke C Pilling
- Epidemiology and Public Health, Medical School, University of Exeter, RILD, Exeter EX2 5DW, UK
| | - Roby Joehanes
- National Heart, Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Mathematical and Statistical Computing Laboratory, Center for Information Technology, National Institute of Health, Bethesda, MD, USA
| | - David Melzer
- Epidemiology and Public Health, Medical School, University of Exeter, RILD, Exeter EX2 5DW, UK
| | - Lorna W Harries
- Institute of Biomedical and Clinical Sciences, Medical School, University of Exeter, RILD, Exeter EX2 5DW, UK
| | - William Henley
- Institute for Health Services Research, University of Exeter Medical School, Exeter EX1 2LU, UK
| | - Josée Dupuis
- National Heart, Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
| | - Honghuang Lin
- National Heart, Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA
| | - Marcus Mitchell
- Institute of Biomedical and Clinical Sciences, Medical School, University of Exeter, RILD, Exeter EX2 5DW, UK
| | - Dena Hernandez
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA
| | - Sai-Xia Ying
- National Heart, Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Mathematical and Statistical Computing Laboratory, Center for Information Technology, National Institute of Health, Bethesda, MD, USA
| | - Kathryn L Lunetta
- National Heart, Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
| | - Emelia J Benjamin
- National Heart, Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Section of Cardiovascular Medicine and Preventive Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA; Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA
| | - Andrew Singleton
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA
| | - Daniel Levy
- National Heart, Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; The Population Sciences Branch, National Heart, Lung, and Blood Institute, Bethesda, MD, USA
| | - Peter Munson
- National Heart, Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Mathematical and Statistical Computing Laboratory, Center for Information Technology, National Institute of Health, Bethesda, MD, USA
| | - Joanne M Murabito
- National Heart, Lung and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA
| | - Luigi Ferrucci
- Clinical Research Branch, National Institute on Aging, Baltimore, MD, USA.
| |
Collapse
|
111
|
Lunetta KL, Day FR, Sulem P, Ruth KS, Tung JY, Hinds DA, Esko T, Elks CE, Altmaier E, He C, Huffman JE, Mihailov E, Porcu E, Robino A, Rose LM, Schick UM, Stolk L, Teumer A, Thompson DJ, Traglia M, Wang CA, Yerges-Armstrong LM, Antoniou AC, Barbieri C, Coviello AD, Cucca F, Demerath EW, Dunning AM, Gandin I, Grove ML, Gudbjartsson DF, Hocking LJ, Hofman A, Huang J, Jackson RD, Karasik D, Kriebel J, Lange EM, Lange LA, Langenberg C, Li X, Luan J, Mägi R, Morrison AC, Padmanabhan S, Pirie A, Polasek O, Porteous D, Reiner AP, Rivadeneira F, Rudan I, Sala CF, Schlessinger D, Scott RA, Stöckl D, Visser JA, Völker U, Vozzi D, Wilson JG, Zygmunt M, Boerwinkle E, Buring JE, Crisponi L, Easton DF, Hayward C, Hu FB, Liu S, Metspalu A, Pennell CE, Ridker PM, Strauch K, Streeten EA, Toniolo D, Uitterlinden AG, Ulivi S, Völzke H, Wareham NJ, Wellons M, Franceschini N, Chasman DI, Thorsteinsdottir U, Murray A, Stefansson K, Murabito JM, Ong KK, Perry JRB. Rare coding variants and X-linked loci associated with age at menarche. Nat Commun 2015; 6:7756. [PMID: 26239645 PMCID: PMC4538850 DOI: 10.1038/ncomms8756] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/27/2015] [Accepted: 06/06/2015] [Indexed: 01/03/2023] Open
Abstract
More than 100 loci have been identified for age at menarche by genome-wide association studies; however, collectively these explain only ∼3% of the trait variance. Here we test two overlooked sources of variation in 192,974 European ancestry women: low-frequency protein-coding variants and X-chromosome variants. Five missense/nonsense variants (in ALMS1/LAMB2/TNRC6A/TACR3/PRKAG1) are associated with age at menarche (minor allele frequencies 0.08-4.6%; effect sizes 0.08-1.25 years per allele; P<5 × 10(-8)). In addition, we identify common X-chromosome loci at IGSF1 (rs762080, P=9.4 × 10(-13)) and FAAH2 (rs5914101, P=4.9 × 10(-10)). Highlighted genes implicate cellular energy homeostasis, post-transcriptional gene silencing and fatty-acid amide signalling. A frequently reported mutation in TACR3 for idiopathic hypogonatrophic hypogonadism (p.W275X) is associated with 1.25-year-later menarche (P=2.8 × 10(-11)), illustrating the utility of population studies to estimate the penetrance of reportedly pathogenic mutations. Collectively, these novel variants explain ∼0.5% variance, indicating that these overlooked sources of variation do not substantially explain the 'missing heritability' of this complex trait.
Collapse
Affiliation(s)
- Kathryn L. Lunetta
- Boston University School of Public Health, Department of Biostatistics, Boston, Massachusetts 02118, USA
- NHLBI's and Boston University's Framingham Heart Study, Framingham, Massachusetts 01702-5827, USA
| | - Felix R. Day
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
| | - Patrick Sulem
- deCODE genetics/Amgen, Inc., Reykjavik IS-101, Iceland
| | - Katherine S. Ruth
- Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter EX1 2LU, UK
| | - Joyce Y. Tung
- 23andMe Inc., 1390 Shorebird Way, Mountain View, California 94043, USA
| | - David A. Hinds
- 23andMe Inc., 1390 Shorebird Way, Mountain View, California 94043, USA
| | - Tõnu Esko
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
- Division of Endocrinology, Boston Children's Hospital, Boston, MA 02115, USA
- Department of Genetics, Harvard Medical School, Boston, MA 02115, USA
- Broad Institute of the Massachusetts Institute of Technology and Harvard University, 140, Cambridge, MA 02142, USA
| | - Cathy E. Elks
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
| | - Elisabeth Altmaier
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München–German Research Center for Environmental Health, Neuherberg 85764, Germany
- Institute of Genetic Epidemiology, Helmholtz Zentrum München–German Research Center for Environmental Health, Neuherberg 85764, Germany
| | - Chunyan He
- Department of Epidemiology, Indiana University Richard M. Fairbanks School of Public Health, Indianapolis, IN 46202, USA
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA
| | - Jennifer E. Huffman
- Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Evelin Mihailov
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
| | - Eleonora Porcu
- Institute of Genetics and Biomedical Research, National Research Council, Cagliari, Sardinia 09042, Italy
- University of Sassari, Department of Biomedical Sciences, Sassari, Sassari 07100, Italy
- Center for Statistical Genetics, Ann Arbor, University of Michigan, Michigan 48109-2029, USA
| | - Antonietta Robino
- Institute for Maternal and Child Health—IRCCS “Burlo Garofolo”, Trieste 34137, Italy
| | - Lynda M. Rose
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA 02215
| | - Ursula M. Schick
- Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, WA 98109-1024, USA
| | - Lisette Stolk
- Department of Internal Medicine, Erasmus MC, Rotterdam 3015GE, the Netherlands
| | - Alexander Teumer
- Institute for Community Medicine, University Medicine Greifswald, Greifswald 17475, Germany
| | - Deborah J. Thompson
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
| | - Michela Traglia
- Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milano 20132, Italy
| | - Carol A. Wang
- School of Women's and Infants' Health, The University of Western Australia, WA-6009, Australia
| | - Laura M. Yerges-Armstrong
- Program in Personalized Medicine, Division of Endocrinology, Diabetes and Nutrition—University of Maryland School of Medicine, Baltimore, MD 21201, USA
| | - Antonis C. Antoniou
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
| | - Caterina Barbieri
- Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milano 20132, Italy
| | - Andrea D. Coviello
- Boston University School of Medicine, Department of Medicine, Sections of Preventive Medicine and Endocrinology, Boston, MA, USA
| | - Francesco Cucca
- Institute of Genetics and Biomedical Research, National Research Council, Cagliari, Sardinia 09042, Italy
- University of Sassari, Department of Biomedical Sciences, Sassari, Sassari 07100, Italy
| | - Ellen W. Demerath
- Division of Epidemiology & Community Health, University of Minnesotta, Minneapolis, MN 55455, USA
| | - Alison M. Dunning
- Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK
| | - Ilaria Gandin
- Institute for Maternal and Child Health—IRCCS “Burlo Garofolo”, Trieste 34137, Italy
- Department of Clinical Medical Sciences, Surgical and Health, University of Trieste, Trieste 34149, Italy
| | - Megan L. Grove
- Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
| | - Daniel F. Gudbjartsson
- deCODE genetics/Amgen, Inc., Reykjavik IS-101, Iceland
- School of Engineering and Natural Sciences, University of Iceland, Reykjavik IS-101, Iceland
| | - Lynne J. Hocking
- Musculoskeletal Research Programme, Division of Applied Medicine, University of Aberdeen, Aberdeen AB25 2ZD, UK
| | - Albert Hofman
- Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, Rotterdam 3015 GE, the Netherlands
| | - Jinyan Huang
- State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
| | - Rebecca D. Jackson
- Department of Internal Medicine, The Ohio State University, Columbus, Ohio 43210, USA
| | - David Karasik
- Hebrew SeniorLife Institute for Aging Research, Boston, MA 02131, USA
- Harvard Medical School, Boston, MA 02115, USA
| | - Jennifer Kriebel
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München–German Research Center for Environmental Health, Neuherberg 85764, Germany
- German Center for Diabetes Research, Neuherberg 85764, Germany
| | - Ethan M. Lange
- Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA
- Department of Biostatistics, University of North Carolina, Chapel Hill, NC 27599, USA
| | - Leslie A. Lange
- Department of Genetics, University of North Carolina, Chapel Hill, NC 27599, USA
| | - Claudia Langenberg
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
| | - Xin Li
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
| | - Jian'an Luan
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
| | - Reedik Mägi
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
| | - Alanna C. Morrison
- Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
| | - Sandosh Padmanabhan
- British Heart Foundation Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, UK
| | - Ailith Pirie
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
| | - Ozren Polasek
- Faculty of Medicine, University of Split, Split, Croatia
| | - David Porteous
- Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Alex P. Reiner
- Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, WA 98109-1024, USA
| | - Fernando Rivadeneira
- Department of Internal Medicine, Erasmus MC, Rotterdam 3015GE, the Netherlands
- Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, Rotterdam 3015 GE, the Netherlands
| | - Igor Rudan
- Institute for Population Health Sciences and Informatics, University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
| | - Cinzia F. Sala
- Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milano 20132, Italy
| | - David Schlessinger
- National Institute on Aging, Intramural Research Program, Baltimore, MD 20892, USA
| | - Robert A. Scott
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
| | - Doris Stöckl
- Institute of Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg 85764, Germany
| | - Jenny A. Visser
- Department of Internal Medicine, Erasmus MC, Rotterdam 3015GE, the Netherlands
| | - Uwe Völker
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald 17475, Germany
| | - Diego Vozzi
- Institute for Maternal and Child Health—IRCCS “Burlo Garofolo”, Trieste 34137, Italy
| | - James G. Wilson
- Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS 39216, USA
| | - Marek Zygmunt
- Department of Obstetrics and Gynecology, University Medicine Greifswald, Greifswald 17475, Germany
| | - Eric Boerwinkle
- Human Genetics Center, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA
| | - Julie E. Buring
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA 02215
- Harvard Medical School, Boston, MA 02115, USA
| | - Laura Crisponi
- Institute of Genetics and Biomedical Research, National Research Council, Cagliari, Sardinia 09042, Italy
| | - Douglas F. Easton
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, UK
- Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK
| | - Caroline Hayward
- Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh EH4 2XU, UK
| | - Frank B. Hu
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA
- Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
| | - Simin Liu
- Departments of Epidemiology and Medicine Brown University, Brown University, Providence, RI 02912, USA
| | - Andres Metspalu
- Estonian Genome Center, University of Tartu, Tartu 51010, Estonia
- Institute of Molecular and Cell Biology, University of Tartu, Tartu 51010, Estonia
| | - Craig E. Pennell
- School of Women's and Infants' Health, The University of Western Australia, WA-6009, Australia
| | - Paul M. Ridker
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA 02215
- Harvard Medical School, Boston, MA 02115, USA
| | - Konstantin Strauch
- Institute of Genetic Epidemiology, Helmholtz Zentrum München–German Research Center for Environmental Health, Neuherberg 85764, Germany
- Institute of Medical Informatics, Biometry and Epidemiology, Chair of Genetic Epidemiology, Ludwig-Maximilians-Universität, Munich 81377, Germany
| | - Elizabeth A. Streeten
- Program in Personalized Medicine, Division of Endocrinology, Diabetes and Nutrition—University of Maryland School of Medicine, Baltimore, MD 21201, USA
| | - Daniela Toniolo
- Division of Genetics and Cell Biology, San Raffaele Scientific Institute, Milano 20132, Italy
| | - André G. Uitterlinden
- Department of Internal Medicine, Erasmus MC, Rotterdam 3015GE, the Netherlands
- Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, Rotterdam 3015 GE, the Netherlands
| | - Sheila Ulivi
- Institute for Maternal and Child Health—IRCCS “Burlo Garofolo”, Trieste 34137, Italy
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, Greifswald 17475, Germany
| | - Nicholas J. Wareham
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
| | - Melissa Wellons
- Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37203, USA
| | - Nora Franceschini
- Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27599, USA
| | - Daniel I. Chasman
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, MA 02215
- Harvard Medical School, Boston, MA 02115, USA
| | - Unnur Thorsteinsdottir
- deCODE genetics/Amgen, Inc., Reykjavik IS-101, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik IS-101, Iceland
| | - Anna Murray
- Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter EX1 2LU, UK
| | - Kari Stefansson
- deCODE genetics/Amgen, Inc., Reykjavik IS-101, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik IS-101, Iceland
| | - Joanne M. Murabito
- NHLBI's and Boston University's Framingham Heart Study, Framingham, Massachusetts 01702-5827, USA
- Boston University School of Medicine, Department of Medicine, Section of General Internal Medicine, Boston, MA 02118, USA
| | - Ken K. Ong
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
- Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK
| | - John R. B. Perry
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK
| |
Collapse
|
112
|
Long MT, Pedley A, Massaro JM, Hoffmann U, Esliger DW, Vasan RS, Fox CS, Murabito JM. Hepatic steatosis is associated with lower levels of physical activity measured via accelerometry. Obesity (Silver Spring) 2015; 23:1259-66. [PMID: 25959049 PMCID: PMC4446168 DOI: 10.1002/oby.21058] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/10/2014] [Accepted: 01/28/2015] [Indexed: 12/11/2022]
Abstract
OBJECTIVE Prior studies on the association of physical activity (PA) and nonalcoholic fatty liver disease are limited by reliance on subjective measures of PA. We examined the association between objectively measured PA and hepatic steatosis defined by computed tomography (CT). METHODS We conducted a cross-sectional study of 1,060 Framingham Heart Study participants who participated in the Multidetector CT 2 substudy and who underwent assessment of PA via accelerometry. Hepatic steatosis was estimated by liver attenuation, as measured by CT. We explored the relationship between liver attenuation and PA using multivariable regression models. RESULTS In multivariable-adjusted models, we observed an inverse association between PA and liver attenuation. Each 30 minutes/day increase in moderate to vigorous PA (MVPA) was associated with a reduced odds of hepatic steatosis (OR = 0.62, P < 0.001). This association was attenuated and no longer statistically significant after adjustment for body mass index (BMI) (OR = 0.77, P = 0.05) or visceral adipose tissue (VAT) (OR = 0.83, P = 0.18). Participants who met the national PA recommendations of engaging in ≥150 minutes/week of MVPA had the lowest odds of hepatic steatosis, even after adjusting for BMI (OR = 0.63, P = 0.007) or VAT (OR = 0.67, P = 0.03). CONCLUSIONS There is an inverse association between PA and hepatic steatosis. Participants who met the national PA guidelines had the lowest prevalence of hepatic steatosis.
Collapse
Affiliation(s)
- Michelle T. Long
- Division of Gastroenterology, Boston Medical Center, Boston University School of Medicine, Boston, MA
- National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA
| | - Alison Pedley
- National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA
| | - Joseph M. Massaro
- National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA
- Department of Mathematics and Statistics, Boston University, Boston, MA
| | - Udo Hoffmann
- Radiology Department, Massachusetts General Hospital, Harvard Medical School, Boston, MA
| | - Dale W. Esliger
- School of Sport, Exercise, and Health Sciences, Loughborough University, Loughborough, United Kingdom
| | - Ramachandran S. Vasan
- National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA
- Section of Preventive Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA
| | - Caroline S. Fox
- National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA
- Division of Endocrinology, Hypertension, and Metabolism, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA
| | - Joanne M. Murabito
- National Heart, Lung, and Blood Institute’s Framingham Heart Study, Framingham, MA
- Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA
| |
Collapse
|
113
|
Dauriz M, Porneala BC, Guo X, Bielak LF, Peyser PA, Durant NH, Carnethon MR, Bonadonna RC, Bonora E, Bowden DW, Florez JC, Fornage M, Hivert MF, Jacobs DR, Kabagambe EK, Lewis CE, Murabito JM, Rasmussen-Torvik LJ, Rich SS, Vassy JL, Yao J, Carr JJ, Kardia SL, Siscovick D, O'Donnell CJ, Rotter JI, Dupuis J, Meigs JB. Association of a 62 Variants Type 2 Diabetes Genetic Risk Score With Markers of Subclinical Atherosclerosis: A Transethnic, Multicenter Study. Circ Cardiovasc Genet 2015; 8:507-15. [PMID: 25805414 PMCID: PMC4472563 DOI: 10.1161/circgenetics.114.000740] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/10/2014] [Accepted: 03/09/2015] [Indexed: 12/19/2022]
Abstract
BACKGROUND Type 2 diabetes mellitus (T2D) and cardiovascular disease share risk factors and subclinical atherosclerosis (SCA) predicts events in those with and without diabetes mellitus. T2D genetic risk may predict both T2D and SCA. We hypothesized that greater T2D genetic risk is associated with higher extent of SCA. METHODS AND RESULTS In a cross-sectional analysis, including ≤9210 European Americans, 3773 African Americans, 1446 Hispanic Americans, and 773 Chinese Americans without known cardiovascular disease and enrolled in the Framingham Heart Study, Coronary Artery Risk Development in Young Adults, Multi-Ethnic Study of Atherosclerosis, and Genetic Epidemiology Network of Arteriopathy studies, we tested a 62 T2D-loci genetic risk score for association with measures of SCA, including coronary artery or abdominal aortic calcium score, common and internal carotid artery intima-media thickness, and ankle-brachial index. We used ancestry-stratified linear regression models, with random effects accounting for family relatedness when appropriate, applying a genetic-only (adjusted for sex) and a full SCA risk factors-adjusted model (significance, P<0.01=0.05/5, number of traits analyzed). An inverse association with coronary artery calcium score in Multi-Ethnic Study of Atherosclerosis Europeans (fully-adjusted P=0.004) and with common carotid artery intima-media thickness in the Framingham Heart Study (P=0.009) was not confirmed in other study cohorts, either separately or in meta-analysis. Secondary analyses showed no consistent associations with β-cell and insulin resistance genetic risk sub-scores in the Framingham Heart Study and in the Coronary Artery Risk Development in Young Adults. CONCLUSIONS SCA does not have a major genetic component linked to a burden of 62 T2D loci identified by large genome-wide association studies. A shared T2D-SCA genetic basis, if any, might become apparent from better functional information about both T2D and cardiovascular disease risk loci.
Collapse
Affiliation(s)
- Marco Dauriz
- General Medicine Division, Massachusetts General Hospital, Boston, MA
- Department of Medicine, Harvard Medical School, Boston, MA
- Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Verona Medical School & Hospital Trust of Verona, Verona, Italy
| | - Bianca C. Porneala
- General Medicine Division, Massachusetts General Hospital, Boston, MA
- Department of Medicine, Harvard Medical School, Boston, MA
| | - Xiuqing Guo
- Institute for Translational Genomics & Population Sciences, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
| | - Lawrence F. Bielak
- Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI
| | - Patricia A. Peyser
- Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI
| | - Nefertiti H. Durant
- Division of Pediatrics & Adolescent Medicine, Department of Pediatrics, University of Alabama Birmingham School of Medicine, Birmingham, AL
| | - Mercedes R. Carnethon
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
| | - Riccardo C. Bonadonna
- Division of Endocrinology, Department of Clinical & Experimental Medicine, University of Parma School of Medicine & AOI of Parma, Parma, Italy
| | - Enzo Bonora
- Division of Endocrinology, Diabetes & Metabolism, Department of Medicine, University of Verona Medical School & Hospital Trust of Verona, Verona, Italy
| | - Donald W. Bowden
- Centers for Diabetes Research & Human Genomics, Wake Forest School of Medicine, Winston-Salem, NC
- Department of Biochemistry & Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC
| | - Jose C. Florez
- Department of Medicine, Harvard Medical School, Boston, MA
- Diabetes Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA
- Program in Medical & Population Genetics, Broad Institute, Cambridge, MA
| | - Myriam Fornage
- Institute of Molecular Medicine & Human Genetics Center, University of Texas Health Science Center at Houston, Houston, TX
| | - Marie-France Hivert
- Harvard Pilgrim Health Care Institute, Department of Population Medicine, Harvard Medical School, Boston, MA
- Diabetes Unit, Massachusetts General Hospital, Boston, MA
- Division of Endocrinology & Metabolism, Department of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada
| | - David R. Jacobs
- Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN
| | - Edmond K. Kabagambe
- Division of Epidemiology, Department of Medicine, Vanderbilt University, Nashville, TN
| | - Cora E. Lewis
- Department of Epidemiology, University of Alabama Birmingham School of Public Health, Birmingham, AL
| | - Joanne M. Murabito
- Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Boston
- National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA
| | | | - Stephen S. Rich
- Center for Public Health Genomics, University of Virginia, Charlottesville, VA
| | - Jason L. Vassy
- Department of Medicine, Harvard Medical School, Boston, MA
- Section of General Internal Medicine, VA Boston Healthcare System, Boston, MA
- Division of General Internal Medicine & Primary Care, Brigham and Women's Hospital, Boston, MA
| | - Jie Yao
- Institute for Translational Genomics & Population Sciences, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
| | | | - Sharon L.R. Kardia
- Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI
| | | | - Christopher J. O'Donnell
- Department of Medicine, Harvard Medical School, Boston, MA
- National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA
- Cardiology Division, Department of Medicine, Massachusetts General Hospital & Harvard Medical School, Boston, MA
| | - Jerome I. Rotter
- Institute for Translational Genomics & Population Sciences, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA
| | - Josée Dupuis
- National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA
- Department of Biostatistics, Boston University School of Public Health, Boston, MA
| | - James B. Meigs
- General Medicine Division, Massachusetts General Hospital, Boston, MA
- Department of Medicine, Harvard Medical School, Boston, MA
| |
Collapse
|
114
|
Cheng S, Larson MG, McCabe EL, Murabito JM, Rhee EP, Ho JE, Jacques PF, Ghorbani A, Magnusson M, Souza AL, Deik AA, Pierce KA, Bullock K, O'Donnell CJ, Melander O, Clish CB, Vasan RS, Gerszten RE, Wang TJ. Distinct metabolomic signatures are associated with longevity in humans. Nat Commun 2015; 6:6791. [PMID: 25864806 PMCID: PMC4396657 DOI: 10.1038/ncomms7791] [Citation(s) in RCA: 92] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2014] [Accepted: 02/27/2015] [Indexed: 01/07/2023] Open
Abstract
Alterations in metabolism influence lifespan in experimental models, but data in humans are lacking. Here we use liquid chromatography/mass spectrometry to quantify 217 plasma metabolites and examine their relation to longevity in a large cohort of men and women. In 647 individuals followed for up to 20 years, higher concentrations of the citric acid cycle intermediate, isocitrate, and the bile acid, taurocholate, are associated with lower odds of longevity, defined as attaining 80 years of age. In a larger cohort of 2,327 individuals with metabolite data available, higher concentrations of isocitrate but not taurocholate are also associated with worse cardiovascular health at baseline, as well as risk of future cardiovascular disease and death. None of the metabolites identified are associated with cancer risk. Our findings suggest that some, but not all, metabolic pathways to human longevity are dependent on modifying risk for the two most common causes of death.
Collapse
Affiliation(s)
- Susan Cheng
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Martin G Larson
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Elizabeth L McCabe
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Joanne M Murabito
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Eugene P Rhee
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Jennifer E Ho
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Paul F Jacques
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Anahita Ghorbani
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Martin Magnusson
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Amanda L Souza
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Amy A Deik
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Kerry A Pierce
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Kevin Bullock
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Christopher J O'Donnell
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Olle Melander
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Clary B Clish
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Ramachandran S Vasan
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Robert E Gerszten
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| | - Thomas J Wang
- Framingham Heart Study of the National Heart, Lung and Blood Institute and Boston University School of Medicine, Framingham, MA (SC, MGL, JMM, JEH, CJO, RSV, TJW); Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (SC); Department of Mathematics and Statistics, Boston University, Boston, MA (MGL); Department of Biostatistics, Boston University School of Public Health, Boston, MA (ELM); Cardiology Division (JEH, AG, CJO, REG), Cardiovascular Research Center (REG), and Renal Division (EPR), Massachusetts General Hospital, Harvard Medical School, Boston, MA; General Internal Medicine (JMM), Cardiology (JEH, RSV), and Preventive Medicine (RSV), Department of Medicine, Boston University School of Medicine, Boston, MA; Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, MA (PFJ); Department of Clinical Sciences, Lund University, Malmö (MM, OM); Broad Institute of MIT and Harvard, Cambridge, MA (ALS, AAD, KAP, KB, CBC, REG); National Heart, Lung & Blood Institute Division of Intramural Research, Bethesda, MD (CJO); and, Division of Cardiovascular Medicine, Vanderbilt University, Nashville, TN (TJW)
| |
Collapse
|
115
|
Andersson C, Lyass A, Larson MG, Spartano NL, Vita JA, Benjamin EJ, Murabito JM, Esliger DW, Blease SJ, Hamburg NM, Mitchell GF, Vasan RS. Physical activity measured by accelerometry and its associations with cardiac structure and vascular function in young and middle-aged adults. J Am Heart Assoc 2015; 4:e001528. [PMID: 25792127 PMCID: PMC4392434 DOI: 10.1161/jaha.114.001528] [Citation(s) in RCA: 55] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
BACKGROUND Physical activity is associated with several health benefits, including lower cardiovascular disease risk. The independent influence of physical activity on cardiac and vascular function in the community, however, has been sparsely investigated. MEASURES AND RESULTS We related objective measures of moderate- to vigorous-intensity physical activity (MVPA, assessed by accelerometry) to cardiac and vascular indices in 2376 participants of the Framingham Heart Study third generation cohort (54% women, mean age 47 years). Using multivariable regression models, we related MVPA to the following echocardiographic and vascular measures: left ventricular mass, left atrial and aortic root sizes, carotid-femoral pulse wave velocity, augmentation index, and forward pressure wave. Men and women engaged in MVPA 29.9±21.4 and 25.5±19.4 min/day, respectively. Higher values of MVPA (per 10-minute increment) were associated with lower carotid-femoral pulse wave velocity (estimate -0.53 ms/m; P=0.006) and lower forward pressure wave (estimate -0.23 mm Hg; P=0.03) but were not associated with augmentation index (estimate 0.13%; P=0.25). MVPA was associated positively with log(e) left ventricular mass (estimate 0.006 log(e) [g/m(2)]; P=0.0003), left ventricular wall thickness (estimate 0.07 mm; P=0.0001), and left atrial dimension (estimate 0.10 mm; P=0.01). MVPA also tended to be positively associated with aortic root dimension (estimate 0.05 mm; P=0.052). Associations of MVPA with cardiovascular measures were similar, in general, for bouts lasting <10 versus ≥10 minutes. CONCLUSIONS In our community-based sample, greater physical activity was associated with lower vascular stiffness but with higher echocardiographic left ventricular mass and left atrial size. These findings suggest complex relations of usual levels of physical activity and cardiovascular remodeling.
Collapse
Affiliation(s)
- Charlotte Andersson
- Framingham Heart Study, Framingham, MA (C.A., A.L., M.G.L., E.J.B., J.M.M., S.J.B., R.S.V.) Department of Epidemiology, Boston University School of Public Health, Boston, MA (C.A., N.L.S., E.J.B., J.M.M., R.S.V.) Department of Cardiology, Gentofte Hospital, University of Copenhagen, Denmark (C.A.)
| | - Asya Lyass
- Framingham Heart Study, Framingham, MA (C.A., A.L., M.G.L., E.J.B., J.M.M., S.J.B., R.S.V.) Department of Mathematics and Statistics, Boston University, Boston, MA (A.L., M.G.L.)
| | - Martin G Larson
- Framingham Heart Study, Framingham, MA (C.A., A.L., M.G.L., E.J.B., J.M.M., S.J.B., R.S.V.) Department of Mathematics and Statistics, Boston University, Boston, MA (A.L., M.G.L.)
| | - Nicole L Spartano
- Department of Epidemiology, Boston University School of Public Health, Boston, MA (C.A., N.L.S., E.J.B., J.M.M., R.S.V.) The Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA (N.L.S., J.A.V., N.M.H.)
| | - Joseph A Vita
- The Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA (N.L.S., J.A.V., N.M.H.)
| | - Emelia J Benjamin
- Framingham Heart Study, Framingham, MA (C.A., A.L., M.G.L., E.J.B., J.M.M., S.J.B., R.S.V.) Department of Epidemiology, Boston University School of Public Health, Boston, MA (C.A., N.L.S., E.J.B., J.M.M., R.S.V.) Sections of Preventive Medicine and Cardiology, Department of Medicine, Boston University School of Medicine, Boston, MA (E.J.B., R.S.V.)
| | - Joanne M Murabito
- Framingham Heart Study, Framingham, MA (C.A., A.L., M.G.L., E.J.B., J.M.M., S.J.B., R.S.V.) Department of Epidemiology, Boston University School of Public Health, Boston, MA (C.A., N.L.S., E.J.B., J.M.M., R.S.V.)
| | - Dale W Esliger
- School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, United Kingdom (D.W.E.)
| | - Susan J Blease
- Framingham Heart Study, Framingham, MA (C.A., A.L., M.G.L., E.J.B., J.M.M., S.J.B., R.S.V.)
| | - Naomi M Hamburg
- The Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA (N.L.S., J.A.V., N.M.H.)
| | | | - Ramachandran S Vasan
- Framingham Heart Study, Framingham, MA (C.A., A.L., M.G.L., E.J.B., J.M.M., S.J.B., R.S.V.) Department of Epidemiology, Boston University School of Public Health, Boston, MA (C.A., N.L.S., E.J.B., J.M.M., R.S.V.) Sections of Preventive Medicine and Cardiology, Department of Medicine, Boston University School of Medicine, Boston, MA (E.J.B., R.S.V.)
| |
Collapse
|
116
|
Minster RL, Sanders JL, Singh J, Kammerer CM, Barmada MM, Matteini AM, Zhang Q, Wojczynski MK, Daw EW, Brody JA, Arnold AM, Lunetta KL, Murabito JM, Christensen K, Perls TT, Province MA, Newman AB. Genome-Wide Association Study and Linkage Analysis of the Healthy Aging Index. J Gerontol A Biol Sci Med Sci 2015; 70:1003-8. [PMID: 25758594 DOI: 10.1093/gerona/glv006] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2014] [Accepted: 01/19/2015] [Indexed: 12/13/2022] Open
Abstract
BACKGROUND The Healthy Aging Index (HAI) is a tool for measuring the extent of health and disease across multiple systems. METHODS We conducted a genome-wide association study and a genome-wide linkage analysis to map quantitative trait loci associated with the HAI and a modified HAI weighted for mortality risk in 3,140 individuals selected for familial longevity from the Long Life Family Study. The genome-wide association study used the Long Life Family Study as the discovery cohort and individuals from the Cardiovascular Health Study and the Framingham Heart Study as replication cohorts. RESULTS There were no genome-wide significant findings from the genome-wide association study; however, several single-nucleotide polymorphisms near ZNF704 on chromosome 8q21.13 were suggestively associated with the HAI in the Long Life Family Study (p < 10(-) (6)) and nominally replicated in the Cardiovascular Health Study and Framingham Heart Study. Linkage results revealed significant evidence (log-odds score = 3.36) for a quantitative trait locus for mortality-optimized HAI in women on chromosome 9p24-p23. However, results of fine-mapping studies did not implicate any specific candidate genes within this region of interest. CONCLUSIONS ZNF704 may be a potential candidate gene for studies of the genetic underpinnings of longevity.
Collapse
Affiliation(s)
| | - Jason L Sanders
- Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania
| | | | | | | | - Amy M Matteini
- Division of Geriatric Medicine and Gerontology, School of Medicine, Johns Hopkins University, Baltimore, Maryland
| | - Qunyuan Zhang
- Division of Statistical Genomics, School of Medicine, Washington University in St. Louis, Missouri
| | - Mary K Wojczynski
- Division of Statistical Genomics, School of Medicine, Washington University in St. Louis, Missouri
| | - E Warwick Daw
- Division of Statistical Genomics, School of Medicine, Washington University in St. Louis, Missouri
| | | | - Alice M Arnold
- Department of Biostatistics, University of Washington, Seattle
| | - Kathryn L Lunetta
- Department of Biostatistics, Boston University School of Public Health, Massachusetts
| | - Joanne M Murabito
- National Heart, Lung and Blood Institute Framingham Heart Study, Massachusetts. Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Massachusetts
| | - Kaare Christensen
- Department of Epidemiology, Institute of Public Health, University of Southern Denmark, Odense
| | - Thomas T Perls
- Section of Geriatrics, Department of Medicine, Boston University, Boston School of Medicine and Boston Medical Center, Massachusetts
| | - Michael A Province
- Division of Statistical Genomics, School of Medicine, Washington University in St. Louis, Missouri
| | - Anne B Newman
- Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania.
| |
Collapse
|
117
|
Murabito JM, Pedley A, Massaro JM, Vasan RS, Esliger D, Blease SJ, Hoffman U, Fox CS. Moderate-to-vigorous physical activity with accelerometry is associated with visceral adipose tissue in adults. J Am Heart Assoc 2015; 4:e001379. [PMID: 25736442 PMCID: PMC4392428 DOI: 10.1161/jaha.114.001379] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
Abstract
Background We examined the relation between objectively measured physical activity with accelerometry and subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) in a community‐based sample. Methods and Results We evaluated 1249 participants of the Framingham Third Generation and Omni II cohorts (mean age 51.7 years, 47% women) who underwent assessment of moderate‐to‐vigorous physical activity (MVPA) with accelerometry over 5 to 7 days, and multi‐detector computed tomography for measurement of SAT and VAT volume; fat attenuation was estimated by SAT and VAT hounsfield units (HU). In women, higher levels of MVPA were associated with decreased SAT (P<0.0001) and VAT volume (P<0.0001). The average decrement in VAT per 30 minute/day increase in MVPA was −453 cm3 (95% CI −574, −331). The association was attenuated but persisted upon adjustment for BMI (−122 cm3, P=0.002). Higher levels of MVPA were associated with higher SAT HU (all P≤0.01), a marker of fat quality, even after adjustment for SAT volume. Similar findings were observed in men but the magnitude of the association was less. Sedentary time was not associated with SAT or VAT volume or quality in men or women. Conclusions MVPA was associated with less VAT and SAT and better fat quality.
Collapse
Affiliation(s)
- Joanne M Murabito
- Department of Medicine, Section of General Internal Medicine, Section of Preventive Medicine, Boston University School of Medicine, Boston, MA (J.M.M., R.S.V.) National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA (J.M.M., A.P., J.M.M., R.S.V., S.J.B., C.S.F.)
| | - Alison Pedley
- National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA (J.M.M., A.P., J.M.M., R.S.V., S.J.B., C.S.F.)
| | - Joseph M Massaro
- National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA (J.M.M., A.P., J.M.M., R.S.V., S.J.B., C.S.F.) Department of Biostatistics, Boston University School of Public Health, Boston, MA (J.M.M.)
| | - Ramachandran S Vasan
- Department of Medicine, Section of General Internal Medicine, Section of Preventive Medicine, Boston University School of Medicine, Boston, MA (J.M.M., R.S.V.) National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA (J.M.M., A.P., J.M.M., R.S.V., S.J.B., C.S.F.)
| | - Dale Esliger
- School of Sport, Exercise and Health Sciences, Loughborough University, UK (D.E.)
| | - Susan J Blease
- National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA (J.M.M., A.P., J.M.M., R.S.V., S.J.B., C.S.F.)
| | - Udo Hoffman
- Department of Cardiac MR PET CT & Harvard Medical School, Massachusetts General Hospital, Boston, MA (U.H.)
| | - Caroline S Fox
- National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA (J.M.M., A.P., J.M.M., R.S.V., S.J.B., C.S.F.) Division of Intra-mural Research and the Center for Population Studies, National Heart, Lung and Blood Institute, Framingham, MA (C.S.F.) Division of Endocrinology & Harvard Medical School, Brigham and Women's Hospital, Boston, MA (C.S.F.)
| |
Collapse
|
118
|
Shungin D, Winkler TW, Croteau-Chonka DC, Ferreira T, Locke AE, Mägi R, Strawbridge RJ, Pers TH, Fischer K, Justice AE, Workalemahu T, Wu JMW, Buchkovich ML, Heard-Costa NL, Roman TS, Drong AW, Song C, Gustafsson S, Day FR, Esko T, Fall T, Kutalik Z, Luan J, Randall JC, Scherag A, Vedantam S, Wood AR, Chen J, Fehrmann R, Karjalainen J, Kahali B, Liu CT, Schmidt EM, Absher D, Amin N, Anderson D, Beekman M, Bragg-Gresham JL, Buyske S, Demirkan A, Ehret GB, Feitosa MF, Goel A, Jackson AU, Johnson T, Kleber ME, Kristiansson K, Mangino M, Mateo Leach I, Medina-Gomez C, Palmer CD, Pasko D, Pechlivanis S, Peters MJ, Prokopenko I, Stančáková A, Ju Sung Y, Tanaka T, Teumer A, Van Vliet-Ostaptchouk JV, Yengo L, Zhang W, Albrecht E, Ärnlöv J, Arscott GM, Bandinelli S, Barrett A, Bellis C, Bennett AJ, Berne C, Blüher M, Böhringer S, Bonnet F, Böttcher Y, Bruinenberg M, Carba DB, Caspersen IH, Clarke R, Warwick Daw E, Deelen J, Deelman E, Delgado G, Doney ASF, Eklund N, Erdos MR, Estrada K, Eury E, Friedrich N, Garcia ME, Giedraitis V, Gigante B, Go AS, Golay A, Grallert H, Grammer TB, Gräßler J, Grewal J, Groves CJ, Haller T, Hallmans G, Hartman CA, Hassinen M, Hayward C, Heikkilä K, Herzig KH, Helmer Q, Hillege HL, Holmen O, Hunt SC, Isaacs A, Ittermann T, James AL, Johansson I, Juliusdottir T, Kalafati IP, Kinnunen L, Koenig W, Kooner IK, Kratzer W, Lamina C, Leander K, Lee NR, Lichtner P, Lind L, Lindström J, Lobbens S, Lorentzon M, Mach F, Magnusson PKE, Mahajan A, McArdle WL, Menni C, Merger S, Mihailov E, Milani L, Mills R, Moayyeri A, Monda KL, Mooijaart SP, Mühleisen TW, Mulas A, Müller G, Müller-Nurasyid M, Nagaraja R, Nalls MA, Narisu N, Glorioso N, Nolte IM, Olden M, Rayner NW, Renstrom F, Ried JS, Robertson NR, Rose LM, Sanna S, Scharnagl H, Scholtens S, Sennblad B, Seufferlein T, Sitlani CM, Vernon Smith A, Stirrups K, Stringham HM, Sundström J, Swertz MA, Swift AJ, Syvänen AC, Tayo BO, Thorand B, Thorleifsson G, Tomaschitz A, Troffa C, van Oort FVA, Verweij N, Vonk JM, Waite LL, Wennauer R, Wilsgaard T, Wojczynski MK, Wong A, Zhang Q, Hua Zhao J, Brennan EP, Choi M, Eriksson P, Folkersen L, Franco-Cereceda A, Gharavi AG, Hedman ÅK, Hivert MF, Huang J, Kanoni S, Karpe F, Keildson S, Kiryluk K, Liang L, Lifton RP, Ma B, McKnight AJ, McPherson R, Metspalu A, Min JL, Moffatt MF, Montgomery GW, Murabito JM, Nicholson G, Nyholt DR, Olsson C, Perry JRB, Reinmaa E, Salem RM, Sandholm N, Schadt EE, Scott RA, Stolk L, Vallejo EE, Westra HJ, Zondervan KT, Amouyel P, Arveiler D, Bakker SJL, Beilby J, Bergman RN, Blangero J, Brown MJ, Burnier M, Campbell H, Chakravarti A, Chines PS, Claudi-Boehm S, Collins FS, Crawford DC, Danesh J, de Faire U, de Geus EJC, Dörr M, Erbel R, Eriksson JG, Farrall M, Ferrannini E, Ferrières J, Forouhi NG, Forrester T, Franco OH, Gansevoort RT, Gieger C, Gudnason V, Haiman CA, Harris TB, Hattersley AT, Heliövaara M, Hicks AA, Hingorani AD, Hoffmann W, Hofman A, Homuth G, Humphries SE, Hyppönen E, Illig T, Jarvelin MR, Johansen B, Jousilahti P, Jula AM, Kaprio J, Kee F, Keinanen-Kiukaanniemi SM, Kooner JS, Kooperberg C, Kovacs P, Kraja AT, Kumari M, Kuulasmaa K, Kuusisto J, Lakka TA, Langenberg C, Le Marchand L, Lehtimäki T, Lyssenko V, Männistö S, Marette A, Matise TC, McKenzie CA, McKnight B, Musk AW, Möhlenkamp S, Morris AD, Nelis M, Ohlsson C, Oldehinkel AJ, Ong KK, Palmer LJ, Penninx BW, Peters A, Pramstaller PP, Raitakari OT, Rankinen T, Rao DC, Rice TK, Ridker PM, Ritchie MD, Rudan I, Salomaa V, Samani NJ, Saramies J, Sarzynski MA, Schwarz PEH, Shuldiner AR, Staessen JA, Steinthorsdottir V, Stolk RP, Strauch K, Tönjes A, Tremblay A, Tremoli E, Vohl MC, Völker U, Vollenweider P, Wilson JF, Witteman JC, Adair LS, Bochud M, Boehm BO, Bornstein SR, Bouchard C, Cauchi S, Caulfield MJ, Chambers JC, Chasman DI, Cooper RS, Dedoussis G, Ferrucci L, Froguel P, Grabe HJ, Hamsten A, Hui J, Hveem K, Jöckel KH, Kivimaki M, Kuh D, Laakso M, Liu Y, März W, Munroe PB, Njølstad I, Oostra BA, Palmer CNA, Pedersen NL, Perola M, Pérusse L, Peters U, Power C, Quertermous T, Rauramaa R, Rivadeneira F, Saaristo TE, Saleheen D, Sinisalo J, Eline Slagboom P, Snieder H, Spector TD, Thorsteinsdottir U, Stumvoll M, Tuomilehto J, Uitterlinden AG, Uusitupa M, van der Harst P, Veronesi G, Walker M, Wareham NJ, Watkins H, Wichmann HE, Abecasis GR, Assimes TL, Berndt SI, Boehnke M, Borecki IB, Deloukas P, Franke L, Frayling TM, Groop LC, Hunter DJ, Kaplan RC, O’Connell JR, Qi L, Schlessinger D, Strachan DP, Stefansson K, van Duijn CM, Willer CJ, Visscher PM, Yang J, Hirschhorn JN, Carola Zillikens M, McCarthy MI, Speliotes EK, North KE, Fox CS, Barroso I, Franks PW, Ingelsson E, Heid IM, Loos RJF, Cupples LA, Morris AP, Lindgren CM, Mohlke KL. New genetic loci link adipose and insulin biology to body fat distribution. Nature 2015; 518:187-196. [PMID: 25673412 PMCID: PMC4338562 DOI: 10.1038/nature14132] [Citation(s) in RCA: 1046] [Impact Index Per Article: 116.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2013] [Accepted: 12/02/2014] [Indexed: 12/17/2022]
Abstract
Body fat distribution is a heritable trait and a well-established predictor of adverse metabolic outcomes, independent of overall adiposity. To increase our understanding of the genetic basis of body fat distribution and its molecular links to cardiometabolic traits, we conducted genome-wide association meta-analyses of waist and hip circumference-related traits in up to 224,459 individuals. We identified 49 loci (33 new) associated with waist-to-hip ratio adjusted for body mass index (WHRadjBMI) and an additional 19 loci newly associated with related waist and hip circumference measures (P<5×10−8). Twenty of the 49 WHRadjBMI loci showed significant sexual dimorphism, 19 of which displayed a stronger effect in women. The identified loci were enriched for genes expressed in adipose tissue and for putative regulatory elements in adipocytes. Pathway analyses implicated adipogenesis, angiogenesis, transcriptional regulation, and insulin resistance as processes affecting fat distribution, providing insight into potential pathophysiological mechanisms.
Collapse
|
119
|
Marioni RE, Shah S, McRae AF, Chen BH, Colicino E, Harris SE, Gibson J, Henders AK, Redmond P, Cox SR, Pattie A, Corley J, Murphy L, Martin NG, Montgomery GW, Feinberg AP, Fallin MD, Multhaup ML, Jaffe AE, Joehanes R, Schwartz J, Just AC, Lunetta KL, Murabito JM, Starr JM, Horvath S, Baccarelli AA, Levy D, Visscher PM, Wray NR, Deary IJ. DNA methylation age of blood predicts all-cause mortality in later life. Genome Biol 2015; 16:25. [PMID: 25633388 PMCID: PMC4350614 DOI: 10.1186/s13059-015-0584-6] [Citation(s) in RCA: 720] [Impact Index Per Article: 80.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2014] [Accepted: 01/12/2015] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND DNA methylation levels change with age. Recent studies have identified biomarkers of chronological age based on DNA methylation levels. It is not yet known whether DNA methylation age captures aspects of biological age. RESULTS Here we test whether differences between people's chronological ages and estimated ages, DNA methylation age, predict all-cause mortality in later life. The difference between DNA methylation age and chronological age (Δage) was calculated in four longitudinal cohorts of older people. Meta-analysis of proportional hazards models from the four cohorts was used to determine the association between Δage and mortality. A 5-year higher Δage is associated with a 21% higher mortality risk, adjusting for age and sex. After further adjustments for childhood IQ, education, social class, hypertension, diabetes, cardiovascular disease, and APOE e4 status, there is a 16% increased mortality risk for those with a 5-year higher Δage. A pedigree-based heritability analysis of Δage was conducted in a separate cohort. The heritability of Δage was 0.43. CONCLUSIONS DNA methylation-derived measures of accelerated aging are heritable traits that predict mortality independently of health status, lifestyle factors, and known genetic factors.
Collapse
Affiliation(s)
- Riccardo E Marioni
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. .,Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK. .,Queensland Brain Institute, The University of Queensland, Brisbane, 4072, QLD, Australia.
| | - Sonia Shah
- Queensland Brain Institute, The University of Queensland, Brisbane, 4072, QLD, Australia. .,University of Queensland Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, 4072, QLD, Australia.
| | - Allan F McRae
- Queensland Brain Institute, The University of Queensland, Brisbane, 4072, QLD, Australia. .,University of Queensland Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, 4072, QLD, Australia.
| | - Brian H Chen
- The NHLBI's Framingham Heart Study, Framingham, MA, 01702, USA. .,Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD, 01702, USA.
| | - Elena Colicino
- Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.
| | - Sarah E Harris
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. .,Medical Genetics Section, Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, EH4 2XU, UK.
| | - Jude Gibson
- Wellcome Trust Clinical Research Facility, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK.
| | - Anjali K Henders
- Queensland Institute of Medical Research Berghofer Medical Research Institute, Brisbane, 4029, QLD, Australia.
| | - Paul Redmond
- Department of Psychology, University of Edinburgh, Edinburgh, EH8 9JZ, UK.
| | - Simon R Cox
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. .,Department of Psychology, University of Edinburgh, Edinburgh, EH8 9JZ, UK.
| | - Alison Pattie
- Department of Psychology, University of Edinburgh, Edinburgh, EH8 9JZ, UK.
| | - Janie Corley
- Department of Psychology, University of Edinburgh, Edinburgh, EH8 9JZ, UK.
| | - Lee Murphy
- Wellcome Trust Clinical Research Facility, University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, UK.
| | - Nicholas G Martin
- Queensland Institute of Medical Research Berghofer Medical Research Institute, Brisbane, 4029, QLD, Australia.
| | - Grant W Montgomery
- Queensland Institute of Medical Research Berghofer Medical Research Institute, Brisbane, 4029, QLD, Australia.
| | - Andrew P Feinberg
- Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. .,Departments of Medicine, Molecular Biology/Genetics, Oncology, and Biostatistics, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
| | - M Daniele Fallin
- Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA. .,Department of Mental Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, 21205, USA.
| | - Michael L Multhaup
- Center for Epigenetics, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
| | - Andrew E Jaffe
- Department of Mental Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, 21205, USA. .,Lieber Institute for Brain Development, Baltimore, MD, 21205, USA.
| | - Roby Joehanes
- The NHLBI's Framingham Heart Study, Framingham, MA, 01702, USA. .,Harvard Medical School, Boston, MA, 02115, USA. .,Hebrew Senior Life, Boston, MA, 02131, USA.
| | - Joel Schwartz
- Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. .,Department of Epidemiology, Harvard T.H. Chan School of Public Health, 665 Huntington Ave, Boston, MA, 02115, USA.
| | - Allan C Just
- Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.
| | - Kathryn L Lunetta
- The NHLBI's Framingham Heart Study, Framingham, MA, 01702, USA. .,Department of Biostatistics, Boston University School of Public Health, Boston, MA, 02118, USA.
| | - Joanne M Murabito
- The NHLBI's Framingham Heart Study, Framingham, MA, 01702, USA. .,Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, 02118, USA.
| | - John M Starr
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. .,Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, EH8 9JZ, UK.
| | - Steve Horvath
- Human Genetics, Gonda Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095-7088, USA. .,Biostatistics, School of Public Health, University of California Los Angeles, Los Angeles, CA, 90095, USA.
| | - Andrea A Baccarelli
- Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA. .,Department of Epidemiology, Harvard T.H. Chan School of Public Health, 665 Huntington Ave, Boston, MA, 02115, USA.
| | - Daniel Levy
- The NHLBI's Framingham Heart Study, Framingham, MA, 01702, USA. .,Population Sciences Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, Bethesda, MD, 01702, USA.
| | - Peter M Visscher
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. .,Queensland Brain Institute, The University of Queensland, Brisbane, 4072, QLD, Australia. .,University of Queensland Diamantina Institute, Translational Research Institute, The University of Queensland, Brisbane, 4072, QLD, Australia.
| | - Naomi R Wray
- Queensland Brain Institute, The University of Queensland, Brisbane, 4072, QLD, Australia.
| | - Ian J Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, 7 George Square, Edinburgh, EH8 9JZ, UK. .,Department of Psychology, University of Edinburgh, Edinburgh, EH8 9JZ, UK.
| |
Collapse
|
120
|
Nishtala A, Himali JJ, Beiser A, Murabito JM, Seshadri S, Wolf PA, Au R. Midlife Hypertension Risk and Cognition in the Non-Demented Oldest Old: Framingham Heart Study. J Alzheimers Dis 2015; 47:197-204. [PMID: 26402768 PMCID: PMC4827717 DOI: 10.3233/jad-141881] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
Midlife cardiovascular risk, hypertension (HTN) in particular, has been related cross-sectionally to poorer neuropsychological (NP) performance in middle age and older adults. This study investigated whether a similar relationship persists between midlife HTN or systolic blood pressure (SBP) and NP performance approximately 30 years later. 378 Framingham stroke and dementia-free Original cohort participants, with HTN and SBP ascertained between 50-60 years of age (mean age 55 ± 1, 65% women), were administered a NP assessment at age ≥80 years. Tests included Logical Memory, Visual Reproduction, Paired Associate, Hooper Visual Organization Test, Trail Making A & B, Digit Span Forward and Backward, Controlled Word Association Test (COWAT), and Similarities. Multivariable linear regression, adjusted for age, time interval between risk factor and NP testing, gender, and premorbid intelligence, assessed association between midlife HTN/SBP and NP outcomes. Midlife HTN was not significantly associated with NP outcome measures. Midlife SBP was associated with poorer Digit Span Forward and COWAT performance (p < 0.05). No significant interaction of age on HTN/SBP to NP associations was found. There was a significant interaction between ApoE4 status and SBP in their effects on COWAT (pinteraction = 0.074); SBP was negatively associated with COWAT only in those with the ApoE4 allele (p = 0.025). While midlife HTN is not associated with late life cognitive impairment, midlife SBP is related to late life attention and verbal fluency impairments, particularly among ApoE4+ individuals. These results offer insight into processes that are operative in the absence of overt cognitive impairment and dementia.
Collapse
Affiliation(s)
- Arvind Nishtala
- Framingham Heart Study, Department of Neurology, Boston University School of Medicine, Boston, MA, USA
| | - Jayandra J. Himali
- Framingham Heart Study, Department of Neurology, Boston University School of Medicine, Boston, MA, USA
| | - Alexa Beiser
- Framingham Heart Study, Department of Neurology, Boston University School of Medicine, Boston, MA, USA
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
| | - Joanne M. Murabito
- Framingham Heart Study, Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Boston, MA, USA
| | - Sudha Seshadri
- Framingham Heart Study, Department of Neurology, Boston University School of Medicine, Boston, MA, USA
| | - Philip A. Wolf
- Framingham Heart Study, Department of Neurology, Boston University School of Medicine, Boston, MA, USA
| | - Rhoda Au
- Framingham Heart Study, Department of Neurology, Boston University School of Medicine, Boston, MA, USA
| |
Collapse
|
121
|
Broer L, Buchman AS, Deelen J, Evans DS, Faul JD, Lunetta KL, Sebastiani P, Smith JA, Smith AV, Tanaka T, Yu L, Arnold AM, Aspelund T, Benjamin EJ, De Jager PL, Eirkisdottir G, Evans DA, Garcia ME, Hofman A, Kaplan RC, Kardia SLR, Kiel DP, Oostra BA, Orwoll ES, Parimi N, Psaty BM, Rivadeneira F, Rotter JI, Seshadri S, Singleton A, Tiemeier H, Uitterlinden AG, Zhao W, Bandinelli S, Bennett DA, Ferrucci L, Gudnason V, Harris TB, Karasik D, Launer LJ, Perls TT, Slagboom PE, Tranah GJ, Weir DR, Newman AB, van Duijn CM, Murabito JM. GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy. J Gerontol A Biol Sci Med Sci 2015; 70:110-8. [PMID: 25199915 PMCID: PMC4296168 DOI: 10.1093/gerona/glu166] [Citation(s) in RCA: 218] [Impact Index Per Article: 24.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2014] [Accepted: 08/07/2014] [Indexed: 01/08/2023] Open
Abstract
BACKGROUND The genetic contribution to longevity in humans has been estimated to range from 15% to 25%. Only two genes, APOE and FOXO3, have shown association with longevity in multiple independent studies. METHODS We conducted a meta-analysis of genome-wide association studies including 6,036 longevity cases, age ≥90 years, and 3,757 controls that died between ages 55 and 80 years. We additionally attempted to replicate earlier identified single nucleotide polymorphism (SNP) associations with longevity. RESULTS In our meta-analysis, we found suggestive evidence for the association of SNPs near CADM2 (odds ratio [OR] = 0.81; p value = 9.66 × 10(-7)) and GRIK2 (odds ratio = 1.24; p value = 5.09 × 10(-8)) with longevity. When attempting to replicate findings earlier identified in genome-wide association studies, only the APOE locus consistently replicated. In an additional look-up of the candidate gene FOXO3, we found that an earlier identified variant shows a highly significant association with longevity when including published data with our meta-analysis (odds ratio = 1.17; p value = 1.85×10(-10)). CONCLUSIONS We did not identify new genome-wide significant associations with longevity and did not replicate earlier findings except for APOE and FOXO3. Our inability to find new associations with survival to ages ≥90 years because longevity represents multiple complex traits with heterogeneous genetic underpinnings, or alternatively, that longevity may be regulated by rare variants that are not captured by standard genome-wide genotyping and imputation of common variants.
Collapse
Affiliation(s)
- Linda Broer
- Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. Netherlands Consortium for Healthy Ageing, Leiden University Medical Center, The Netherlands. Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
| | - Aron S Buchman
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois
| | - Joris Deelen
- Netherlands Consortium for Healthy Ageing, Leiden University Medical Center, The Netherlands. Department of Molecular Epidemiology, Leiden University Medical Center, The Netherlands
| | - Daniel S Evans
- California Pacific Medical Center Research Institute, San Francisco
| | - Jessica D Faul
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor
| | - Kathryn L Lunetta
- Department of Biostatistics, Boston University School of Public Health, Massachusetts. NHLBI's and Boston Univesity's Framingham Heart Study, Massachusetts
| | - Paola Sebastiani
- Department of Biostatistics, Boston University School of Public Health, Massachusetts
| | | | - Albert V Smith
- Icelandic Heart Association, Kopavogur, Iceland. Department of Medicine, University of Iceland, Reykjavik
| | - Toshiko Tanaka
- Translational Gerontology Branch, National Institute on Aging, Baltimore, Maryland
| | - Lei Yu
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois
| | - Alice M Arnold
- Department of Biostatistics, University of Washington, Seattle
| | - Thor Aspelund
- Icelandic Heart Association, Kopavogur, Iceland. Department of Medicine, University of Iceland, Reykjavik
| | - Emelia J Benjamin
- NHLBI's and Boston Univesity's Framingham Heart Study, Massachusetts. Department of Medicine, Sections of Preventive Medicine and Cardiology, Boston University School of Medicine, Massachusetts. Department of Epidemiology, Boston University School of Public Health, Massachusetts
| | - Philip L De Jager
- Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Departments of Neurology and Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts
| | | | - Denis A Evans
- Rush Institute for Healthy Aging and Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois
| | - Melissa E Garcia
- Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Bethesda, Maryland
| | - Albert Hofman
- Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. Netherlands Consortium for Healthy Ageing, Leiden University Medical Center, The Netherlands
| | - Robert C Kaplan
- Department of Epidemiology and Population Health, Albert Einstein College, Bronx, New York
| | | | - Douglas P Kiel
- Harvard Medical School, Boston, Massachusetts. Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School Department of Medicine, Boston, Massachusetts. Division of Gerontology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts
| | - Ben A Oostra
- Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. Netherlands Consortium for Healthy Ageing, Leiden University Medical Center, The Netherlands
| | - Eric S Orwoll
- School of Medicine, Oregon Health and Science University, Portland
| | - Neeta Parimi
- California Pacific Medical Center Research Institute, San Francisco
| | - Bruce M Psaty
- Department of Medicine, University of Washington, Seattle. Deparment of Epidemiology, University of Washington, Seattle. Department of Health Services, University of Washington, Seattle. Group Health Research Institute, Group Health Cooperative, Seattle, Washington
| | - Fernando Rivadeneira
- Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School Department of Medicine, Boston, Massachusetts
| | - Jerome I Rotter
- Institute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute and Department of Pediatrics, Harbor-UCLA Medical Center, Torrance, California
| | - Sudha Seshadri
- Department of Biostatistics, Boston University School of Public Health, Massachusetts. Department of Neurology, Boston University School of Medicine, Massachusetts
| | - Andrew Singleton
- Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland
| | - Henning Tiemeier
- Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. Netherlands Consortium for Healthy Ageing, Leiden University Medical Center, The Netherlands. Department of Child and Adolescent Psychiatry, Erasmus MC and Sophia Children's Hospital, Rotterdam, The Netherlands
| | - André G Uitterlinden
- Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. Netherlands Consortium for Healthy Ageing, Leiden University Medical Center, The Netherlands. Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands
| | - Wei Zhao
- Department of Epidemiology, University of Michigan, Ann Arbor
| | | | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, Illinois
| | - Luigi Ferrucci
- Translational Gerontology Branch, National Institute on Aging, Baltimore, Maryland
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur, Iceland. Department of Medicine, University of Iceland, Reykjavik
| | - Tamara B Harris
- Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Bethesda, Maryland
| | - David Karasik
- Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School Department of Medicine, Boston, Massachusetts. Faculty of Medicine in The Galilee, Bar-Ilan University, Safed, Israel
| | - Lenore J Launer
- Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Bethesda, Maryland
| | - Thomas T Perls
- Section of Geriatrics, Boston University School of Medicine and Boston Medical Center, Massachusetts
| | - P Eline Slagboom
- Netherlands Consortium for Healthy Ageing, Leiden University Medical Center, The Netherlands. Department of Molecular Epidemiology, Leiden University Medical Center, The Netherlands
| | - Gregory J Tranah
- California Pacific Medical Center Research Institute, San Francisco. Department of Epidemiology and Biostatistics, University of California, San Francisco
| | - David R Weir
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor
| | - Anne B Newman
- Department of Epidemiology, University of Pittsburgh, Pennsylvania. *These authors contributed equally to this work
| | - Cornelia M van Duijn
- Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands. Netherlands Consortium for Healthy Ageing, Leiden University Medical Center, The Netherlands. *These authors contributed equally to this work
| | - Joanne M Murabito
- NHLBI's and Boston Univesity's Framingham Heart Study, Massachusetts. Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Massachusetts. *These authors contributed equally to this work.
| |
Collapse
|
122
|
Rosenquist KJ, Massaro JM, Pedley A, Long MT, Kreger BE, Vasan RS, Murabito JM, Hoffmann U, Fox CS. Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality. J Clin Endocrinol Metab 2015; 100:227-34. [PMID: 25226289 PMCID: PMC5399496 DOI: 10.1210/jc.2013-4296] [Citation(s) in RCA: 63] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
CONTEXT Cellular characteristics of fat quality have been associated with cardiometabolic risk and can be estimated by computed tomography (CT) attenuation. OBJECTIVE The aim was to determine the association between CT attenuation (measured in Hounsfield units [HU]) and clinical outcomes. METHODS This was a prospective community-based cohort study using data from the Framingham Heart Study (n = 3324, 48% women, mean age 51 years) and Cox proportional hazard models. MAIN OUTCOMES The primary outcomes of interest were incident cardiovascular disease (CVD) and all-cause mortality. The secondary outcomes of interest were incident cancer, non-CVD death, and cancer death. RESULTS There were 111 incident CVD events, 137 incident cancers, 85 deaths including 69 non-CVD deaths, and 45 cancer deaths in up to 23 047 person-years of follow-up. A 1-SD increment in visceral adipose tissue (VAT) HU was inversely associated with incident CVD in the age- and sex-adjusted model (hazard ratio [HR] 0.78, P = .02) but not after multivariable adjustment (HR 0.83, P = .11). VAT HU was directly associated with all-cause mortality (multivariable HR 1.40, P = .003), which maintained significance after additional adjustment for body mass index (HR 1.53, P < .001) and VAT volume (HR 1.99, P < .001). Non-CVD death remained significant in all 3 models, including after adjustment for VAT volume (HR 1.97, P < .001). VAT HU was also associated with cancer mortality (HR 1.93, P = .002). Similar results were obtained for sc adipose tissue HU. CONCLUSIONS Fat quality, as estimated by CT attenuation, is associated with all-cause mortality, non-CVD death, and cancer death. These associations highlight how indirect indices of fat quality can potentially add to a better understanding of obesity-related complications.
Collapse
Affiliation(s)
- Klara J Rosenquist
- Division of Endocrinology and Metabolism (K.J.R., C.S.F.), Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, 02115; National Heart, Lung, and Blood Institute (NHLBI) Framingham Heart Study (K.J.R., A.P., M.T.L., B.E.K., R.S.V., J.M.Mu., C.S.F.) and Division of Intramural Research and the Center for Population Studies (K.J.R., A.P., M.T.L., C.S.F.), Framingham, Massachusetts, 01702; Department of Biostatistics (J.M.Ma.), Boston University School of Public Health; Department of Medicine (M.T.L.), Section of Gastroenterology; Department of Medicine (B.E.K., J.M.Mu.), Section of General Internal Medicine; and Department of Medicine (R.S.V., U.H.), Section of Preventive Medicine and Epidemiology and Cardiology, Boston Medical Center and Boston University School of Medicine, Boston, Massachusetts, 02118; and Departments of Medicine and Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, 02114
| | | | | | | | | | | | | | | | | |
Collapse
|
123
|
Bihlmeyer NA, Brody JA, Smith AV, Lunetta KL, Nalls M, Smith JA, Tanaka T, Davies G, Yu L, Mirza SS, Teumer A, Coresh J, Pankow JS, Franceschini N, Scaria A, Oshima J, Psaty BM, Gudnason V, Eiriksdottir G, Harris TB, Li H, Karasik D, Kiel DP, Garcia M, Liu Y, Faul JD, Kardia SL, Zhao W, Ferrucci L, Allerhand M, Liewald DC, Redmond P, Starr JM, De Jager PL, Evans DA, Direk N, Ikram MA, Uitterlinden A, Homuth G, Lorbeer R, Grabe HJ, Launer L, Murabito JM, Singleton AB, Weir DR, Bandinelli S, Deary IJ, Bennett DA, Tiemeier H, Kocher T, Lumley T, Arking DE. Genetic diversity is a predictor of mortality in humans. BMC Genet 2014; 15:159. [PMID: 25543667 PMCID: PMC4301661 DOI: 10.1186/s12863-014-0159-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/22/2014] [Accepted: 12/19/2014] [Indexed: 01/14/2023] Open
Abstract
Background It has been well-established, both by population genetics theory and direct observation in many organisms, that increased genetic diversity provides a survival advantage. However, given the limitations of both sample size and genome-wide metrics, this hypothesis has not been comprehensively tested in human populations. Moreover, the presence of numerous segregating small effect alleles that influence traits that directly impact health directly raises the question as to whether global measures of genomic variation are themselves associated with human health and disease. Results We performed a meta-analysis of 17 cohorts followed prospectively, with a combined sample size of 46,716 individuals, including a total of 15,234 deaths. We find a significant association between increased heterozygosity and survival (P = 0.03). We estimate that within a single population, every standard deviation of heterozygosity an individual has over the mean decreases that person’s risk of death by 1.57%. Conclusions This effect was consistent between European and African ancestry cohorts, men and women, and major causes of death (cancer and cardiovascular disease), demonstrating the broad positive impact of genomic diversity on human survival. Electronic supplementary material The online version of this article (doi:10.1186/s12863-014-0159-7) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Nathan A Bihlmeyer
- Predoctoral Training Program in Human Genetics, McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. .,McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, BRB Room 447, 733 N. Broadway St, Baltimore, MD, 21205, USA.
| | - Jennifer A Brody
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, WA, USA.
| | - Albert Vernon Smith
- Icelandic Heart Association, Kopavogur, Iceland. .,University of Iceland, Reykjavik, Iceland.
| | - Kathryn L Lunetta
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA. .,The National Heart Lung and Blood Institute's Framingham Heart Study, Framingham, MA, USA.
| | - Mike Nalls
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
| | - Jennifer A Smith
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
| | - Toshiko Tanaka
- Translational Gerontology Branch, National Institute on Aging, Baltimore, MD, USA.
| | - Gail Davies
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, Edinburgh, UK. .,Department of Psychology, The University of Edinburgh, Edinburgh, UK.
| | - Lei Yu
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
| | - Saira Saeed Mirza
- Department of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands.
| | - Alexander Teumer
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany. .,Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
| | - Josef Coresh
- Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
| | - James S Pankow
- Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, MN, USA.
| | - Nora Franceschini
- Department of Epidemiology, School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27514, USA.
| | - Anish Scaria
- Department of Statistics, University of Auckland, 303.325 Science Centre, Private Bag 92019, Auckland, 1142, New Zealand.
| | - Junko Oshima
- Department of Pathology, University of Washington, Seattle, WA, USA.
| | - Bruce M Psaty
- Departments of Medicine, Epidemiology, and Health Services, University of Washington, Seattle, WA, USA.
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur, Iceland. .,University of Iceland, Reykjavik, Iceland.
| | | | - Tamara B Harris
- National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
| | - Hanyue Li
- Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
| | - David Karasik
- Institute for Aging Research, Hebrew Senior Life, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Cambridge, MA, USA.
| | - Douglas P Kiel
- Institute for Aging Research, Hebrew Senior Life, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Cambridge, MA, USA.
| | - Melissa Garcia
- Laboratory of Epidemiology, Demography and Biometry, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
| | - Yongmei Liu
- Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
| | - Jessica D Faul
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.
| | - Sharon Lr Kardia
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
| | - Wei Zhao
- Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
| | - Luigi Ferrucci
- Translational Gerontology Branch, National Institute on Aging, Baltimore, MD, USA.
| | - Michael Allerhand
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, Edinburgh, UK.
| | - David C Liewald
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, Edinburgh, UK.
| | - Paul Redmond
- Department of Psychology, The University of Edinburgh, Edinburgh, UK.
| | - John M Starr
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, Edinburgh, UK. .,Alzheimer Scotland Dementia Research Centre, The University of Edinburgh, Edinburgh, UK.
| | - Philip L De Jager
- Program in Translational NeuroPsychiatric Genomics, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
| | - Denis A Evans
- Rush Institute for Healthy Aging and Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA.
| | - Nese Direk
- Department of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands.
| | - Mohammed Arfan Ikram
- Department of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands. .,Department of Neurology, Erasmus Medical Centre, Rotterdam, The Netherlands. .,Department of Radiology, Erasmus Medical Centre, Rotterdam, The Netherlands.
| | - André Uitterlinden
- Department of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands. .,Department of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.
| | - Georg Homuth
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
| | - Roberto Lorbeer
- Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
| | - Hans J Grabe
- Department of Psychiatry and Psychotherapy, University Medicine Greifswald, HELIOS Hospital Stralsund, Greifswald, Germany. .,German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.
| | - Lenore Launer
- National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
| | - Joanne M Murabito
- The National Heart Lung and Blood Institute's Framingham Heart Study, Framingham, MA, USA. .,Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
| | - Andrew B Singleton
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
| | - David R Weir
- Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.
| | | | - Ian J Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology, The University of Edinburgh, Edinburgh, UK. .,Department of Psychology, The University of Edinburgh, Edinburgh, UK.
| | - David A Bennett
- Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
| | - Henning Tiemeier
- Department of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands. .,Department of Child and Adolescent Psychiatry, Erasmus Medical Centre, Rotterdam, The Netherlands. .,Department of Psychiatry, Erasmus Medical Centre, Rotterdam, The Netherlands.
| | - Thomas Kocher
- Unit of Periodontology, Department of Restorative Dentistry, Periodontology and Endodontology, University Medicine Greifswald, Greifswald, Germany.
| | - Thomas Lumley
- Department of Statistics, University of Auckland, 303.325 Science Centre, Private Bag 92019, Auckland, 1142, New Zealand.
| | - Dan E Arking
- McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, BRB Room 447, 733 N. Broadway St, Baltimore, MD, 21205, USA.
| |
Collapse
|
124
|
Lin H, Joehanes R, Pilling LC, Dupuis J, Lunetta KL, Ying SX, Benjamin EJ, Hernandez D, Singleton A, Melzer D, Munson PJ, Levy D, Ferrucci L, Murabito JM. Whole blood gene expression and interleukin-6 levels. Genomics 2014; 104:490-5. [PMID: 25311648 DOI: 10.1016/j.ygeno.2014.10.003] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2014] [Revised: 09/03/2014] [Accepted: 10/03/2014] [Indexed: 12/29/2022]
Abstract
BACKGROUND Circulating interleukin-6 levels increase with advancing age and are a risk factor for various diseases and mortality. The characterization of gene expression profiles associated with interleukin-6 levels might suggest important molecular events underlying its regulation. METHODS AND RESULTS We studied the association of transcriptional profiles with interleukin-6 levels in 2422 participants from the Framingham Heart Study Offspring Cohort using Affymetrix Human Exon 1.0 ST Array. We identified 4139 genes that were significantly associated with interleukin-6 levels (FDR<0.05) after adjusting for age, sex and blood cell components. We then replicated 807 genes in the InCHIANTI study with 694 participants. Many of the top genes are involved in inflammation-related pathways or erythrocyte function, including JAK/Stat signaling pathway and interleukin-10 signaling pathway. CONCLUSION We identified and replicated 807 genes that were associated with circulating interleukin-6 levels. Future characterization of interleukin-6 regulation networks may facilitate the identification of additional potential targets for treating inflammation-related diseases.
Collapse
Affiliation(s)
- Honghuang Lin
- Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA; National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA.
| | - Roby Joehanes
- National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Mathematical and Statistical Computing Laboratory, Center for Information Technology, National Institute of Health, Bethesda, MD, USA; Population Sciences Branch, National Heart, Lung, and Blood Institute, Bethesda, MD, USA
| | - Luke C Pilling
- Epidemiology and Public Health, Medical School, University of Exeter, Exeter EX1 2 LU, UK
| | - Josée Dupuis
- National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
| | - Kathryn L Lunetta
- National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA
| | - Sai-Xia Ying
- Mathematical and Statistical Computing Laboratory, Center for Information Technology, National Institute of Health, Bethesda, MD, USA
| | - Emelia J Benjamin
- National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Section of Cardiovascular Medicine and Preventive Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA; Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA
| | - Dena Hernandez
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
| | - Andrew Singleton
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
| | - David Melzer
- Epidemiology and Public Health, Medical School, University of Exeter, Exeter EX1 2 LU, UK
| | - Peter J Munson
- National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Mathematical and Statistical Computing Laboratory, Center for Information Technology, National Institute of Health, Bethesda, MD, USA; Population Sciences Branch, National Heart, Lung, and Blood Institute, Bethesda, MD, USA
| | - Daniel Levy
- National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Population Sciences Branch, National Heart, Lung, and Blood Institute, Bethesda, MD, USA
| | - Luigi Ferrucci
- Clinical Research Branch, National Institute on Aging, Baltimore, MD, USA
| | - Joanne M Murabito
- National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA; Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
| |
Collapse
|
125
|
Perry JRB, Day F, Elks CE, Sulem P, Thompson DJ, Ferreira T, He C, Chasman DI, Esko T, Thorleifsson G, Albrecht E, Ang WQ, Corre T, Cousminer DL, Feenstra B, Franceschini N, Ganna A, Johnson AD, Kjellqvist S, Lunetta KL, McMahon G, Nolte IM, Paternoster L, Porcu E, Smith AV, Stolk L, Teumer A, Tšernikova N, Tikkanen E, Ulivi S, Wagner EK, Amin N, Bierut LJ, Byrne EM, Hottenga JJ, Koller DL, Mangino M, Pers TH, Yerges-Armstrong LM, Zhao JH, Andrulis IL, Anton-Culver H, Atsma F, Bandinelli S, Beckmann MW, Benitez J, Blomqvist C, Bojesen SE, Bolla MK, Bonanni B, Brauch H, Brenner H, Buring JE, Chang-Claude J, Chanock S, Chen J, Chenevix-Trench G, Collée JM, Couch FJ, Couper D, Coveillo AD, Cox A, Czene K, D’adamo AP, Smith GD, De Vivo I, Demerath EW, Dennis J, Devilee P, Dieffenbach AK, Dunning AM, Eiriksdottir G, Eriksson JG, Fasching PA, Ferrucci L, Flesch-Janys D, Flyger H, Foroud T, Franke L, Garcia ME, García-Closas M, Geller F, de Geus EEJ, Giles GG, Gudbjartsson DF, Gudnason V, Guénel P, Guo S, Hall P, Hamann U, Haring R, Hartman CA, Heath AC, Hofman A, Hooning MJ, Hopper JL, Hu FB, Hunter DJ, Karasik D, Kiel DP, Knight JA, Kosma VM, Kutalik Z, Lai S, Lambrechts D, Lindblom A, Mägi R, Magnusson PK, Mannermaa A, Martin NG, Masson G, McArdle PF, McArdle WL, Melbye M, Michailidou K, Mihailov E, Milani L, Milne RL, Nevanlinna H, Neven P, Nohr EA, Oldehinkel AJ, Oostra BA, Palotie A, Peacock M, Pedersen NL, Peterlongo P, Peto J, Pharoah PDP, Postma DS, Pouta A, Pylkäs K, Radice P, Ring S, Rivadeneira F, Robino A, Rose LM, Rudolph A, Salomaa V, Sanna S, Schlessinger D, Schmidt MK, Southey MC, Sovio U, Stampfer MJ, Stöckl D, Storniolo AM, Timpson NJ, Tyrer J, Visser JA, Vollenweider P, Völzke H, Waeber G, Waldenberger M, Wallaschofski H, Wang Q, Willemsen G, Winqvist R, Wolffenbuttel BHR, Wright MJ, Boomsma DI, Econs MJ, Khaw KT, Loos RJF, McCarthy MI, Montgomery GW, Rice JP, Streeten EA, Thorsteinsdottir U, van Duijn CM, Alizadeh BZ, Bergmann S, Boerwinkle E, Boyd HA, Crisponi L, Gasparini P, Gieger C, Harris TB, Ingelsson E, Järvelin MR, Kraft P, Lawlor D, Metspalu A, Pennell CE, Ridker PM, Snieder H, Sørensen TIA, Spector TD, Strachan DP, Uitterlinden AG, Wareham NJ, Widen E, Zygmunt M, Murray A, Easton DF, Stefansson K, Murabito JM, Ong KK. Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature 2014; 514:92-97. [PMID: 25231870 PMCID: PMC4185210 DOI: 10.1038/nature13545] [Citation(s) in RCA: 378] [Impact Index Per Article: 37.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2013] [Accepted: 05/30/2014] [Indexed: 02/02/2023]
Abstract
Age at menarche is a marker of timing of puberty in females. It varies widely between individuals, is a heritable trait and is associated with risks for obesity, type 2 diabetes, cardiovascular disease, breast cancer and all-cause mortality. Studies of rare human disorders of puberty and animal models point to a complex hypothalamic-pituitary-hormonal regulation, but the mechanisms that determine pubertal timing and underlie its links to disease risk remain unclear. Here, using genome-wide and custom-genotyping arrays in up to 182,416 women of European descent from 57 studies, we found robust evidence (P < 5 × 10(-8)) for 123 signals at 106 genomic loci associated with age at menarche. Many loci were associated with other pubertal traits in both sexes, and there was substantial overlap with genes implicated in body mass index and various diseases, including rare disorders of puberty. Menarche signals were enriched in imprinted regions, with three loci (DLK1-WDR25, MKRN3-MAGEL2 and KCNK9) demonstrating parent-of-origin-specific associations concordant with known parental expression patterns. Pathway analyses implicated nuclear hormone receptors, particularly retinoic acid and γ-aminobutyric acid-B2 receptor signalling, among novel mechanisms that regulate pubertal timing in humans. Our findings suggest a genetic architecture involving at least hundreds of common variants in the coordinated timing of the pubertal transition.
Collapse
Affiliation(s)
- John RB Perry
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
- University of Exeter Medical School, University of Exeter, Exeter, UK EX1 2LU
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
- Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK
| | - Felix Day
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - Cathy E Elks
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | | | - Deborah J Thompson
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, UK
| | - Teresa Ferreira
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
| | - Chunyan He
- Department of Epidemiology, Indiana University Richard M. Fairbanks School of Public Health, Indianapolis, IN 46202, USA
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA
| | - Daniel I Chasman
- Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA 02215
- Harvard Medical School, Boston, MA 02115
| | - Tõnu Esko
- Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia
- Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Boston Children’s Hospital, Boston, MA 02115, USA
- Broad Institute of the Massachusetts Institute of Technology and Harvard University, 140 Cambridge 02142, MA, USA
- Department of Genetics, Harvard Medical School, Boston, MA 02115, USA
| | | | - Eva Albrecht
- Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
| | - Wei Q Ang
- School of Women’s and Infants’ Health, The University of Western Australia
| | - Tanguy Corre
- Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland
- Swiss Institute of Bioinformatics, Lausanne, Switzerland
| | - Diana L Cousminer
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
| | - Bjarke Feenstra
- Department of Epidemiology Research, Statens Serum Institut, DK-2300 Copenhagen, Denmark
| | - Nora Franceschini
- Department of Epidemiology, University of North Carolina, Chapel Hill, NC
| | - Andrea Ganna
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden
| | - Andrew D Johnson
- NHLBI’s and Boston University’s Framingham Heart Study, Framingham, MA
| | - Sanela Kjellqvist
- Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden
| | - Kathryn L Lunetta
- NHLBI’s and Boston University’s Framingham Heart Study, Framingham, MA
- Boston University School of Public Health, Department of Biostatistics. Boston, MA
| | - George McMahon
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
- School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK
| | - Ilja M Nolte
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | | | - Eleonora Porcu
- Institute of Genetics and Biomedical Research, National Research Council, Cagliari, Italy
- University of Sassari, Dept. Of Biomedical Sciences, Sassari, Italy
| | - Albert V Smith
- Icelandic Heart Association, Kopavogur, Iceland
- University of Iceland, Reykjavik, Iceland
| | - Lisette Stolk
- Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands
- Netherlands Consortium on Health Aging and National Genomics Initiative, Leiden, the Netherlands
| | - Alexander Teumer
- Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, 17475 Greifswald, Germany
| | - Natalia Tšernikova
- Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia
- Department of Biotechnology, University of Tartu, Tartu, 51010, Estonia
| | - Emmi Tikkanen
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
- Hjelt Institute, University of Helsinki, Finland
| | - Sheila Ulivi
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo” – Trieste, Italy
| | - Erin K Wagner
- Department of Epidemiology, Indiana University Richard M. Fairbanks School of Public Health, Indianapolis, IN 46202, USA
- Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN 46202, USA
| | - Najaf Amin
- Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
| | - Laura J Bierut
- Dept. of Psychiatry, Washington University, St. Louis, MO 63110
| | - Enda M Byrne
- The University of Queensland, Queensland Brain Institute, St.Lucia, QLD, Australia
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
| | - Jouke-Jan Hottenga
- Department of Biological Psychology, VU University Amsterdam, van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands
| | - Daniel L Koller
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana USA
| | - Massimo Mangino
- Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK
| | - Tune H Pers
- Divisions of Endocrinology and Genetics and Center for Basic and Translational Obesity Research, Boston Children’s Hospital, Boston, MA 02115, USA
- Broad Institute of the Massachusetts Institute of Technology and Harvard University, 140 Cambridge 02142, MA, USA
- Medical and Population Genetics, Broad Institute, Cambridge, MA 02142, US
- Center for Biological Sequence Analysis, Department of Systems Biology, Technical 142 University of Denmark, Lyngby 2800, Denmark
| | - Laura M Yerges-Armstrong
- Program in Personalized and Genomic Medicine, and Department of Medicine, Division of Endocrinology, Diabetes and Nutrition - University of Maryland School of Medicine, USA. Baltimore, MD 21201
| | - Jing Hua Zhao
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - Irene L Andrulis
- Ontario Cancer Genetics Network, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada
- Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada
| | - Hoda Anton-Culver
- Department of Epidemiology, University of California Irvine, Irvine, California, USA
| | | | - Stefania Bandinelli
- Tuscany Regional Health Agency, Florence, Italy, I.O.T. and Department of Medical and Surgical Critical Care, University of Florence, Florence, Italy
- Geriatric Unit, Azienda Sanitaria di Firenze, Florence, Italy
| | - Matthias W Beckmann
- University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
| | - Javier Benitez
- Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
- Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia, Spain
| | - Carl Blomqvist
- Department of Oncology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
| | - Stig E Bojesen
- Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark
- Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark
| | - Manjeet K Bolla
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, UK
| | - Bernardo Bonanni
- Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy
| | - Hiltrud Brauch
- Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart
- University of Tübingen, Germany
| | - Hermann Brenner
- Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
- German Cancer Consortium (DKTK), Heidelberg, Germany
| | - Julie E Buring
- Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA 02215
- Harvard Medical School, Boston, MA 02115
| | - Jenny Chang-Claude
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Stephen Chanock
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA
| | - Jinhui Chen
- Departments of Anatomy and Neurological Surgery, Indiana University school of Medicine, Indianapolis, IN 46202, USA
- Stark Neuroscience Research Center, Indiana University school of Medicine, Indianapolis, IN 46202, USA
| | | | - J. Margriet Collée
- Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - Fergus J Couch
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
| | - David Couper
- Department of Biostatistics, University of North Carolina, Chapel Hill, NC
| | - Andrea D Coveillo
- Boston University School of Medicine, Department of Medicine, Sections of Preventive Medicine and Endocrinology, Boston, MA
| | - Angela Cox
- Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, UK
| | - Kamila Czene
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden
| | - Adamo Pio D’adamo
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo” – Trieste, Italy
- Department of Clinical Medical Sciences, Surgical and Health, University of Trieste, Italy
| | - George Davey Smith
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
- School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK
| | - Immaculata De Vivo
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA
| | - Ellen W Demerath
- Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minn., USA
| | - Joe Dennis
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, UK
| | - Peter Devilee
- Department of Human Genetics & Department of Pathology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands
| | - Aida K Dieffenbach
- Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany
- German Cancer Consortium (DKTK), Heidelberg, Germany
| | - Alison M Dunning
- Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, UK
| | | | - Johan G Eriksson
- National Institute for Health and Welfare, Finland
- Department of General Practice and Primary health Care, University of Helsinki, Finland
- Helsinki University Central Hospital, Unit of General Practice, Helsinki, Finland
- Folkhalsan Research Centre, Helsinki, Finland
| | - Peter A Fasching
- University Breast Center Franconia, Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany
| | - Luigi Ferrucci
- Longitudinal Studies Section, Clinical Research Branch, Gerontology Research Center, National Institute on Aging, Baltimore, Maryland, United States of America
| | - Dieter Flesch-Janys
- Department of Cancer Epidemiology/Clinical Cancer Registry and Institute for Medical Biometrics and Epidemiology, University Clinic Hamburg-Eppendorf, Hamburg, Germany
| | - Henrik Flyger
- Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark
| | - Tatiana Foroud
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana USA
| | - Lude Franke
- Department of Genetics, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
| | - Melissa E Garcia
- National Insitute on Aging, National Institutes of Health, Baltimore, MD 20892, USA
| | - Montserrat García-Closas
- Division of Genetics and Epidemiology, Institute of Cancer Research, Sutton, Surrey, UK
- Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, UK
| | - Frank Geller
- Department of Epidemiology Research, Statens Serum Institut, DK-2300 Copenhagen, Denmark
| | - Eco EJ de Geus
- Department of Biological Psychology, VU University Amsterdam, van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands
- EMGO + Institute for Health and Care Research, VU University Medical Centre, Van der Boechorststraat 7, 1081 Bt, Amsterdam, The Netherlands
| | - Graham G Giles
- Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
| | - Daniel F Gudbjartsson
- deCODE Genetics, Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur, Iceland
- University of Iceland, Reykjavik, Iceland
| | - Pascal Guénel
- Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France
- University Paris-Sud, UMRS 1018, Villejuif, France
| | - Suiqun Guo
- Department of Obstetrics and Gynecology, Southern Medical University, Guangzhou, China
| | - Per Hall
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden
| | - Ute Hamann
- Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany
| | - Robin Haring
- Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, 17475 Greifswald, Germany
| | - Catharina A Hartman
- Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Andrew C Heath
- Washington University, Department of Psychiatry, St.Louis, Missouri, USA
| | - Albert Hofman
- Department of Epidemiology, Erasmus MC, Rotterdan, the Netherlands
| | - Maartje J Hooning
- Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands
| | - John L Hopper
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
| | - Frank B Hu
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA
- Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
| | - David J Hunter
- Broad Institute of the Massachusetts Institute of Technology and Harvard University, 140 Cambridge 02142, MA, USA
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA
| | - David Karasik
- Harvard Medical School, Boston, MA 02115
- Hebrew SeniorLife Institute for Aging Research, Boston, MA
| | - Douglas P Kiel
- Hebrew SeniorLife Institute for Aging Research, Boston, MA
- Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02115
| | - Julia A Knight
- Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada
- Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
| | - Veli-Matti Kosma
- School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland
- Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland
| | - Zoltan Kutalik
- Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland
- Swiss Institute of Bioinformatics, Lausanne, Switzerland
| | - Sandra Lai
- Institute of Genetics and Biomedical Research, National Research Council, Cagliari, Italy
| | - Diether Lambrechts
- Vesalius Research Center (VRC), VIB, Leuven, Belgium
- Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium
| | - Annika Lindblom
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
| | - Reedik Mägi
- Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia
| | - Patrik K Magnusson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden
| | - Arto Mannermaa
- School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland
- Imaging Center, Department of Clinical Pathology, Kuopio University Hospital, Kuopio, Finland
| | - Nicholas G Martin
- Department of Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia
| | | | - Patrick F McArdle
- Program in Personalized and Genomic Medicine, and Department of Medicine, Division of Endocrinology, Diabetes and Nutrition - University of Maryland School of Medicine, USA. Baltimore, MD 21201
| | - Wendy L McArdle
- School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK
| | - Mads Melbye
- Department of Epidemiology Research, Statens Serum Institut, DK-2300 Copenhagen, Denmark
- Department of Medicine, Stanford School of Medicine, Stanford, USA
| | - Kyriaki Michailidou
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, UK
| | - Evelin Mihailov
- Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia
- Department of Biotechnology, University of Tartu, Tartu, 51010, Estonia
| | - Lili Milani
- Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia
| | - Roger L Milne
- Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
| | - Heli Nevanlinna
- Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland
| | - Patrick Neven
- KULeuven (University of Leuven), Department of Oncology, Multidisciplinary Breast Center, University Hospitals Leuven, Belgium
| | - Ellen A Nohr
- Research Unit of Obstetrics & Gynecology, Institute of Clinical Research, University of Southern denmark, DK
| | - Albertine J Oldehinkel
- Interdisciplinary Center Psychopathology and Emotion Regulation, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Ben A Oostra
- Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
| | - Aarno Palotie
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
- Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
- Program in Medical and Population Genetics, Broad Institute, Cambridge, MA, USA
- Psychiatric & Neurodevelopmental Genetics Unit, Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
| | - Munro Peacock
- Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana USA
| | - Nancy L Pedersen
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden
| | - Paolo Peterlongo
- IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy
| | - Julian Peto
- Non-communicable Disease Epidemiology Department, London School of Hygiene and Tropical Medicine, London, UK
| | - Paul DP Pharoah
- Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, UK
| | - Dirkje S Postma
- University Groningen, University Medical Center Groningen, Department Pulmonary Medicine and Tuberculosis, GRIAC Research Institute, Groningen, The Netherlands
| | - Anneli Pouta
- National Institute for Health and Welfare, Finland
- Department of Obstetrics and Gynecology, Oulu University Hospital, Finland
| | - Katri Pylkäs
- Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu University Hospital/NordLab Oulu, Oulu, Finland
| | - Paolo Radice
- Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy
| | - Susan Ring
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
- School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK
| | - Fernando Rivadeneira
- Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands
- Netherlands Consortium on Health Aging and National Genomics Initiative, Leiden, the Netherlands
- Department of Epidemiology, Erasmus MC, Rotterdan, the Netherlands
| | - Antonietta Robino
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo” – Trieste, Italy
- Department of Clinical Medical Sciences, Surgical and Health, University of Trieste, Italy
| | - Lynda M Rose
- Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA 02215
| | - Anja Rudolph
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | | | - Serena Sanna
- Institute of Genetics and Biomedical Research, National Research Council, Cagliari, Italy
| | - David Schlessinger
- National Institute on Aging, Intramural Research Program, Baltimore, MD, USA
| | - Marjanka K Schmidt
- Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital, Amsterdam, The Netherlands
| | - Mellissa C Southey
- Department of Pathology, The University of Melbourne, Melbourne, Australia
| | - Ulla Sovio
- Department of Epidemiology and Biostatistics, MRC Health Protection Agency (HPA) Centre for Environment and Health, School of Public Health, Imperial College London, UK
- Department of Obstetrics and Gynaecology, University of Cambridge, Cambridge, United Kingdom
| | - Meir J Stampfer
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
- Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115, USA
- Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
| | - Doris Stöckl
- Institute of Epidemiology II, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
- Department of Obstetrics and Gynaecology, Campus Grosshadern, Ludwig-Maximilians- University, Munich, Germany
| | - Anna M Storniolo
- Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana USA
| | - Nicholas J Timpson
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
- School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK
| | - Jonathan Tyrer
- Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, UK
| | - Jenny A Visser
- Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands
| | - Peter Vollenweider
- Department of Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland
| | - Henry Völzke
- Institute for Community Medicine, University Medicine Greifswald, 17475 Greifswald, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Greifswald, 17475 Greifswald, Germany
| | - Gerard Waeber
- Department of Internal Medicine, Lausanne University Hospital, Lausanne, Switzerland
| | - Melanie Waldenberger
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
| | - Henri Wallaschofski
- Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, 17475 Greifswald, Germany
- DZHK (German Centre for Cardiovascular Research), partner site Greifswald, 17475 Greifswald, Germany
| | - Qin Wang
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, UK
| | - Gonneke Willemsen
- Department of Biological Psychology, VU University Amsterdam, van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands
| | - Robert Winqvist
- Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, Oulu University Hospital/NordLab Oulu, Oulu, Finland
| | - Bruce HR Wolffenbuttel
- Department of Endocrinology, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands
| | - Margaret J Wright
- Queensland Insitute of Medical Research, Brisbane, Queensland, Australia
| | - Australian Ovarian Cancer Study
- QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia
- Peter MacCallum Cancer Centre, Melbourne, Australia
| | - The GENICA Network
- Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart
- University of Tübingen, Germany
- Molecular Genetics of Breast Cancer, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance, Institute of the Ruhr University Bochum (IPA), Bochum, Germany
- Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany
- Institute of Pathology, Medical Faculty of the University of Bonn, Bonn, Germany
- Institute of Occupational Medicine and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
| | - kConFab
- Peter MacCallum Cancer Centre, Melbourne, Australia
| | | | | | | | - Dorret I Boomsma
- Department of Biological Psychology, VU University Amsterdam, van der Boechorststraat 1, 1081 BT, Amsterdam, The Netherlands
| | - Michael J Econs
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana USA
- Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana USA
| | - Kay-Tee Khaw
- Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Cambridge, CB2 0QQ, UK
| | - Ruth JF Loos
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
- Genetics of Obesity and Related Metabolic Traits Program, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, Box 1003, New York, NY 10029, USA
| | - Mark I McCarthy
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK
- NIHR Oxford Biomedical Research Centre, Churchill Hospital, OX3 7LE Oxford, UK
- Oxford Centre for Diabetes, Endocrinology, & Metabolism, University of Oxford, Churchill Hospital, OX37LJ Oxford, UK
| | - Grant W Montgomery
- Queensland Insitute of Medical Research, Brisbane, Queensland, Australia
| | - John P Rice
- Dept. of Psychiatry, Washington University, St. Louis, MO 63110
| | - Elizabeth A Streeten
- Program in Personalized and Genomic Medicine, and Department of Medicine, Division of Endocrinology, Diabetes and Nutrition - University of Maryland School of Medicine, USA. Baltimore, MD 21201
- Geriatric Research and Education Clinical Center (GRECC) - Veterans Administration Medical Center, USA. Baltimore, MD 21201
| | - Unnur Thorsteinsdottir
- deCODE Genetics, Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Cornelia M van Duijn
- Netherlands Consortium on Health Aging and National Genomics Initiative, Leiden, the Netherlands
- Genetic Epidemiology Unit Department of Epidemiology, Erasmus MC, Rotterdam, the Netherlands
- Centre of Medical Systems Biology, Leiden, the Netherlands
| | - Behrooz Z Alizadeh
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Sven Bergmann
- Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland
- Swiss Institute of Bioinformatics, Lausanne, Switzerland
| | - Eric Boerwinkle
- Human Genetics Center and Div. of Epidemiology, University of Houston, TX
| | - Heather A Boyd
- Department of Epidemiology Research, Statens Serum Institut, DK-2300 Copenhagen, Denmark
| | - Laura Crisponi
- Institute of Genetics and Biomedical Research, National Research Council, Cagliari, Italy
| | - Paolo Gasparini
- Institute for Maternal and Child Health - IRCCS “Burlo Garofolo” – Trieste, Italy
- Department of Clinical Medical Sciences, Surgical and Health, University of Trieste, Italy
| | - Christian Gieger
- Institute of Genetic Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
| | - Tamara B Harris
- National Insitute on Aging, National Institutes of Health, Baltimore, MD 20892, USA
| | - Erik Ingelsson
- Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden
| | - Marjo-Riitta Järvelin
- Department of Epidemiology and Biostatistics, MRC Health Protection Agency (HPA) Centre for Environment and Health, School of Public Health, Imperial College London, UK
- Institute of Health Sciences, P.O.Box 5000, FI-90014 University of Oulu, Finland
- Biocenter Oulu, P.O.Box 5000, Aapistie 5A, FI-90014 University of Oulu, Finland
- Department of Children and Young People and Families, National Institute for Health and Welfare, Aapistie 1, Box 310, FI-90101 Oulu, Finland
- Unit of Primary Care, Oulu University Hospital, Kajaanintie 50, P.O.Box 20, FI-90220 Oulu, 90029 OYS, Finland
| | - Peter Kraft
- Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
- Department of Biostatistics, Harvard School of Public Health, Boston, MA 02115, USA
| | - Debbie Lawlor
- MRC Integrative Epidemiology Unit, University of Bristol, Bristol, UK
- School of Social and Community Medicine, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, UK
| | - Andres Metspalu
- Estonian Genome Center, University of Tartu, Tartu, 51010, Estonia
- Department of Biotechnology, University of Tartu, Tartu, 51010, Estonia
| | - Craig E Pennell
- School of Women’s and Infants’ Health, The University of Western Australia
| | - Paul M Ridker
- Division of Preventive Medicine, Brigham and Women’s Hospital, Boston, MA 02215
- Harvard Medical School, Boston, MA 02115
| | - Harold Snieder
- Department of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Thorkild IA Sørensen
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
- Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospitals, The Capital Region, Copenhagen, Denmark
| | - Tim D Spector
- Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK
| | - David P Strachan
- Division of Population Health Sciences and Education, St George’s, University of London, Cranmer Terrace, London SW17 0RE, UK
| | - André G Uitterlinden
- Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands
- Netherlands Consortium on Health Aging and National Genomics Initiative, Leiden, the Netherlands
- Department of Epidemiology, Erasmus MC, Rotterdan, the Netherlands
| | - Nicholas J Wareham
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
| | - Elisabeth Widen
- Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
| | - Marek Zygmunt
- Department of Obstetrics and Gynecology, University Medicine Greifswald, 17475 Greifswald, Germany
| | - Anna Murray
- University of Exeter Medical School, University of Exeter, Exeter, UK EX1 2LU
| | - Douglas F Easton
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, UK
| | - Kari Stefansson
- deCODE Genetics, Reykjavik, Iceland
- Faculty of Medicine, University of Iceland, Reykjavik, Iceland
| | - Joanne M Murabito
- NHLBI’s and Boston University’s Framingham Heart Study, Framingham, MA
- Boston University School of Medicine, Department of Medicine, Section of General Internal Medicine, Boston, MA
| | - Ken K Ong
- MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Box 285 Institute of Metabolic Science, Cambridge Biomedical Campus, Cambridge, CB2 0QQ, UK
- Department of Paediatrics,University of Cambridge,Cambridge,UK
| |
Collapse
|
126
|
Xanthakis V, Enserro DM, Murabito JM, Polak JF, Wollert KC, Januzzi JL, Wang TJ, Tofler G, Vasan RS. Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study. Circulation 2014; 130:1676-83. [PMID: 25274000 DOI: 10.1161/circulationaha.114.009273] [Citation(s) in RCA: 152] [Impact Index Per Article: 15.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
BACKGROUND The American Heart Association Cardiovascular Health score (CVH score) is inversely associated with cardiovascular disease (CVD) incidence, but the mechanisms underlying this association warrant exploration. METHODS AND RESULTS We related the CVH score to circulating biomarkers and prevalent subclinical CVD (defined as ≥1 of the following: increased carotid intima-media thickness or stenosis, left ventricular hypertrophy [by ECG or echocardiography], left ventricular systolic dysfunction, microalbuminuria, and a reduced ankle-brachial index) in 2680 Framingham Study participants (mean age, 58 years; 55% women). After adjustment for age and sex, an ideal CVH score (nonsmoking status, ideal body mass index, regular physical activity, healthy diet, and an optimal profile of serum cholesterol, blood pressure, and glucose; 1 point for each) was associated with higher circulating concentrations of natriuretic peptides (N-terminal pro-atrial natriuretic peptide and B-type natriuretic peptide) and lower blood concentrations of plasminogen activator inhibitor-1, aldosterone, C-reactive protein, D-dimer, fibrinogen, homocysteine, and growth differentiation factor-15 levels (P<0.001 for all), as well as lower odds of subclinical disease (odds ratio, 0.74 per 1-unit increase in CVH score; 95% confidence interval, 0.68-0.80). The incidence of CVD (267 events over 16 years) was inversely associated with the CVH score in age- and sex-adjusted models (hazard ratio, 0.77 per 1-unit increase in CVH score; 95% confidence interval, 0.70-0.86), which was slightly attenuated upon adjustment for biomarkers and subclinical disease (hazard ratio, 0.87; 95% confidence interval, 0.78-0.97). CONCLUSION In our prospective community-based study, the inverse association between an ideal cardiovascular health score and CVD incidence was partly attributable to its favorable impact on CVD biomarker levels and subclinical disease.
Collapse
Affiliation(s)
- Vanessa Xanthakis
- From the Framingham Heart Study, Framingham, MA (V.X., J.M.M., R.S.V.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (V.X., D.M.E.); Section of Preventive Medicine and Epidemiology (V.X., R.S.V.) and Section of General Internal Medicine, Department of Medicine (J.M.M.), Boston University School of Medicine, Boston, MA; Department of Radiology, Tufts University Medical Center, Boston, MA (J.F.P.); Division of Molecular and Translational Cardiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany (K.C.W.); Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (J.L.J.); Cardiology Division, Vanderbilt University Medical Center, Nashville, TN (T.J.W.); and Royal North Shore Hospital University of Sydney, Sydney, Australia (G.T.).
| | - Danielle M Enserro
- From the Framingham Heart Study, Framingham, MA (V.X., J.M.M., R.S.V.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (V.X., D.M.E.); Section of Preventive Medicine and Epidemiology (V.X., R.S.V.) and Section of General Internal Medicine, Department of Medicine (J.M.M.), Boston University School of Medicine, Boston, MA; Department of Radiology, Tufts University Medical Center, Boston, MA (J.F.P.); Division of Molecular and Translational Cardiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany (K.C.W.); Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (J.L.J.); Cardiology Division, Vanderbilt University Medical Center, Nashville, TN (T.J.W.); and Royal North Shore Hospital University of Sydney, Sydney, Australia (G.T.)
| | - Joanne M Murabito
- From the Framingham Heart Study, Framingham, MA (V.X., J.M.M., R.S.V.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (V.X., D.M.E.); Section of Preventive Medicine and Epidemiology (V.X., R.S.V.) and Section of General Internal Medicine, Department of Medicine (J.M.M.), Boston University School of Medicine, Boston, MA; Department of Radiology, Tufts University Medical Center, Boston, MA (J.F.P.); Division of Molecular and Translational Cardiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany (K.C.W.); Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (J.L.J.); Cardiology Division, Vanderbilt University Medical Center, Nashville, TN (T.J.W.); and Royal North Shore Hospital University of Sydney, Sydney, Australia (G.T.)
| | - Joseph F Polak
- From the Framingham Heart Study, Framingham, MA (V.X., J.M.M., R.S.V.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (V.X., D.M.E.); Section of Preventive Medicine and Epidemiology (V.X., R.S.V.) and Section of General Internal Medicine, Department of Medicine (J.M.M.), Boston University School of Medicine, Boston, MA; Department of Radiology, Tufts University Medical Center, Boston, MA (J.F.P.); Division of Molecular and Translational Cardiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany (K.C.W.); Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (J.L.J.); Cardiology Division, Vanderbilt University Medical Center, Nashville, TN (T.J.W.); and Royal North Shore Hospital University of Sydney, Sydney, Australia (G.T.)
| | - Kai C Wollert
- From the Framingham Heart Study, Framingham, MA (V.X., J.M.M., R.S.V.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (V.X., D.M.E.); Section of Preventive Medicine and Epidemiology (V.X., R.S.V.) and Section of General Internal Medicine, Department of Medicine (J.M.M.), Boston University School of Medicine, Boston, MA; Department of Radiology, Tufts University Medical Center, Boston, MA (J.F.P.); Division of Molecular and Translational Cardiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany (K.C.W.); Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (J.L.J.); Cardiology Division, Vanderbilt University Medical Center, Nashville, TN (T.J.W.); and Royal North Shore Hospital University of Sydney, Sydney, Australia (G.T.)
| | - James L Januzzi
- From the Framingham Heart Study, Framingham, MA (V.X., J.M.M., R.S.V.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (V.X., D.M.E.); Section of Preventive Medicine and Epidemiology (V.X., R.S.V.) and Section of General Internal Medicine, Department of Medicine (J.M.M.), Boston University School of Medicine, Boston, MA; Department of Radiology, Tufts University Medical Center, Boston, MA (J.F.P.); Division of Molecular and Translational Cardiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany (K.C.W.); Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (J.L.J.); Cardiology Division, Vanderbilt University Medical Center, Nashville, TN (T.J.W.); and Royal North Shore Hospital University of Sydney, Sydney, Australia (G.T.)
| | - Thomas J Wang
- From the Framingham Heart Study, Framingham, MA (V.X., J.M.M., R.S.V.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (V.X., D.M.E.); Section of Preventive Medicine and Epidemiology (V.X., R.S.V.) and Section of General Internal Medicine, Department of Medicine (J.M.M.), Boston University School of Medicine, Boston, MA; Department of Radiology, Tufts University Medical Center, Boston, MA (J.F.P.); Division of Molecular and Translational Cardiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany (K.C.W.); Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (J.L.J.); Cardiology Division, Vanderbilt University Medical Center, Nashville, TN (T.J.W.); and Royal North Shore Hospital University of Sydney, Sydney, Australia (G.T.)
| | - Geoffrey Tofler
- From the Framingham Heart Study, Framingham, MA (V.X., J.M.M., R.S.V.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (V.X., D.M.E.); Section of Preventive Medicine and Epidemiology (V.X., R.S.V.) and Section of General Internal Medicine, Department of Medicine (J.M.M.), Boston University School of Medicine, Boston, MA; Department of Radiology, Tufts University Medical Center, Boston, MA (J.F.P.); Division of Molecular and Translational Cardiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany (K.C.W.); Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (J.L.J.); Cardiology Division, Vanderbilt University Medical Center, Nashville, TN (T.J.W.); and Royal North Shore Hospital University of Sydney, Sydney, Australia (G.T.)
| | - Ramachandran S Vasan
- From the Framingham Heart Study, Framingham, MA (V.X., J.M.M., R.S.V.); Department of Biostatistics, Boston University School of Public Health, Boston, MA (V.X., D.M.E.); Section of Preventive Medicine and Epidemiology (V.X., R.S.V.) and Section of General Internal Medicine, Department of Medicine (J.M.M.), Boston University School of Medicine, Boston, MA; Department of Radiology, Tufts University Medical Center, Boston, MA (J.F.P.); Division of Molecular and Translational Cardiology, Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany (K.C.W.); Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston (J.L.J.); Cardiology Division, Vanderbilt University Medical Center, Nashville, TN (T.J.W.); and Royal North Shore Hospital University of Sydney, Sydney, Australia (G.T.)
| |
Collapse
|
127
|
Chen CTL, Liu CT, Chen GK, Andrews JS, Arnold AM, Dreyfus J, Franceschini N, Garcia ME, Kerr KF, Li G, Lohman KK, Musani SK, Nalls MA, Raffel LJ, Smith J, Ambrosone CB, Bandera EV, Bernstein L, Britton A, Brzyski RG, Cappola A, Carlson CS, Couper D, Deming SL, Goodarzi MO, Heiss G, John EM, Lu X, Le Marchand L, Marciante K, Mcknight B, Millikan R, Nock NL, Olshan AF, Press MF, Vaiyda D, Woods NF, Taylor HA, Zhao W, Zheng W, Evans MK, Harris TB, Henderson BE, Kardia SLR, Kooperberg C, Liu Y, Mosley TH, Psaty B, Wellons M, Windham BG, Zonderman AB, Cupples LA, Demerath EW, Haiman C, Murabito JM, Rajkovic A. Meta-analysis of loci associated with age at natural menopause in African-American women. Hum Mol Genet 2014; 23:3327-42. [PMID: 24493794 PMCID: PMC4030781 DOI: 10.1093/hmg/ddu041] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2014] [Revised: 01/11/2014] [Accepted: 01/27/2014] [Indexed: 12/23/2022] Open
Abstract
Age at menopause marks the end of a woman's reproductive life and its timing associates with risks for cancer, cardiovascular and bone disorders. GWAS and candidate gene studies conducted in women of European ancestry have identified 27 loci associated with age at menopause. The relevance of these loci to women of African ancestry has not been previously studied. We therefore sought to uncover additional menopause loci and investigate the relevance of European menopause loci by performing a GWAS meta-analysis in 6510 women with African ancestry derived from 11 studies across the USA. We did not identify any additional loci significantly associated with age at menopause in African Americans. We replicated the associations between six loci and age at menopause (P-value < 0.05): AMHR2, RHBLD2, PRIM1, HK3/UMC1, BRSK1/TMEM150B and MCM8. In addition, associations of 14 loci are directionally consistent with previous reports. We provide evidence that genetic variants influencing reproductive traits identified in European populations are also important in women of African ancestry residing in USA.
Collapse
Affiliation(s)
- Christina T L Chen
- Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
| | - Ching-Ti Liu
- Department of Biostatistics, School of Public Health, Boston University, Boston, MA 02118, USA National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA 01702, USA
| | | | - Jeanette S Andrews
- Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
| | | | - Jill Dreyfus
- Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55455, USA
| | | | - Melissa E Garcia
- Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Bethesda, MD 20814, USA
| | | | - Guo Li
- Department of Medicine, University of Washington, Seattle, WA 98195, USA
| | - Kurt K Lohman
- Department of Biostatistical Sciences, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
| | - Solomon K Musani
- University of Mississippi Medical Center, Jackson, MS 39216, USA
| | - Michael A Nalls
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA
| | | | - Jennifer Smith
- Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109, USA
| | - Christine B Ambrosone
- Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY 14263, USA
| | - Elisa V Bandera
- The Cancer Institute of New Jersey, New Brunswick, NJ 08903, USA
| | - Leslie Bernstein
- Division of Cancer Etiology, Department of Population Science, Beckman Research Institute, City of Hope, Duarte, CA 91010, USA
| | - Angela Britton
- Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA
| | - Robert G Brzyski
- Department of Obstetrics and Gynecology, University of Texas Health Science Center, San Antonio, TX 78229, USA
| | - Anne Cappola
- Division of Endocrinology, Diabetes, and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
| | - Christopher S Carlson
- Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
| | - David Couper
- Department of Biostatistics, Gillings School of Global Public Health
| | - Sandra L Deming
- Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
| | - Mark O Goodarzi
- Division of Endocrinology, Diabetes, and Metabolism, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
| | - Gerardo Heiss
- Department of Epidemiology, Gillings School of Global Public Health
| | - Esther M John
- Division of Epidemiology, Department of Health Research & Policy, Stanford University School of Medicine, Stanford, CA 94305, USA
| | - Xiaoning Lu
- Department of Biostatistics, School of Public Health, Boston University, Boston, MA 02118, USA Division of Clinical Informatics, Beth Israel Deaconess Medical Center, Boston, MA 02118, USA
| | - Loic Le Marchand
- Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, HI 96813, USA
| | - Kristin Marciante
- Department of Medicine, University of Washington, Seattle, WA 98195, USA
| | | | - Robert Millikan
- Department of Epidemiology, Gillings School of Global Public Health Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA
| | - Nora L Nock
- Department of Epidemiology and Biostatistics, Case Western University, Cleveland, OH 44106, USA
| | - Andrew F Olshan
- Department of Epidemiology, Gillings School of Global Public Health Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA
| | - Michael F Press
- Department of Pathology, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90089, USA
| | - Dhananjay Vaiyda
- Department of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA
| | - Nancy F Woods
- Biobehavioral Nursing and Health Systems, University of Washington, Seattle, WA 98109, USA
| | - Herman A Taylor
- University of Mississippi Medical Center, Jackson, MS 39216, USA
| | - Wei Zhao
- Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109, USA
| | - Wei Zheng
- Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA
| | - Michele K Evans
- Health Disparities Research Section, Clinical Research Branch
| | - Tamara B Harris
- Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Bethesda, MD 20814, USA
| | | | - Sharon L R Kardia
- Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109, USA
| | - Charles Kooperberg
- Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
| | - Yongmei Liu
- Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA
| | - Thomas H Mosley
- Division of Geriatric Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA
| | - Bruce Psaty
- Departments of Medicine, Epidemiology and Health Services, University of Washington and Group Health Research Institute, Seattle, WA, USA
| | - Melissa Wellons
- School of Medicine, Vanderbilt University, Nashville, TN 37240, USA
| | - Beverly G Windham
- Division of Geriatric Medicine, University of Mississippi Medical Center, Jackson, MS 39216, USA
| | - Alan B Zonderman
- Laboratory of Personality and Cognition, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, USA
| | - L Adrienne Cupples
- Department of Biostatistics, School of Public Health, Boston University, Boston, MA 02118, USA National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA 01702, USA
| | - Ellen W Demerath
- Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55455, USA
| | | | - Joanne M Murabito
- National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, MA 01702, USA Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Boston, MA, USA
| | - Aleksandar Rajkovic
- Department of Obstetrics, Gynecology and Reproductive Science, University of Pittsburgh, Pittsburgh, PA 15213, USA
| |
Collapse
|
128
|
Perry JR, Hsu YH, Chasman DI, Johnson AD, Elks C, Albrecht E, Andrulis IL, Beesley J, Berenson GS, Bergmann S, Bojesen SE, Bolla MK, Brown J, Buring JE, Campbell H, Chang-Claude J, Chenevix-Trench G, Corre T, Couch FJ, Cox A, Czene K, D'adamo AP, Davies G, Deary IJ, Dennis J, Easton DF, Engelhardt EG, Eriksson JG, Esko T, Fasching PA, Figueroa JD, Flyger H, Fraser A, Garcia-Closas M, Gasparini P, Gieger C, Giles G, Guenel P, Hägg S, Hall P, Hayward C, Hopper J, Ingelsson E, Kardia SL, Kasiman K, Knight JA, Lahti J, Lawlor DA, Magnusson PK, Margolin S, Marsh JA, Metspalu A, Olson JE, Pennell CE, Polasek O, Rahman I, Ridker PM, Robino A, Rudan I, Rudolph A, Salumets A, Schmidt MK, Schoemaker MJ, Smith EN, Smith JA, Southey M, Stöckl D, Swerdlow AJ, Thompson DJ, Truong T, Ulivi S, Waldenberger M, Wang Q, Wild S, Wilson JF, Wright AF, Zgaga L, Ong KK, Murabito JM, Karasik D, Murray A. DNA mismatch repair gene MSH6 implicated in determining age at natural menopause. Hum Mol Genet 2014; 23:2490-7. [PMID: 24357391 PMCID: PMC3976329 DOI: 10.1093/hmg/ddt620] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2013] [Revised: 11/19/2013] [Accepted: 12/06/2013] [Indexed: 12/17/2022] Open
Abstract
The length of female reproductive lifespan is associated with multiple adverse outcomes, including breast cancer, cardiovascular disease and infertility. The biological processes that govern the timing of the beginning and end of reproductive life are not well understood. Genetic variants are known to contribute to ∼50% of the variation in both age at menarche and menopause, but to date the known genes explain <15% of the genetic component. We have used genome-wide association in a bivariate meta-analysis of both traits to identify genes involved in determining reproductive lifespan. We observed significant genetic correlation between the two traits using genome-wide complex trait analysis. However, we found no robust statistical evidence for individual variants with an effect on both traits. A novel association with age at menopause was detected for a variant rs1800932 in the mismatch repair gene MSH6 (P = 1.9 × 10(-9)), which was also associated with altered expression levels of MSH6 mRNA in multiple tissues. This study contributes to the growing evidence that DNA repair processes play a key role in ovarian ageing and could be an important therapeutic target for infertility.
Collapse
Affiliation(s)
- John R.B. Perry
- University of Exeter Medical School, Exeter, UK,
- Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK,
- Department of Twin Research and Genetic Epidemiology, King's College London, London, UK,
- Medical Research Council (MRC) Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK,
| | - Yi-Hsiang Hsu
- Hebrew SeniorLife Institute for Aging Research and Harvard Medical School, Boston, MA, USA,
- Molecular and Integrative Physiological Sciences Program, Harvard School of Public Health, Boston, MA, USA,
| | - Daniel I. Chasman
- Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston MA 02215, USA,
- Harvard Medical School, Boston, MA, USA,
| | - Andrew D. Johnson
- The National Heart Lung and Blood Institute's Framingham Heart Study, Framingham, MA, USA,
- NHLBI Cardiovascular Epidemiology & Human Genomics Branch, Bethesda, MD, USA,
| | - Cathy Elks
- Medical Research Council (MRC) Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK,
| | | | - Irene L. Andrulis
- Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada,
- Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada,
| | - Jonathan Beesley
- Department of Genetics, Queensland Institute of Medical Research, Brisbane, QLD, Australia,
| | | | - Sven Bergmann
- Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland,
- Swiss Institute of Bioinformatics, Lausanne, Switzerland,
| | - Stig E. Bojesen
- Department of Clinical Biochemistry and the Copenhagen General Population Study, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark,
| | - Manjeet K. Bolla
- Centre for Cancer Genetic Epidemiology and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK,
| | - Judith Brown
- Centre for Cancer Genetic Epidemiology and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK,
| | - Julie E. Buring
- Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston MA 02215, USA,
- Harvard Medical School, Boston, MA, USA,
| | - Harry Campbell
- Centre for Population Health Sciences, University of Edinburgh, EdinburghEH8 9AG, UK,
| | - Jenny Chang-Claude
- Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany,
| | | | - Tanguy Corre
- Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland,
- Swiss Institute of Bioinformatics, Lausanne, Switzerland,
| | - Fergus J. Couch
- Departments of Laboratory Medicine and Pathology, and Health Science Research
| | - Angela Cox
- CR-UK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, UK,
| | - Kamila Czene
- Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden,
| | - Adamo Pio D'adamo
- Institute for Maternal and Child Health, IRCCS ‘Burlo Garofolo’, University of Trieste, Trieste, Italy,
| | - Gail Davies
- Centre for Cognitive Ageing and Cognitive Epidemiology
- Department of Psychology and
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK,
| | - Ian J. Deary
- Centre for Cognitive Ageing and Cognitive Epidemiology
- Department of Psychology and
| | - Joe Dennis
- Centre for Cancer Genetic Epidemiology and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK,
| | - Douglas F. Easton
- Centre for Cancer Genetic Epidemiology and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK,
| | | | - Johan G. Eriksson
- Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland,
- National Institute for Health and Welfare, Helsinki, Finland,
- Folkhälsan Research Centre, Helsinki, Finland,
- University Central Hospital, Unit of General Practice, Helsinki, Finland,
- Vasa Central Hospital, Vasa, Finland,
| | - Tõnu Esko
- Divisions of Endocrinology, Children's Hospital, Boston, MA, USA,
- Broad Institute, Cambridge, MA, USA,
- Estonian Genome Center, University of Tartu, 51010Tartu, Estonia,
| | - Peter A. Fasching
- Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany,
| | - Jonine D. Figueroa
- Division of Cancer Epidemiology & Genetics, National Cancer Institute, Maryland, USA,
| | - Henrik Flyger
- Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark,
| | - Abigail Fraser
- School of Social and Community Medicine, MRC Centre for Causal Analyses in Translational Epidemiology, University of Bristol, Bristol, UK,
| | - Montse Garcia-Closas
- Divisions of Breast Cancer Research and of Genetics and Epidemiology, and the Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK,
| | - Paolo Gasparini
- Institute for Maternal and Child Health, IRCCS ‘Burlo Garofolo’, University of Trieste, Trieste, Italy,
| | | | - Graham Giles
- Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Melbourne, VIC, Australia,
- Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, VIC, Australia,
| | - Pascal Guenel
- Environmental Epidemiology of Cancer, Inserm U1018, Villejuif, France,
| | - Sara Hägg
- Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden,
- Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden,
| | - Per Hall
- Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden,
| | - Caroline Hayward
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, EdinburghEH4 2XU, UK,
| | - John Hopper
- Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Melbourne, VIC, Australia,
| | - Erik Ingelsson
- Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden,
| | | | | | - Katherine Kasiman
- Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden,
| | - Julia A. Knight
- Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada,
| | - Jari Lahti
- Folkhälsan Research Centre, Helsinki, Finland,
- Institute of Behavioural Science, University of Helsinki, Helsinki, Finland,
| | - Debbie A. Lawlor
- School of Social and Community Medicine, MRC Centre for Causal Analyses in Translational Epidemiology, University of Bristol, Bristol, UK,
| | | | - Sara Margolin
- Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden,
| | - Julie A. Marsh
- School of Women's and Infants’ Health, University of Western Australia, Australia,
| | - Andres Metspalu
- Estonian Genome Center, University of Tartu, 51010Tartu, Estonia,
| | - Janet E. Olson
- Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA,
| | - Craig E. Pennell
- School of Women's and Infants’ Health, University of Western Australia, Australia,
| | - Ozren Polasek
- Department of Public Health, Faculty of Medicine, University of Split, Croatia,
| | - Iffat Rahman
- Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden,
| | - Paul M. Ridker
- Division of Preventive Medicine, Brigham and Women's Hospital, 900 Commonwealth Avenue East, Boston MA 02215, USA,
- Harvard Medical School, Boston, MA, USA,
| | - Antonietta Robino
- Institute for Maternal and Child Health, IRCCS ‘Burlo Garofolo’, University of Trieste, Trieste, Italy,
| | - Igor Rudan
- Centre for Population Health Sciences, University of Edinburgh, EdinburghEH8 9AG, UK,
| | - Anja Rudolph
- Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany,
| | - Andres Salumets
- Department of Obstetrics and Gynecology, University of Tartu, 51014 Tartu, Estonia,
- Competence Centre on Reproductive Medicine and Biology, 50410 Tartu, Estonia,
| | - Marjanka K. Schmidt
- Division of Psychosocial Research and Epidemiology and
- Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands,
| | - Minouk J. Schoemaker
- Divisions of Breast Cancer Research and of Genetics and Epidemiology, and the Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK,
| | - Erin N. Smith
- Department of Pediatrics and Rady Children's Hospital, University of California San Diego, La Jolla, CA 92093, USA,
| | - Jennifer A. Smith
- Department of Epidemiology, University of Michigan, Ann Arbor, MI, USA,
| | - Melissa Southey
- Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Melbourne, VIC, Australia,
| | - Doris Stöckl
- Institute of Epidemiology II and
- Department of Obstetrics and Gynaecology, Campus Grosshadern, Ludwig-Maximilians-University, Munich, Germany,
| | - Anthony J. Swerdlow
- Divisions of Breast Cancer Research and of Genetics and Epidemiology, and the Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK,
| | - Deborah J. Thompson
- Centre for Cancer Genetic Epidemiology and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK,
| | - Therese Truong
- Environmental Epidemiology of Cancer, Inserm U1018, Villejuif, France,
| | - Sheila Ulivi
- Institute for Maternal and Child Health, IRCCS ‘Burlo Garofolo’, Trieste, Italy,
| | - Melanie Waldenberger
- Research Unit of Molecular Epidemiology, Helmholtz Zentrum München – German Research Center for Environmental Health, Neuherberg, Germany,
| | - Qin Wang
- Centre for Cancer Genetic Epidemiology and Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK,
| | - Sarah Wild
- Centre for Population Health Sciences, University of Edinburgh, EdinburghEH8 9AG, UK,
| | - James F Wilson
- Centre for Population Health Sciences, University of Edinburgh, EdinburghEH8 9AG, UK,
| | - Alan F. Wright
- MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK,
| | - Lina Zgaga
- Centre for Population Health Sciences, University of Edinburgh, EdinburghEH8 9AG, UK,
| | | | - Ken K. Ong
- Medical Research Council (MRC) Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK,
- Department of Paediatrics, University of Cambridge, Cambridge, UK,
| | - Joanne M. Murabito
- The National Heart Lung and Blood Institute's Framingham Heart Study, Framingham, MA, USA,
- Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA
| | - David Karasik
- Hebrew SeniorLife Institute for Aging Research and Harvard Medical School, Boston, MA, USA,
| | - Anna Murray
- University of Exeter Medical School, Exeter, UK,
| |
Collapse
|
129
|
Murabito JM, Beiser AS, Decarli C, Seshadri S, Wolf PA, Au R. Parental longevity is associated with cognition and brain ageing in middle-aged offspring. Age Ageing 2014; 43:358-63. [PMID: 24212919 DOI: 10.1093/ageing/aft175] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
BACKGROUND offspring of long-lived individuals have lower risk for dementia. We examined the relation between parental longevity and cognition and subclinical markers of brain ageing in community-dwelling adult offspring. METHODS offspring participants with both parents in the Framingham Heart Study, aged ≥55 years and dementia-free underwent baseline and repeat neuropsychological (NP) testing and brain magnetic resonance imaging (MRI). Parental longevity was defined as having at least one parent survive to age ≥85 years. To test the association between parental longevity and measures of cognition and brain volumes, we used multivariable linear and logistic regression adjusting for age, sex, education and time to NP testing or brain MRI. RESULTS of 728 offspring (mean age 66 years, 54% women), 407 (56%) had ≥1 parent achieve longevity. In cross-sectional analysis, parental longevity was associated with better scores on attention (beta 0.21 ± 0.08, P = 0.006) and a lower odds of extensive white matter hyperintensity on brain MRI (odds ratio 0.59, 95% CI: 0.38, 0.92, P = 0.019). The association with white matter hyperintensity was no longer significant in models adjusted for cardiovascular risk factors and disease. In longitudinal analysis (6.7 ± 1.7 years later), offspring with parental longevity had slower decline in attention (0.18 ± 0.08, P = 0.038), executive function (beta 0.19 ± 0.09, P = 0.031) and visual memory (beta -0.18 ± 0.08, P = 0.023), and less increase in temporal horn volume (beta -0.25 ± 0.09, P = 0.005). The associations persisted in fully adjusted models. CONCLUSION parental longevity is associated with better brain ageing in middle-aged offspring.
Collapse
Affiliation(s)
- Joanne M Murabito
- Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA, USA
| | | | | | | | | | | |
Collapse
|
130
|
Lubitz SA, Lunetta KL, Lin H, Arking DE, Trompet S, Li G, Krijthe BP, Chasman DI, Barnard J, Kleber ME, Dörr M, Ozaki K, Smith AV, Müller-Nurasyid M, Walter S, Agarwal SK, Bis JC, Brody JA, Chen LY, Everett BM, Ford I, Franco OH, Harris TB, Hofman A, Kääb S, Mahida S, Kathiresan S, Kubo M, Launer LJ, MacFarlane PW, Magnani JW, McKnight B, McManus DD, Peters A, Psaty BM, Rose LM, Rotter JI, Silbernagel G, Smith JD, Sotoodehnia N, Stott DJ, Taylor KD, Tomaschitz A, Tsunoda T, Uitterlinden AG, Van Wagoner DR, Völker U, Völzke H, Murabito JM, Sinner MF, Gudnason V, Felix SB, März W, Chung M, Albert CM, Stricker BH, Tanaka T, Heckbert SR, Jukema JW, Alonso A, Benjamin EJ, Ellinor PT. Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. J Am Coll Cardiol 2014; 63:1200-1210. [PMID: 24486271 PMCID: PMC4009240 DOI: 10.1016/j.jacc.2013.12.015] [Citation(s) in RCA: 106] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/08/2013] [Revised: 11/10/2013] [Accepted: 12/03/2013] [Indexed: 10/25/2022]
Abstract
OBJECTIVES This study sought to identify nonredundant atrial fibrillation (AF) genetic susceptibility signals and examine their cumulative relations with AF risk. BACKGROUND AF-associated loci span broad genomic regions that may contain multiple susceptibility signals. Whether multiple signals exist at AF loci has not been systematically explored. METHODS We performed association testing conditioned on the most significant, independently associated genetic markers at 9 established AF loci using 2 complementary techniques in 64,683 individuals of European ancestry (3,869 incident and 3,302 prevalent AF cases). Genetic risk scores were created and tested for association with AF in Europeans and an independent sample of 11,309 individuals of Japanese ancestry (7,916 prevalent AF cases). RESULTS We observed at least 4 distinct AF susceptibility signals on chromosome 4q25 upstream of PITX2, but not at the remaining 8 AF loci. A multilocus score comprised 12 genetic markers demonstrated an estimated 5-fold gradient in AF risk. We observed a similar spectrum of risk associated with these markers in Japanese. Regions containing AF signals on chromosome 4q25 displayed a greater degree of evolutionary conservation than the remainder of the locus, suggesting that they may tag regulatory elements. CONCLUSIONS The chromosome 4q25 AF locus is architecturally complex and harbors at least 4 AF susceptibility signals in individuals of European ancestry. Similar polygenic AF susceptibility exists between Europeans and Japanese. Future work is necessary to identify causal variants, determine mechanisms by which associated loci predispose to AF, and explore whether AF susceptibility signals classify individuals at risk for AF and related morbidity.
Collapse
Affiliation(s)
- Steven A. Lubitz
- Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, Massachusetts, USA
- Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Kathryn L. Lunetta
- Boston University and National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, USA
- Department of Biostatistics, School of Public Health, Boston University, Boston, Massachusetts, USA
| | - Honghuang Lin
- Boston University and National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, USA
- Section of Computational Biomedicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
| | - Dan E. Arking
- McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
| | - Stella Trompet
- Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands
- Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, the Netherlands
| | - Guo Li
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA
| | - Bouwe P. Krijthe
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
- Netherlands Consortium on Healthy Aging (NCHA), The Netherlands
| | - Daniel I. Chasman
- Harvard Medical School, Boston, Massachusetts, USA
- Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - John Barnard
- Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Marcus E. Kleber
- Institute of Public Health, Social and Preventive Medicine, Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany
| | - Marcus Dörr
- Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany
- DZHK (German Centre for Cardiovascular Research), Partner site Greifswald, Germany
| | - Kouichi Ozaki
- Laboratory for Cardiovascular Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
| | - Albert V. Smith
- Icelandic Heart Association, Kopavogur Iceland and University of Iceland Reykjavik, Iceland
| | - Martina Müller-Nurasyid
- Department of Medicine I, University Hospital Grosshadern, Ludwig-Maximilians-University, Munich, Germany
- Institute of Genetic Epidemiology, Helmholtz Zentrum Munich, German Research Center for Environmental Health, Neuherberg, Germany
- Institute of Medical Informatics, Biometry and Epidemiology, Chair of Genetic Epidemiology, Ludwig-Maximilians University, Munich, Germany
| | - Stefan Walter
- Department of Society, Human Development & Health, Harvard School of Public Health, Boston, Massachusetts, USA
| | - Sunil K. Agarwal
- Welch Center for Prevention, Epidemiology, and Clinical Research, Johns Hopkins University, Baltimore, Maryland, USA
| | - Joshua C. Bis
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA
| | - Jennifer A. Brody
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA
| | - Lin Y. Chen
- Cardiovascular Division, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA
| | - Brendan M. Everett
- Harvard Medical School, Boston, Massachusetts, USA
- Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - Ian Ford
- Robertson Center for Biostatistics, University of Glasgow, United Kingdom
| | - Oscar H. Franco
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
- Netherlands Consortium on Healthy Aging (NCHA), The Netherlands
| | - Tamara B. Harris
- Laboratory of Epidemiology and Population Sciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Albert Hofman
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
- Netherlands Consortium on Healthy Aging (NCHA), The Netherlands
| | - Stefan Kääb
- Department of Medicine I, University Hospital Grosshadern, Ludwig-Maximilians-University, Munich, Germany
- Deutsches Forschungszentrum für Herz-Kreislauferkrankungen (DZHK), Partner site Munich Heart Alliance, Munich, Germany
| | - Saagar Mahida
- Leeds General Infirmary, Great George Street, Leeds, UK
| | - Sekar Kathiresan
- Center for Human Genetic Research and Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Michiaki Kubo
- Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
| | - Lenore J. Launer
- Laboratory of Epidemiology and Population Sciences, Intramural Research Program, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA
| | - Peter W. MacFarlane
- Institute of Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom
| | - Jared W. Magnani
- Boston University and National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, USA
- Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
| | - Barbara McKnight
- Department of Biostatistics, University of Washington, Seattle, Washington, USA
| | - David D. McManus
- Departments of Medicine and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA
| | - Annette Peters
- Deutsches Forschungszentrum für Herz-Kreislauferkrankungen (DZHK), Partner site Munich Heart Alliance, Munich, Germany
- Institute of Epidemiology II, Helmholtz Zentrum Munich, German Research Center for Environmental Health, Neuherberg, Germany
| | - Bruce M. Psaty
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA
- Department of Health Services, University of Washington, Seattle, Washington, USA
- Department of Epidemiology, University of Washington, Seattle, Washington, USA
- Group Health Research Institute, Group Health Cooperative, Seattle, Washington, USA
| | - Lynda M. Rose
- Division of Preventive Medicine, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - Jerome I. Rotter
- Institute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, Calif, USA
| | - Guenther Silbernagel
- Department of Angiology, Swiss Cardiovascular Centre, Bern University Hospital, Bern, Switzerland
| | - Jonathan D. Smith
- Department of Cellular and Molecular Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Nona Sotoodehnia
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA
- Division of Cardiology, University of Washington, Seattle, Washington, USA
| | - David J. Stott
- Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom
| | - Kent D. Taylor
- Medical Genetics Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
| | | | - Tatsuhiko Tsunoda
- Laboratory for Medical Science Mathematics, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
| | - Andre G. Uitterlinden
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
- Netherlands Consortium on Healthy Aging (NCHA), The Netherlands
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
| | - David R. Van Wagoner
- Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Uwe Völker
- DZHK (German Centre for Cardiovascular Research), Partner site Greifswald, Germany
- Interfaculty Institute for Genetics and Functional Genomics, Ernst Moritz Arndt University Greifswald, Greifswald, Germany
| | - Henry Völzke
- DZHK (German Centre for Cardiovascular Research), Partner site Greifswald, Germany
- Institute for Community Medicine, Ernst Moritz Arndt University Greifswald, Greifswald, Germany
| | - Joanne M. Murabito
- Boston University and National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, USA
- Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
| | - Moritz F. Sinner
- Department of Medicine I, University Hospital Grosshadern, Ludwig-Maximilians-University, Munich, Germany
| | - Vilmundur Gudnason
- Icelandic Heart Association, Kopavogur Iceland and University of Iceland Reykjavik, Iceland
| | - Stephan B. Felix
- Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany
- DZHK (German Centre for Cardiovascular Research), Partner site Greifswald, Germany
| | - Winfried März
- Institute of Public Health, Social and Preventive Medicine, Mannheim Medical Faculty, University of Heidelberg, Mannheim, Germany
- Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria
- Synlab Academy, Synlab Services GmbH, Mannheim, Germany
| | - Mina Chung
- Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio, USA
| | - Christine M. Albert
- Harvard Medical School, Boston, Massachusetts, USA
- Division of Cardiology, Brigham and Women's Hospital, Boston, Massachusetts, USA
- Division of Preventive Medicine, Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | - Bruno H. Stricker
- Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands
- Netherlands Consortium on Healthy Aging (NCHA), The Netherlands
- Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands
- Inspectorate for Health Care, the Hague, The Netherlands
| | - Toshihiro Tanaka
- Laboratory for Cardiovascular Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan
- Department of Human Genetics and Disease Diversity, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
| | - Susan R. Heckbert
- Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA
- Department of Epidemiology, University of Washington, Seattle, Washington, USA
- Group Health Research Institute, Group Health Cooperative, Seattle, Washington, USA
| | - J. Wouter Jukema
- Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands and Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands
| | - Alvaro Alonso
- Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, USA
| | - Emelia J. Benjamin
- Boston University and National Heart, Lung and Blood Institute's Framingham Heart Study, Framingham, Massachusetts, USA
- Section of Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
- Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, USA
- Preventive Medicine Section, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA
| | - Patrick T. Ellinor
- Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, Massachusetts, USA
- Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts, USA
| |
Collapse
|
131
|
Magnani JW, Moser CB, Murabito JM, Sullivan LM, Wang N, Ellinor PT, Vasan RS, Benjamin EJ, Coviello AD. Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study. Circ Arrhythm Electrophysiol 2014; 7:307-12. [PMID: 24610804 DOI: 10.1161/circep.113.001322] [Citation(s) in RCA: 67] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Endogenous sex hormones have been related to cardiovascular outcomes and mortality. We hypothesized that sex hormones are related to atrial fibrillation (AF) in a community-based cohort of middle-aged to older men. METHODS AND RESULTS We examined testosterone, estradiol, and dehydroepiandrosterone sulfate in relation to incident AF in men participating in the Framingham Heart Study. We assessed the 10-year risk of AF in multivariable-adjusted hazard models. The cohort consisted of 1251 men (age, 68.0±8.2 years), of whom 275 developed incident AF. We identified a significant interaction between age and testosterone and, therefore, stratified men into age 55 to 69 years (n=786), 70 to 79 years (n=351), and ≥80 years (n=114). In men aged 55 to 69 years, each 1 SD decrease in testosterone was associated with hazard ratio (HR) 1.30 (95% confidence interval [CI], 1.07-1.59) for incident AF. The association between testosterone and 10-year incident AF in men 70 to 79 years did not reach statistical significance. In men≥80 years, a 1 SD decrease in testosterone was associated with HR 3.53 (95% CI, 1.96-6.37) for AF risk. Estradiol was associated with incident AF (HR, 1.12; 95% CI, 1.01-1.26). Dehydroepiandrosterone sulfate had a borderline association with risk of AF that was not statistically significant (HR, 1.12; 95% CI, 0.99-1.28). CONCLUSIONS Testosterone and estradiol are associated with incident AF in a cohort of older men. Testosterone deficiency in men≥80 years is strongly associated with AF risk. The clinical and electrophysiological mechanisms underlying the associations between sex hormones and AF in older men merit continued investigation.
Collapse
Affiliation(s)
- Jared W Magnani
- National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Boston, MA
| | | | | | | | | | | | | | | | | |
Collapse
|
132
|
Weinberg I, Gona P, O'Donnell CJ, Jaff MR, Murabito JM. The systolic blood pressure difference between arms and cardiovascular disease in the Framingham Heart Study. Am J Med 2014; 127:209-15. [PMID: 24287007 PMCID: PMC4066378 DOI: 10.1016/j.amjmed.2013.10.027] [Citation(s) in RCA: 100] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/19/2013] [Revised: 10/23/2013] [Accepted: 10/23/2013] [Indexed: 11/13/2022]
Abstract
BACKGROUND An increased interarm systolic blood pressure difference is an easily determined physical examination finding. The relationship between interarm systolic blood pressure difference and risk of future cardiovascular disease is uncertain. We described the prevalence and risk factor correlates of interarm systolic blood pressure difference in the Framingham Heart Study (FHS) original and offspring cohorts and examined the association between interarm systolic blood pressure difference and incident cardiovascular disease and all-cause mortality. METHODS An increased interarm systolic blood pressure difference was defined as ≥ 10 mm Hg using the average of initial and repeat blood pressure measurements obtained in both arms. Participants were followed through 2010 for incident cardiovascular disease events. Multivariable Cox proportional hazards regression analyses were performed to investigate the effect of interarm systolic blood pressure difference on incident cardiovascular disease. RESULTS We examined 3390 (56.3% female) participants aged 40 years and older, free of cardiovascular disease at baseline, mean age of 61.1 years, who attended a FHS examination between 1991 and 1994 (original cohort) and from 1995 to 1998 (offspring cohort). The mean absolute interarm systolic blood pressure difference was 4.6 mm Hg (range 0-78). Increased interarm systolic blood pressure difference was present in 317 (9.4%) participants. The median follow-up time was 13.3 years, during which time 598 participants (17.6%) experienced a first cardiovascular event, including 83 (26.2%) participants with interarm systolic blood pressure difference ≥ 10 mm Hg. Compared with those with normal interarm systolic blood pressure difference, participants with an elevated interarm systolic blood pressure difference were older (63.0 years vs 60.9 years), had a greater prevalence of diabetes mellitus (13.3% vs 7.5%,), higher systolic blood pressure (136.3 mm Hg vs 129.3 mm Hg), and a higher total cholesterol level (212.1 mg/dL vs 206.5 mg/dL). Interarm systolic blood pressure difference was associated with a significantly increased hazard of incident cardiovascular events in the multivariable adjusted model (hazard ratio 1.38; 95% CI, 1.09-1.75). For each 1-SD-unit increase in absolute interarm systolic blood pressure difference, the hazard ratio for incident cardiovascular events was 1.07 (95% CI, 1.00-1.14) in the fully adjusted model. There was no such association with mortality (hazard ratio 1.02; 95% CI 0.76-1.38). CONCLUSIONS In this community-based cohort, an interarm systolic blood pressure difference is common and associated with a significant increased risk for future cardiovascular events, even when the absolute difference in arm systolic blood pressure is modest. These findings support research to expand clinical use of this simple measurement.
Collapse
Affiliation(s)
- Ido Weinberg
- Institute for Heart Vascular and Stroke Care, Massachusetts General Hospital, Boston, Mass
| | - Philimon Gona
- National Heart, Lung and Blood Institute (NHLBI) Framingham Heart Study, Framingham, Mass; Division of Biostatistics and Health Services Research, Department of Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Mass
| | - Christopher J O'Donnell
- Institute for Heart Vascular and Stroke Care, Massachusetts General Hospital, Boston, Mass; National Heart, Lung and Blood Institute (NHLBI) Framingham Heart Study, Framingham, Mass; NHLBI Division of Intramural Research, Bethesda, Md
| | - Michael R Jaff
- Institute for Heart Vascular and Stroke Care, Massachusetts General Hospital, Boston, Mass.
| | - Joanne M Murabito
- National Heart, Lung and Blood Institute (NHLBI) Framingham Heart Study, Framingham, Mass; Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Mass
| |
Collapse
|
133
|
Cheng S, Enserro D, Xanthakis V, Sullivan LM, Murabito JM, Benjamin EJ, Polak JF, O'Donnell CJ, Wolf PA, O'Connor GT, Keaney JF, Vasan RS. Association of exhaled carbon monoxide with subclinical cardiovascular disease and their conjoint impact on the incidence of cardiovascular outcomes. Eur Heart J 2014; 35:2980-7. [PMID: 24574370 DOI: 10.1093/eurheartj/ehu052] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
AIMS Whereas endogenous carbon monoxide (CO) is cytoprotective at physiologic levels, excess CO concentrations are associated with cardiometabolic risk and may represent an important marker of progression from subclinical to clinical cardiovascular disease (CVD). METHODS AND RESULTS In 1926 participants of the Framingham Offspring Study (aged 57 ± 10 years, 46% women), we investigated the relationship of exhaled CO, a surrogate of blood CO concentration, with both prevalent subclinical CVD and incident clinical CVD events. Presence of subclinical CVD was determined using a comprehensive panel of diagnostic tests used to assess cardiac and vascular structure and function. Individuals with the highest (>5 p.p.m.) compared with lowest (≤4 p.p.m.) CO exposure were more likely to have subclinical CVD [odds ratios (OR): 1.67, 95% CI: 1.32-2.12; P < 0.001]. During the follow-up period (mean 5 ± 3 years), 193 individuals developed overt CVD. Individuals with both high CO levels and any baseline subclinical CVD developed overt CVD at an almost four-fold higher rate compared with those with low CO levels and no subclinical disease (22.1 vs. 6.3%). Notably, elevated CO was associated with incident CVD in the presence [hazards ration (HR): 1.83, 95% CI: 1.08-3.11; P = 0.026] but not in the absence (HR: 0.80, 95% CI: 0.42-1.53; P = 0.51) of subclinical CVD (Pinteraction = 0.019). Similarly, subclinical CVD was associated with incident CVD in the presence of high but not low CO exposure. CONCLUSION Our findings in a community-based sample suggest that elevated CO is a marker of greater subclinical CVD burden and, furthermore, a potential key component in the progression from subclinical to clinical CVD.
Collapse
Affiliation(s)
- Susan Cheng
- National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | | | - Vanessa Xanthakis
- National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA Department of Biostatistics, Boston University, Boston, MA, USA Sections of Preventive Medicine, Boston University School of Medicine, Boston, MA, USA
| | - Lisa M Sullivan
- Department of Biostatistics, Boston University, Boston, MA, USA
| | - Joanne M Murabito
- National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA General Internal Medicine, Boston University School of Medicine, Boston, MA, USA
| | - Emelia J Benjamin
- National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA Department of Cardiology, Boston University School of Medicine, Boston, MA, USA
| | - Joseph F Polak
- Department of Radiology, New England Medical Center, Boston, MA, USA
| | - Christopher J O'Donnell
- National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA Center for Population Studies, National Heart, Lung, and Blood Institute, Bethesda, MD, USA
| | - Philip A Wolf
- National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA Department of Neurology, Boston University School of Medicine, Boston, MA, USA
| | - George T O'Connor
- National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA Pulmonary Center, Boston University School of Medicine, Boston, MA, USA
| | - John F Keaney
- Cardiovascular Medicine, Department of Medicine, University of Massachusetts Medical School, Boston, MA, USA
| | - Ramachandran S Vasan
- National Heart, Lung, and Blood Institute's Framingham Heart Study, Framingham, MA, USA Sections of Preventive Medicine, Boston University School of Medicine, Boston, MA, USA Department of Cardiology, Boston University School of Medicine, Boston, MA, USA Department of Epidemiology, Boston University School of Medicine, Boston, MA, USA
| |
Collapse
|
134
|
Travison TG, Zhuang WV, Lunetta KL, Karasik D, Bhasin S, Kiel DP, Coviello AD, Murabito JM. The heritability of circulating testosterone, oestradiol, oestrone and sex hormone binding globulin concentrations in men: the Framingham Heart Study. Clin Endocrinol (Oxf) 2014; 80:277-82. [PMID: 23746309 PMCID: PMC3825765 DOI: 10.1111/cen.12260] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/04/2013] [Revised: 01/29/2013] [Accepted: 06/02/2013] [Indexed: 11/29/2022]
Abstract
OBJECTIVE Circulating testosterone, oestradiol and oestrone concentrations vary considerably between men. Although a substantial proportion of this variation may be attributed to morbidity and behavioural factors, these cannot account for its entirety, suggesting genetic inheritance as a potential additional determinant. The analysis described here was intended to estimate the heritability of male circulating total testosterone (TT), calculated free testosterone (cFT), oestrone (E1), oestradiol (E2) and sex hormone binding globulin (SHBG), along with the genetic correlation between these factors. DESIGN Cross-sectional, observational analysis of data from male members of the Offspring and Generation 3 cohorts of the Framingham Heart Study. Data were collected in the years 1998-2005. PARTICIPANTS A total of 3367 community-dwelling men contributed to the analysis, including 1066 father/son and 1284 brother pairs among other family relationships. MEASUREMENTS Levels of serum sex steroids (TT, E1 and E2) were measured by liquid chromatography-tandem mass spectrometry, SHBG by immunofluorometric assay and cFT by mass action equation. Heritability was obtained using variance components analysis with adjustment for covariates including age, diabetes mellitus, body mass index and smoking status. RESULTS Age-adjusted heritability estimates were 0·19, 0·40, 0·40, 0·30 and 0·41 for cFT, TT, E1, E2 and SHBG, respectively. Adjustment for covariates did not substantially attenuate these estimates; SHBG-adjusted TT results were similar to those obtained for cFT. Genetic correlation coefficients (ρG ) indicated substantial genetic association between TT and cFT (ρG = 0·68), between TT and SHBG (pG = 0·87), between E1 and E2 (ρG = 0·46) and between TT and E2 (ρG = 0·48). CONCLUSION Circulating testosterone, oestradiol and oestrone concentrations exhibit substantial heritability in adult men. Significant genetic association between testosterone and oestrogen levels suggests shared genetic pathways.
Collapse
Affiliation(s)
- T G Travison
- Research Program on Men's Health, Aging and Metabolism, Brigham and Women's Hospital, Boston, MA, USA
| | | | | | | | | | | | | | | |
Collapse
|
135
|
He C, Murabito JM. Genome-wide association studies of age at menarche and age at natural menopause. Mol Cell Endocrinol 2014; 382:767-779. [PMID: 22613007 DOI: 10.1016/j.mce.2012.05.003] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/15/2011] [Revised: 04/04/2012] [Accepted: 05/07/2012] [Indexed: 11/23/2022]
Abstract
Genome-wide association studies (GWAS) have been successful in uncovering genetic determinants of age at menarche and age at natural menopause. To date, more than 30 novel genetic loci have been identified in GWAS for age at menarche and 17 for age at natural menopause. These findings have stimulated a plethora of follow-up studies particularly with respect to the functional characterization of these novel loci and how these results can be translated into risk prediction. However, the genetic loci identified so far account for only a small fraction of the overall heritability. This review provides an overview of the current state of our knowledge of the genetic basis of menarche and menopause timing. It emphasizes recent GWAS results and outlines strategies for discovering the missing heritability and strategies to further our understanding of the underlying molecular mechanisms of the observed genetic associations.
Collapse
Affiliation(s)
- Chunyan He
- Department of Public Health, Indiana University School of Medicine, 980 West Walnut Street, R3-C241, Indianapolis, IN 46202, USA; Melvin and Bren Simon Cancer Center, Indiana University, 535 Barnhill Drive, Indianapolis, IN 46202, USA.
| | - Joanne M Murabito
- The National Heart Lung and Blood Institute's Framingham Heart Study, 73 Mount Wayte, Suite 2, Framingham, MA 01701, USA; Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, 720 East Concord Street, Boston, MA 02118, USA.
| |
Collapse
|
136
|
Fowkes FGR, Murray GD, Butcher I, Folsom AR, Hirsch AT, Couper DJ, Debacker G, Kornitzer M, Newman AB, Sutton-Tyrrell KC, Cushman M, Lee AJ, Price JF, D'Agostino RB, Murabito JM, Norman P, Masaki KH, Bouter LM, Heine RJ, Stehouwer CDA, McDermott MM, Stoffers HEJH, Knottnerus JA, Ogren M, Hedblad B, Koenig W, Meisinger C, Cauley JA, Franco O, Hunink MGM, Hofman A, Witteman JC, Criqui MH, Langer RD, Hiatt WR, Hamman RF. Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. Eur J Prev Cardiol 2013; 21:310-20. [PMID: 24367001 DOI: 10.1177/2047487313516564] [Citation(s) in RCA: 53] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND The ankle brachial index (ABI) is related to risk of cardiovascular events independent of the Framingham risk score (FRS). The aim of this study was to develop and evaluate a risk model for cardiovascular events incorporating the ABI and FRS. DESIGN An analysis of participant data from 18 cohorts in which 24,375 men and 20,377 women free of coronary heart disease had ABI measured and were followed up for events. METHODS Subjects were divided into a development and internal validation dataset and an external validation dataset. Two models, comprising FRS and FRS + ABI, were fitted for the primary outcome of major coronary events. RESULTS In predicting events in the external validation dataset, C-index for the FRS was 0.672 (95% CI 0.599 to 0.737) in men and 0.578 (95% CI 0.492 to 0.661) in women. The FRS + ABI led to a small increase in C-index in men to 0.685 (95% CI 0.612 to 0.749) and large increase in women to 0.690 (95% CI 0.605 to 0.764) with net reclassification improvement (NRI) of 4.3% (95% CI 0.0 to 7.6%, p = 0.050) and 9.6% (95% CI 6.1 to 16.4%, p < 0.001), respectively. Restricting the FRS + ABI model to those with FRS intermediate 10-year risk of 10 to 19% resulted in higher NRI of 15.9% (95% CI 6.1 to 20.6%, p < 0.001) in men and 23.3% (95% CI 13.8 to 62.5%, p = 0.002) in women. However, incorporating ABI in an improved newly fitted risk factor model had a nonsignificant effect: NRI 2.0% (95% CI 2.3 to 4.2%, p = 0.567) in men and 1.1% (95% CI 1.9 to 4.0%, p = 0.483) in women. CONCLUSIONS An ABI risk model may improve prediction especially in individuals at intermediate risk and when performance of the base risk factor model is modest.
Collapse
Affiliation(s)
- F G R Fowkes
- Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
137
|
Liu CK, Lyass A, Massaro JM, D'Agostino RB, Fox CS, Murabito JM. Chronic kidney disease defined by cystatin C predicts mobility disability and changes in gait speed: the Framingham Offspring Study. J Gerontol A Biol Sci Med Sci 2013; 69:301-7. [PMID: 23913929 DOI: 10.1093/gerona/glt096] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
BACKGROUND As creatinine-based estimates of renal function are inaccurate in older adults, an alternative is an estimated glomerular filtration rate (eGFR(cys)) based on cystatin C. We examined the prospective association between chronic kidney disease (CKD(cys)) as determined by eGFR(cys) with the primary outcome of incident mobility disability and the secondary outcome of change in gait speed. METHODS Framingham Offspring Study participants older than 60 years and free of mobility disability at baseline (1998-2001) were eligible. Baseline CKD(cys) was defined as eGFR(cys) less than 60 mL/min/1.73 m(2). At follow-up (2005-2008), the outcomes of mobility disability, defined as self-reported inability to walk 1/2 mile and/or climb a flight of stairs, and gait speed were measured. Logistic and linear regression models were adjusted for age, sex, body mass index, smoking, diabetes, C reactive protein, and physical activity. RESULTS Of 1,226 participants, 230 (19%) had CKD(cys) at baseline. After a mean follow-up of 6.6 years, 185 (15%) developed mobility disability. Of those with CKD(cys), 60 (26%) developed mobility disability. Those with CKD(cys) had greater odds of mobility disability in the age- and sex-adjusted (odds ratio [OR] 1.91, 95% CI 1.32, 2.75) and fully adjusted (OR 1.55, 95% CI 1.05, 2.31) models compared with those without CKD(cys). In fully adjusted models, participants with CKD(cys) had greater gait speed declines than those without CKD(cys) (β = 0.07 [SE 0.02], p = .0022). CONCLUSION CKD(cys) was associated with higher odds of incident mobility disability and greater decline in gait speed, highlighting the loss of physical independence in elders with CKD.
Collapse
Affiliation(s)
- Christine K Liu
- MS, Boston Medical Center, 88 E Newton Street, Robinson 2, Boston, MA 02118.
| | | | | | | | | | | |
Collapse
|
138
|
Fernández-Rhodes L, Demerath EW, Cousminer DL, Tao R, Dreyfus JG, Esko T, Smith AV, Gudnason V, Harris TB, Launer L, McArdle PF, Yerges-Armstrong LM, Elks CE, Strachan DP, Kutalik Z, Vollenweider P, Feenstra B, Boyd HA, Metspalu A, Mihailov E, Broer L, Zillikens MC, Oostra B, van Duijn CM, Lunetta KL, Perry JRB, Murray A, Koller DL, Lai D, Corre T, Toniolo D, Albrecht E, Stöckl D, Grallert H, Gieger C, Hayward C, Polasek O, Rudan I, Wilson JF, He C, Kraft P, Hu FB, Hunter DJ, Hottenga JJ, Willemsen G, Boomsma DI, Byrne EM, Martin NG, Montgomery GW, Warrington NM, Pennell CE, Stolk L, Visser JA, Hofman A, Uitterlinden AG, Rivadeneira F, Lin P, Fisher SL, Bierut LJ, Crisponi L, Porcu E, Mangino M, Zhai G, Spector TD, Buring JE, Rose LM, Ridker PM, Poole C, Hirschhorn JN, Murabito JM, Chasman DI, Widen E, North KE, Ong KK, Franceschini N. Association of adiposity genetic variants with menarche timing in 92,105 women of European descent. Am J Epidemiol 2013; 178:451-60. [PMID: 23558354 DOI: 10.1093/aje/kws473] [Citation(s) in RCA: 45] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Obesity is of global health concern. There are well-described inverse relationships between female pubertal timing and obesity. Recent genome-wide association studies of age at menarche identified several obesity-related variants. Using data from the ReproGen Consortium, we employed meta-analytical techniques to estimate the associations of 95 a priori and recently identified obesity-related (body mass index (weight (kg)/height (m)(2)), waist circumference, and waist:hip ratio) single-nucleotide polymorphisms (SNPs) with age at menarche in 92,116 women of European descent from 38 studies (1970-2010), in order to estimate associations between genetic variants associated with central or overall adiposity and pubertal timing in girls. Investigators in each study performed a separate analysis of associations between the selected SNPs and age at menarche (ages 9-17 years) using linear regression models and adjusting for birth year, site (as appropriate), and population stratification. Heterogeneity of effect-measure estimates was investigated using meta-regression. Six novel associations of body mass index loci with age at menarche were identified, and 11 adiposity loci previously reported to be associated with age at menarche were confirmed, but none of the central adiposity variants individually showed significant associations. These findings suggest complex genetic relationships between menarche and overall obesity, and to a lesser extent central obesity, in normal processes of growth and development.
Collapse
Affiliation(s)
- Lindsay Fernández-Rhodes
- Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, 137 East Franklin Street, Suite 306, Campus Box 8050, Chapel Hill, NC 27514-8050, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
139
|
Murabito JM, Massaro JM, Clifford B, Hoffmann U, Fox CS. Depressive symptoms are associated with visceral adiposity in a community-based sample of middle-aged women and men. Obesity (Silver Spring) 2013; 21:1713-9. [PMID: 23666906 PMCID: PMC3748158 DOI: 10.1002/oby.20130] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/23/2011] [Accepted: 09/14/2012] [Indexed: 11/09/2022]
Abstract
OBJECTIVE To examine the relation between measures of adiposity and depressive symptoms in a large well characterized community-based sample, we examined the relations of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) to depressive symptoms in 1,581 women (mean age 52.2 years) and 1,718 men (mean age 49.8 years) in the Framingham Heart Study. DESIGN AND METHODS Depressive symptoms were measured using the Center for Epidemiologic Studies Depression (CES-D) scale. Regression models were created to examine the association between each fat depot (exposure) and depressive symptoms (outcome). Sex-specific models were adjusted for age, body mass index, smoking, alcohol consumption, diabetes, hypertension, total and HDL cholesterol, lipid lowering treatment, CVD, menopause, C-reactive protein, and physical activity. RESULTS Mean CES-D scores were 6.8 and 5.6 in women and men. High levels of depressive symptoms were present in 22.5% of women and 12.3% of men. In women, one standard deviation increase in VAT was associated with a 1.3 point higher CES-D score after adjusting for age and BMI (P < 0.01) and remained significant in the fully adjusted model (P = 0.03). The odds ratio of depressive symptoms per 1 standard deviation increase in VAT in women was 1.33 (P = 0.015); results were attenuated in fully adjusted models (OR 1.29, P = 0.055). In men, the association between VAT and CES-D score and depressive symptoms was not significant. SAT was not associated with CES-D score or depressive symptoms. CONCLUSIONS This study supports an association between VAT and depressive symptoms in women. Further work is needed to uncover the complex biologic mechanisms mediating the association.
Collapse
Affiliation(s)
- Joanne M Murabito
- Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Boston, Massachusetts, USA.
| | | | | | | | | |
Collapse
|
140
|
Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol 2013; 62:921-5. [PMID: 23850922 DOI: 10.1016/j.jacc.2013.06.027] [Citation(s) in RCA: 430] [Impact Index Per Article: 39.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/08/2012] [Revised: 05/28/2013] [Accepted: 06/18/2013] [Indexed: 01/10/2023]
Abstract
OBJECTIVES The aim of this study was to determine whether ectopic fat depots are prospectively associated with cardiovascular disease, cancer, and all-cause mortality. BACKGROUND The morbidity associated with excess body weight varies among individuals of similar body mass index. Ectopic fat depots may underlie this risk differential. However, prospective studies of directly measured fat are limited. METHODS Participants from the Framingham Heart Study (n = 3,086; 49% women; mean age of 50.2 years) underwent assessment of fat depots (visceral adipose tissue, pericardial adipose tissue, and periaortic adipose tissue) using multidetector computed tomography and were followed up longitudinally for a median of 5.0 years. Cox proportional hazards regression models were used to examine the association of each fat depot (per 1 SD increment) with the risk of incident cardiovascular disease, cancer, and all-cause mortality after adjustment for standard risk factors, including body mass index. RESULTS Overall, there were 90 cardiovascular events, 141 cancer events, and 71 deaths. After multivariable adjustment, visceral adipose tissue was associated with cardiovascular disease (hazard ratio: 1.44; 95% confidence interval: 1.08 to 1.92; p = 0.01) and cancer (hazard ratio: 1.43; 95% confidence interval: 1.12 to 1.84; p = 0.005). Addition of visceral adipose tissue to a multivariable model that included body mass index modestly improved cardiovascular risk prediction (net reclassification improvement of 16.3%). None of the fat depots were associated with all-cause mortality. CONCLUSIONS Visceral adiposity is associated with incident cardiovascular disease and cancer after adjustment for clinical risk factors and generalized adiposity. These findings support the growing appreciation of a pathogenic role of ectopic fat.
Collapse
Affiliation(s)
- Kathryn A Britton
- Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA
| | | | | | | | | | | |
Collapse
|
141
|
Rienstra M, Lyass A, Murabito JM, Magnani JW, Lubitz SA, Massaro JM, Ellinor PT, Benjamin EJ. Reciprocal relations between physical disability, subjective health, and atrial fibrillation: the Framingham Heart Study. Am Heart J 2013; 166:171-8. [PMID: 23816037 DOI: 10.1016/j.ahj.2013.02.025] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/28/2012] [Accepted: 02/28/2013] [Indexed: 10/26/2022]
Abstract
BACKGROUND Atrial fibrillation (AF)-related symptoms and physical performance are relied upon to guide therapeutic management of patients with AF. We sought to understand whether AF predisposes to or is a result of physical disability and poor subjective health in the community. METHODS We studied relations between physical disability (Rosow-Breslau Functional Health Scale), subjective health (self-report) and incident AF, and the converse, in the Framingham Heart Study. RESULTS In 3,609 participants (age 73 ± 8 years, 59% women), a subset of 861 participants (24%) had prevalent physical disability at baseline. During 5.8 ± 1.8 years of follow-up, 555 participants (10-year age- and sex-adjusted incidence rate 13%) developed incident AF. Prevalent physical disability was related to incident AF (multivariable-adjusted hazard ratio 1.25, 95% CI 1.02-1.54, P = .03). In 3,525 participants, prevalent poor subjective health (n = 333) also was related to incident AF (n = 552, multivariable-adjusted hazard ratio 1.31, 95% CI 1.00-1.70, P = .048). Conversely, in 2,080 participants (age 69 ± 6 years, 55% women), interim AF (n = 106) was associated with newly reported physical disability (n = 573) at a follow-up examination (multivariable-adjusted odds ratio 1.58, 95% CI 1.08-2.31, P = .01). In 1,954 participants, interim AF (n = 96) likewise was related to newly reported poor subjective health (n = 224, multivariable-adjusted odds ratio 1.83, 95% CI 1.10-3.02, P = .02). CONCLUSIONS Physical disability and poor subjective health were related to incident AF in a community-based cohort. Conversely, interim AF was related to newly reported physical disability and poor subjective health. Because AF guidelines incorporate symptoms, it is essential to clarify the temporality and mechanisms linking physical disability, subjective health, and AF.
Collapse
|
142
|
Cousminer DL, Berry DJ, Timpson NJ, Ang W, Thiering E, Byrne EM, Taal HR, Huikari V, Bradfield JP, Kerkhof M, Groen-Blokhuis MM, Kreiner-Møller E, Marinelli M, Holst C, Leinonen JT, Perry JR, Surakka I, Pietiläinen O, Kettunen J, Anttila V, Kaakinen M, Sovio U, Pouta A, Das S, Lagou V, Power C, Prokopenko I, Evans DM, Kemp JP, St Pourcain B, Ring S, Palotie A, Kajantie E, Osmond C, Lehtimäki T, Viikari JS, Kähönen M, Warrington NM, Lye SJ, Palmer LJ, Tiesler CM, Flexeder C, Montgomery GW, Medland SE, Hofman A, Hakonarson H, Guxens M, Bartels M, Salomaa V, Murabito JM, Kaprio J, Sørensen TI, Ballester F, Bisgaard H, Boomsma DI, Koppelman GH, Grant SF, Jaddoe VW, Martin NG, Heinrich J, Pennell CE, Raitakari OT, Eriksson JG, Smith GD, Hyppönen E, Järvelin MR, McCarthy MI, Ripatti S, Widén E. Genome-wide association and longitudinal analyses reveal genetic loci linking pubertal height growth, pubertal timing and childhood adiposity. Hum Mol Genet 2013; 22:2735-47. [PMID: 23449627 PMCID: PMC3674797 DOI: 10.1093/hmg/ddt104] [Citation(s) in RCA: 133] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2012] [Accepted: 02/25/2013] [Indexed: 01/18/2023] Open
Abstract
The pubertal height growth spurt is a distinctive feature of childhood growth reflecting both the central onset of puberty and local growth factors. Although little is known about the underlying genetics, growth variability during puberty correlates with adult risks for hormone-dependent cancer and adverse cardiometabolic health. The only gene so far associated with pubertal height growth, LIN28B, pleiotropically influences childhood growth, puberty and cancer progression, pointing to shared underlying mechanisms. To discover genetic loci influencing pubertal height and growth and to place them in context of overall growth and maturation, we performed genome-wide association meta-analyses in 18 737 European samples utilizing longitudinally collected height measurements. We found significant associations (P < 1.67 × 10(-8)) at 10 loci, including LIN28B. Five loci associated with pubertal timing, all impacting multiple aspects of growth. In particular, a novel variant correlated with expression of MAPK3, and associated both with increased prepubertal growth and earlier menarche. Another variant near ADCY3-POMC associated with increased body mass index, reduced pubertal growth and earlier puberty. Whereas epidemiological correlations suggest that early puberty marks a pathway from rapid prepubertal growth to reduced final height and adult obesity, our study shows that individual loci associating with pubertal growth have variable longitudinal growth patterns that may differ from epidemiological observations. Overall, this study uncovers part of the complex genetic architecture linking pubertal height growth, the timing of puberty and childhood obesity and provides new information to pinpoint processes linking these traits.
Collapse
Affiliation(s)
| | - Diane J. Berry
- Centre for Paediatric Epidemiology and Biostatistics, MRC Centre for Epidemiology of Child Health, UCL Institute of Child Health, London, UK
| | - Nicholas J. Timpson
- The Medical Research Council (MRC) Centre for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine
| | - Wei Ang
- School of Women's and Infants' Health, The University of Western Australia, Perth, WA, Australia
| | - Elisabeth Thiering
- Institute of Epidemiology I, Helmholtz Zentrum München— German Research Center for Environmental Health, Neuherberg, Germany
| | - Enda M. Byrne
- Queensland Institute of Medical Research, Brisbane, Australia
| | - H. Rob Taal
- The Generation R Study Group
- Department of Epidemiology
- Department of Pediatrics, Erasmus Medical Center, Rotterdam, The Netherlands
| | | | | | | | - Maria M. Groen-Blokhuis
- Netherlands Twin Register, Department of Biological Psychology, VU University, Amsterdam, The Netherlands
| | - Eskil Kreiner-Møller
- Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Denmark
| | - Marcella Marinelli
- Center for Research in Environmental Epidemiology (CREAL), Barcelona, Catalonia, Spain
- Hospital del Mar Research Institute (IMIM), Barcelona, Catalonia, Spain
- CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Catalonia, Spain
| | - Claus Holst
- Institute of Preventive Medicine, Copenhagen University Hospital, Copenhagen, Denmark
| | | | - John R.B. Perry
- Genetics of Complex Traits, Exeter medical school, University of Exeter, Exeter, UK
- Wellcome Trust Centre for Human Genetics
- Department of Twin Research and Genetic Epidemiology, King's College London, London, UK
| | - Ida Surakka
- Institute for Molecular Medicine, Finland (FIMM)
- Department of Chronic Disease Prevention
| | - Olli Pietiläinen
- Institute for Molecular Medicine, Finland (FIMM)
- The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
| | - Johannes Kettunen
- Institute for Molecular Medicine, Finland (FIMM)
- Department of Chronic Disease Prevention
| | - Verneri Anttila
- Institute for Molecular Medicine, Finland (FIMM)
- The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
- Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA
- Analytical and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
| | - Marika Kaakinen
- Institute of Health Sciences
- Biocenter Oulu, University of Oulu, Oulu, PO Box 5000, FI-90014, Finland
| | - Ulla Sovio
- Department of Epidemiology and Biostatistics, School of Public Health
- Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK
| | - Anneli Pouta
- Biocenter Oulu, University of Oulu, Oulu, PO Box 5000, FI-90014, Finland
| | - Shikta Das
- Department of Epidemiology and Biostatistics, School of Public Health
| | - Vasiliki Lagou
- Wellcome Trust Centre for Human Genetics
- Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
| | - Chris Power
- Centre for Paediatric Epidemiology and Biostatistics, MRC Centre for Epidemiology of Child Health, UCL Institute of Child Health, London, UK
| | - Inga Prokopenko
- Wellcome Trust Centre for Human Genetics
- Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
| | - David M. Evans
- The Medical Research Council (MRC) Centre for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine
| | - John P. Kemp
- The Medical Research Council (MRC) Centre for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine
- School of Social and Community Medicine, University of Bristol, Bristol, UK
| | - Beate St Pourcain
- School of Social and Community Medicine, University of Bristol, Bristol, UK
| | - Susan Ring
- School of Social and Community Medicine, University of Bristol, Bristol, UK
| | - Aarno Palotie
- Institute for Molecular Medicine, Finland (FIMM)
- The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
- Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA, USA
| | - Eero Kajantie
- Department of Chronic Disease Prevention
- Hospital for Children and Adolescents, Helsinki University Central Hospital and University of Helsinki, Helsinki, Finland
| | - Clive Osmond
- MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK
| | - Terho Lehtimäki
- Department of Clinical Chemistry, Fimlab Laboratories, University Hospital and University of Tampere, Finland
| | | | - Mika Kähönen
- Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku; Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Finland
| | - Nicole M. Warrington
- School of Women's and Infants' Health, The University of Western Australia, Perth, WA, Australia
| | - Stephen J. Lye
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
| | - Lyle J. Palmer
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada
- Ontario Institute for Cancer Research, Toronto, Ontario, Canada
| | - Carla M.T. Tiesler
- Institute of Epidemiology I, Helmholtz Zentrum München— German Research Center for Environmental Health, Neuherberg, Germany
- Division of Metabolic Diseases and Nutritional Medicine, Ludwig-Maximilians-University of Munich, Dr von Hauner Children's Hospital, Munich, Germany
| | - Claudia Flexeder
- Institute of Epidemiology I, Helmholtz Zentrum München— German Research Center for Environmental Health, Neuherberg, Germany
| | | | | | - Albert Hofman
- The Generation R Study Group
- Department of Epidemiology
| | - Hakon Hakonarson
- Center for Applied Genomics
- Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA
- Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Mònica Guxens
- Center for Research in Environmental Epidemiology (CREAL), Barcelona, Catalonia, Spain
- Hospital del Mar Research Institute (IMIM), Barcelona, Catalonia, Spain
- CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Catalonia, Spain
| | - Meike Bartels
- Netherlands Twin Register, Department of Biological Psychology, VU University, Amsterdam, The Netherlands
| | | | | | - Joanne M. Murabito
- Department of Medicine, Section of General Internal Medicine, Boston University School of Medicine, Boston, MA, USA
| | - Jaakko Kaprio
- Institute for Molecular Medicine, Finland (FIMM)
- Department of Public Health
- Department of Mental Health & Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland
| | - Thorkild I.A. Sørensen
- Institute of Preventive Medicine, Copenhagen University Hospital, Copenhagen, Denmark
- The Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark
| | - Ferran Ballester
- CIBER Epidemiologia y Salud Pública (CIBERESP), Barcelona, Catalonia, Spain
- Division of Environment and Health, Center for Public Health Research (CSISP), Valencia, Spain
- School of Nursing, University of Valencia, Valencia, Spain
| | - Hans Bisgaard
- Copenhagen Prospective Studies on Asthma in Childhood, Health Sciences, University of Copenhagen, Copenhagen University Hospital, Gentofte, Denmark
| | - Dorret I. Boomsma
- Netherlands Twin Register, Department of Biological Psychology, VU University, Amsterdam, The Netherlands
| | - Gerard H. Koppelman
- Department of Pediatric Pulmonology and Pediatric Allergology, GRIAC Research Institute, Beatrix Children's Hospital, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| | - Struan F.A. Grant
- Center for Applied Genomics
- Division of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA
- Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
| | - Vincent W.V. Jaddoe
- The Generation R Study Group
- Department of Epidemiology
- Department of Pediatrics, Erasmus Medical Center, Rotterdam, The Netherlands
| | | | - Joachim Heinrich
- Institute of Epidemiology I, Helmholtz Zentrum München— German Research Center for Environmental Health, Neuherberg, Germany
| | - Craig E. Pennell
- School of Women's and Infants' Health, The University of Western Australia, Perth, WA, Australia
| | - Olli T. Raitakari
- Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku; Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Finland
| | - Johan G. Eriksson
- Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland
- Department of Chronic Disease Prevention
- Unit of General Practice
- Folkhalsan Research Centre, Helsinki, Finland
| | - George Davey Smith
- The Medical Research Council (MRC) Centre for Causal Analyses in Translational Epidemiology, School of Social and Community Medicine
| | - Elina Hyppönen
- Centre for Paediatric Epidemiology and Biostatistics, MRC Centre for Epidemiology of Child Health, UCL Institute of Child Health, London, UK
| | - Marjo-Riitta Järvelin
- Institute of Health Sciences
- Biocenter Oulu, University of Oulu, Oulu, PO Box 5000, FI-90014, Finland
- Department of Epidemiology and Biostatistics, MRC Health Protection Agency (HPA) Centre for Environment and Health, School of Public Health, Imperial College, London, UK
- Unit of Primary Care, Oulu University Hospital, Kajaanintie 50, PO Box 20, FI-90220 Oulu, 90029 OYS, Finland
- Department of Children and Young People and Families, National Institute for Health and Welfare, Aapistie 1, Box 310, FI-90101 Oulu, Finland
| | - Mark I. McCarthy
- Wellcome Trust Centre for Human Genetics
- Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK
- Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford OX3 7LJ, UK
| | - Samuli Ripatti
- Institute for Molecular Medicine, Finland (FIMM)
- Department of Chronic Disease Prevention
- The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
| | | | | |
Collapse
|
143
|
Glazer NL, Lyass A, Esliger DW, Blease SJ, Freedson PS, Massaro JM, Murabito JM, Vasan RS. Sustained and shorter bouts of physical activity are related to cardiovascular health. Med Sci Sports Exerc 2013; 45:109-15. [PMID: 22895372 DOI: 10.1249/mss.0b013e31826beae5] [Citation(s) in RCA: 137] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
PURPOSE Whereas greater physical activity (PA) is known to prevent cardiovascular disease (CVD), the relative importance of performing PA in sustained bouts of activity versus shorter bouts of activity on CVD risk is not known. The objective of this study was to investigate the relationship between moderate-to-vigorous PA (MVPA), measured in bouts ≥10 and <10 min, and CVD risk factors in a well-characterized community-based sample of white adults. METHODS We conducted a cross-sectional analysis of 2109 participants in the Third Generation Cohort of the Framingham Heart Study (mean age = 47 yr, 55% women) who underwent objective assessment of PA by accelerometry over 5-7 d. Total MVPA, MVPA done in bouts ≥10 min (MVPA(10+)), and MVPA done in bouts <10 min (MVPA(<10)) were calculated. MVPA exposures were related to individual CVD risk factors, including measures of adiposity and blood lipid and glucose levels, using linear and logistic regression. RESULTS Total MVPA was significantly associated with higher HDL levels and with lower triglycerides, BMI, waist circumference, and Framingham risk score (P < 0.0001). MVPA(<10) showed similar statistically significant associations with these CVD risk factors (P < 0.001). Compliance with national guidelines (≥150 min of total MVPA) was significantly related to lower BMI, triglycerides, Framingham risk score, waist circumference, higher HDL, and a lower prevalence of obesity and impaired fasting glucose (P < 0.001 for all). CONCLUSIONS Our cross-sectional observations on a large middle-age community-based sample confirm a positive association of MVPA with a healthier CVD risk factor profile and indicate that accruing PA in bouts <10 min may favorably influence cardiometabolic risk. Additional investigations are warranted to confirm our findings.
Collapse
Affiliation(s)
- Nicole L Glazer
- Section of Preventive Medicine, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
| | | | | | | | | | | | | | | |
Collapse
|
144
|
Rosenquist KJ, Pedley A, Massaro JM, Therkelsen KE, Murabito JM, Hoffmann U, Fox CS. Visceral and subcutaneous fat quality and cardiometabolic risk. JACC Cardiovasc Imaging 2013; 6:762-71. [PMID: 23664720 DOI: 10.1016/j.jcmg.2012.11.021] [Citation(s) in RCA: 156] [Impact Index Per Article: 14.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/26/2012] [Accepted: 11/09/2012] [Indexed: 01/07/2023]
Abstract
OBJECTIVES The aim of this study was to evaluate whether computed tomography (CT) attenuation, as a measure of fat quality, is associated with cardiometabolic risk factors above and beyond fat quantity. BACKGROUND Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) are pathogenic fat depots associated with cardiometabolic risk. Adipose tissue attenuation in CT images is variable, similar to adipose tissue volume. However, whether the quality of abdominal fat attenuation is associated with cardiometabolic risk independent of the quantity is uncertain. METHODS Participants were drawn from the Framingham Heart Study CT substudy. The VAT and SAT volumes were acquired by semiquantitative assessment. Fat quality was measured by CT attenuation and recorded as mean Hounsfield unit (HU) within each fat depot. Sex-specific linear and logistic multivariable regression models were used to assess the association between standard deviation (SD) decrease in HU and each risk factor. RESULTS Lower CT attenuation of VAT and SAT was correlated with higher body mass index levels in both sexes. Risk factors were generally more adverse with decreasing HU values. For example, in women, per 1 SD decrease in VAT HU, the odds ratio (OR) was increased for hypertension (OR: 1.80), impaired fasting glucose (OR: 2.10), metabolic syndrome (OR: 3.65), and insulin resistance (OR: 3.36; all p < 0.0001). In models that further adjusted for VAT volume, impaired fasting glucose, metabolic syndrome, and insulin resistance remained significant. Trends were similar but less pronounced for SAT and for men. There was evidence of an interaction between HU and fat volume among both women and men. CONCLUSIONS Lower CT attenuation of VAT and SAT is associated with adverse cardiometabolic risk above and beyond total adipose tissue volume. Qualitative indices of abdominal fat depots may provide insight regarding cardiometabolic risk independent of fat quantity.
Collapse
Affiliation(s)
- Klara J Rosenquist
- Division of Endocrinology and Metabolism, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA
| | | | | | | | | | | | | |
Collapse
|
145
|
Schnabel RB, Yin X, Larson MG, Yamamoto JF, Fontes JD, Kathiresan S, Rong J, Levy D, Keaney JF, Wang TJ, Murabito JM, Vasan RS, Benjamin EJ. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol 2013; 33:1728-33. [PMID: 23640499 DOI: 10.1161/atvbaha.112.301174] [Citation(s) in RCA: 73] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
OBJECTIVE Evidence suggests that chronic low-grade inflammation and oxidative stress are related to cardiovascular disease (CVD) and mortality. APPROACH AND RESULTS We examined 11 established and novel biomarkers representing inflammation and oxidative stress (C-reactive protein, fibrinogen, interleukin-6, intercellular adhesion molecule-1, lipoprotein-associated phospholipase-A2 [mass and activity], monocyte chemoattractant protein-1, myeloperoxidase, CD40 ligand, P-selectin, and tumor necrosis factor receptor II [TNFRII]) in relation to incident major CVD and mortality in the community. We studied 3035 participants (mean age, 61 ± 9 years; 53% women). During follow-up (median, 8.9 years), 253 participants experienced a CVD event and 343 died. C-reactive protein (hazard ratio [HR] reported per SD ln-transformed biomarker, 1.18; 95% confidence interval [CI], 1.02-1.35; nominal P=0.02) and TNFRII (HR, 1.15; 95% CI, 1.01-1.32; nominal P=0.04) were retained in multivariable-adjusted models for major CVD, but were not significant after adjustment for multiple testing. The biomarkers related to mortality were TNFRII (HR, 1.33; 95% CI, 1.19-1.49; P<0.0001), ICAM-1 (HR, 1.24; 95% CI, 1.12-1.37; P<0.0001), and interleukin-6 (HR, 1.25; 95% CI, 1.12-1.39; P<0.0001). The addition of these markers to the model, including traditional risk factors, increased discrimination and reclassification for risk of death (P<0.0001), but not for CVD. CONCLUSIONS Of 11 inflammatory biomarkers tumor necrosis factor receptor II was related to cardiovascular disease and mortality in the Framingham Heart Study. The combination of TNFRII with C-reactive protein in relation to CVD and with interleukin-6 to mortality increased the predictive ability in addition to CVD risk factors for total mortality but not for incident CVD.
Collapse
Affiliation(s)
- Renate B Schnabel
- Framingham Heart Study, National Heart, Lung, and Blood Institute, Framingham, MA, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
146
|
Demerath EW, Liu CT, Franceschini N, Chen G, Palmer JR, Smith EN, Chen CTL, Ambrosone CB, Arnold AM, Bandera EV, Berenson GS, Bernstein L, Britton A, Cappola AR, Carlson CS, Chanock SJ, Chen W, Chen Z, Deming SL, Elks CE, Evans MK, Gajdos Z, Henderson BE, Hu JJ, Ingles S, John EM, Kerr KF, Kolonel LN, Le Marchand L, Lu X, Millikan RC, Musani SK, Nock NL, North K, Nyante S, Press MF, Rodriquez-Gil JL, Ruiz-Narvaez EA, Schork NJ, Srinivasan SR, Woods NF, Zheng W, Ziegler RG, Zonderman A, Heiss G, Gwen Windham B, Wellons M, Murray SS, Nalls M, Pastinen T, Rajkovic A, Hirschhorn J, Adrienne Cupples L, Kooperberg C, Murabito JM, Haiman CA. Genome-wide association study of age at menarche in African-American women. Hum Mol Genet 2013; 22:3329-46. [PMID: 23599027 DOI: 10.1093/hmg/ddt181] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
African-American (AA) women have earlier menarche on average than women of European ancestry (EA), and earlier menarche is a risk factor for obesity and type 2 diabetes among other chronic diseases. Identification of common genetic variants associated with age at menarche has a potential value in pointing to the genetic pathways underlying chronic disease risk, yet comprehensive genome-wide studies of age at menarche are lacking for AA women. In this study, we tested the genome-wide association of self-reported age at menarche with common single-nucleotide polymorphisms (SNPs) in a total of 18 089 AA women in 15 studies using an additive genetic linear regression model, adjusting for year of birth and population stratification, followed by inverse-variance weighted meta-analysis (Stage 1). Top meta-analysis results were then tested in an independent sample of 2850 women (Stage 2). First, while no SNP passed the pre-specified P < 5 × 10(-8) threshold for significance in Stage 1, suggestive associations were found for variants near FLRT2 and PIK3R1, and conditional analysis identified two independent SNPs (rs339978 and rs980000) in or near RORA, strengthening the support for this suggestive locus identified in EA women. Secondly, an investigation of SNPs in 42 previously identified menarche loci in EA women demonstrated that 25 (60%) of them contained variants significantly associated with menarche in AA women. The findings provide the first evidence of cross-ethnic generalization of menarche loci identified to date, and suggest a number of novel biological links to menarche timing in AA women.
Collapse
Affiliation(s)
- Ellen W Demerath
- Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
147
|
Rahmani M, Earp MA, Ramezani Tehrani F, Ataee M, Wu J, Treml M, Nudischer R, P-Behnami S, Perry JRB, Murabito JM, Azizi F, Brooks-Wilson A. Shared genetic factors for age at natural menopause in Iranian and European women. Hum Reprod 2013; 28:1987-94. [PMID: 23592221 DOI: 10.1093/humrep/det106] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
STUDY QUESTION Do differences in heritable genetic factors explain some of the difference in age at natural menopause (ANM) among populations? SUMMARY ANSWER One single nucleotide polymorphism (SNP)-ANM association (rs16991615) detected in European women was replicated in Iranian women. WHAT IS KNOWN ALREADY Genetics plays an important role in ANM, and well-powered genome-wide association studies (GWAS) of ANM performed in European women have discovered many statistically significant SNP-ANM associations. Average ANM varies by ethnicity, and population-specific differences in ANM-associated alleles may in part explain these differences. STUDY DESIGN, SIZE, DURATION After quality control procedures, 97 SNPs were analyzed in genotype data of 828 Iranian women who experienced natural menopause. SNP genotyping data were used to perform linear regression analyses with ANM as a quantitative trait. Study participants were drawn from the population-based Tehran Lipid and Glucose Study based in Tehran, Iran. This study was performed between February 2009 and March 2012. PARTICIPANTS/MATERIALS, SETTING AND METHODS Based on an ANM-GWAS literature review, eight SNPs at four loci previously associated with ANM in European women were tested for replication in Iranian women. Linear regression analyses were performed including (n = 828) and excluding (n = 783) women who experience premature ovarian failure (ANM before 40 years of age). In addition, to search for novel population-specific ANM risk alleles, a pool-based GWAS was performed using this collection of Iranian women. Two DNA pools were constructed and compared: an 'early' ANM pool (lower 20(th) percentile of menopause ages, 40-45 years, n = 165) and a 'late' ANM pool (upper 20(th) percentile of menopause ages, 54-65 years, n = 187). Each DNA pool was assayed on four Illumina Human1M-Duo arrays, and allele-based tests of association were used to rank SNPs. One hundred and two highly ranked SNPs were chosen for individual genotyping by Sequenom MassARRAY and association analysis in the Iranian women. MAIN RESULTS AND THE ROLE OF CHANCE One SNP-ANM association previously detected in European women was replicated in Iranian women (rs16991615; β = 1.07, standard error (SE): 0.49, P = 0.02). SNPs at the previously reported 19q13.42 and 6p24.2 loci also approached statistical significance and had consistent SNP effects (magnitude and direction) in Iranian women (rs1172822; β = -0.39, SE: 0.22, P = 0.08; and rs2153157, β = 0.41, SE: 0.21, P = 0.05). We found little evidence for novel SNP-ANM associations in Iranian women; no SNP selected based on the pool-based GWAS achieved genome-wide significance. LIMITATIONS, REASONS FOR CAUTION Due to small sample size this study was powered to reliably detect only moderate-to-large SNP effect sizes. This limited our ability to replicate many of the previously reported SNP-ANM risk alleles and to discover novel SNP-ANM associations' specific to the Iranian population. In performing our pool-based GWAS, a reduction in power was introduced relative to a conventional GWAS. WIDER IMPLICATIONS OF THE FINDINGS Our results imply that European and Iranian women share ANM-associated genetic variants. Our study was underpowered but for all SNPs tested the direction of the effect was consistent with data from the European study. Therefore, we anticipate that many (if not all) of the ANM-associated SNPs discovered in European women will replicate in Iranian women upon genotyping a sufficient number of women. Our data do not support the hypothesis that population-specific SNP-ANM associations explain population-specific differences in the mean ANM.
Collapse
Affiliation(s)
- Maziar Rahmani
- Canada's Michael Smith Genome Sciences Center, BC Cancer Agency, Vancouver, BC, Canada
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
148
|
Haring R, Teng Z, Xanthakis V, Coviello A, Sullivan L, Bhasin S, Murabito JM, Wallaschofski H, Vasan RS. Association of sex steroids, gonadotrophins, and their trajectories with clinical cardiovascular disease and all-cause mortality in elderly men from the Framingham Heart Study. Clin Endocrinol (Oxf) 2013; 78:629-34. [PMID: 22901104 PMCID: PMC4161203 DOI: 10.1111/cen.12013] [Citation(s) in RCA: 59] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/17/2012] [Revised: 04/25/2012] [Accepted: 08/09/2012] [Indexed: 11/28/2022]
Abstract
BACKGROUND Emerging data from longitudinal studies suggest that low sex steroid concentrations in men are associated with increased cardiovascular risk and mortality. The impact of longitudinal trajectory patterns from serial sex steroid and gonadotrophin measurements on the observed associations is unknown to date. METHODS We prospectively evaluated 254 elderly men (mean age, 75·5 years) of the Framingham Heart Study with up to four serial measurements of serum total testosterone (TT), dehydroepiandrosterone sulphate (DHEAS), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and total estradiol (EST); and constructed age- and multivariable-adjusted Cox proportional hazard regression models relating baseline hormone concentrations and their mean, slope and variation over time (modelled as continuous and categorized into quartiles) to the incidence of clinical cardiovascular disease (CVD) and all-cause mortality at 5- and 10-year follow-up. RESULTS We observed no association between baseline concentrations of sex steroids, gonadotrophins and their trajectories with incident clinical CVD over 5- and 10-year follow-up. Although higher baseline TT concentrations were associated with lower mortality risk at 5 years (hazard ratio per quartile increment, 0·74; 95% confidence interval, 0·56-0·98), correction for multiple statistical testing (P < 0·005) rendered this association statistically nonsignificant. Repeat analyses at the 10-year follow-up time point also demonstrated no significant association between sex steroids, gonadotrophins or their trajectories and mortality. CONCLUSION Investigating longitudinal trajectory patterns of serial sex steroid and gonadotrophin measurements, the present study found no consistent associations with incident clinical CVD and all-cause mortality risk in elderly men from the community.
Collapse
Affiliation(s)
- Robin Haring
- Preventive Medicine & Epidemiology Section, School of Medicine, Boston University, Boston, MA, USA.
| | | | | | | | | | | | | | | | | |
Collapse
|
149
|
Pearson TA, Palaniappan LP, Artinian NT, Carnethon MR, Criqui MH, Daniels SR, Fonarow GC, Fortmann SP, Franklin BA, Galloway JM, Goff DC, Heath GW, Frank ATH, Kris-Etherton PM, Labarthe DR, Murabito JM, Sacco RL, Sasson C, Turner MB. American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation 2013; 127:1730-53. [PMID: 23519758 DOI: 10.1161/cir.0b013e31828f8a94] [Citation(s) in RCA: 165] [Impact Index Per Article: 15.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
150
|
Abstract
The field of the "epidemiology of longevity" has been expanding rapidly in recent years. Several long-term cohort studies have followed older adults long enough to identify the most long-lived and to define many factors that lead to a long life span. Very long-lived people such as centenarians have been examined using case-control study designs. Both cohort and case-control studies have been the subject of genome-wide association studies that have identified genetic variants associated with longevity. With growing recognition of the importance of rare variations, family studies of longevity will be useful. Most recently, exome and whole-genome sequencing, gene expression, and epigenetic studies have been undertaken to better define functional variation and regulation of the genome. In this review, we consider how these studies are leading to a deeper understanding of the underlying biologic pathways to longevity.
Collapse
|